Development of liquid crystal-based system for biomolecule and nanomaterial characterization by DENY HARTONO
 DEVELOPMENT OF LIQUID CRYSTAL-BASED SYSTEM FOR 















NATIONAL UNIVERSITY OF SINGAPORE 
2009 
 DEVELOPMENT OF LIQUID CRYSTAL-BASED SYSTEM FOR 












A THESIS SUBMITTED  
FOR THE DEGREE OF DOCTOR OF PHILOSOPHY 
DEPARTMENT OF CHEMICAL AND BIOMOLECULAR ENGINEERING 


























I would like to sincerely express my greatest gratitude to everyone who has had a 
role in shaping my education, especially in my Ph.D. study. – My grandmother, without 
whom, I would not have put much thought to pursue my Ph.D. National University of 
Singapore and AUN/SEED-Net for giving me a research scholarship opportunity to 
pursue my Ph.D. My supervisor, Dr. Lin-Yue Lanry Yung, without his help, it would 
have been impossible for me to accomplish my Ph.D. study. Special thanks to him for 
giving me a large amount of freedom in doing my doctoral research, in a way that I have 
constantly been challenged to create new problems, new solutions and new ways to think. 
My co-supervisor, Dr. Kun-Lin Yang, without him, I would have never known the beauty 
of liquid crystals and the wonders of surface chemistry. I deeply appreciate his sound 
advices throughout my Ph.D. study. Lab technologists, Mdm. Li Xiang, Mdm. Li 
Fengmei, Mr. Jasin, Mr. Boey Kok Hong, Ms. Lee Chai Keeng, Ms. Novel Chew, Ms. 
Alyssa Tay, and professional officers, Mr. Chia Phai Ann, Mdm. Zhang Jixuan, for 
helping me in numerous administration issues and in using many technical 
instrumentations. My family who has given me indescribable and endless supports 
throughout my Ph.D. study. Friends and fellow graduate students in Dr. Yung’s and Dr. 
Yang’s lab, past and present, with them I have shared many encouragement words as well 
as many precious moments during my Ph.D. study. 
 ii
TABLE OF CONTENTS 
ACKNOWLEDGEMENTS................................................................................................. i 
TABLE OF CONTENTS.................................................................................................... ii 
SUMMARY....................................................................................................................... vi 
LIST OF FIGURES ........................................................................................................... ix 
LIST OF TABLES........................................................................................................... xiv 
 
CHAPTER 1. Introduction.................................................................................................. 1 
1.1 Motivation................................................................................................................. 1 
1.2 References................................................................................................................. 5 
 
CHAPTER 2. Literature Review ........................................................................................ 6 
2.1 Liquid Crystals.......................................................................................................... 6 
2.1.2 Properties of liquid crystals ............................................................................... 9 
2.1.2.1 Anisotropic properties of liquid crystals..................................................... 9 
2.1.2.2 Anchoring angles of liquid crystals .......................................................... 11 
2.1.2.3 Optical appearances of liquid crystals ...................................................... 11 
2.1.2.3.1 Planar anchoring ................................................................................ 12 
2.1.2.3.2 Homeotropic anchoring ..................................................................... 14 
2.1.3 Application of liquid crystals as sensor ........................................................... 14 
2.2 Cell membranes ...................................................................................................... 19 
2.2.1 Biological cell membranes............................................................................... 19 
2.2.2 Biomimetic cell membranes ............................................................................ 22 
2.2.2.1 Vesicles ..................................................................................................... 23 
2.2.2.2 Supported lipid bilayer.............................................................................. 25 
2.2.2.3 Lipid monolayer........................................................................................ 28 
2.3 Gold nanoparticles .................................................................................................. 30 
2.3.1 Synthesis of gold nanoparticles ....................................................................... 30 
2.3.2 Properties of gold nanoparticle ........................................................................ 35 
2.3.2.1 Surface plasmon resonance of gold nanoparticles .................................... 35 
2.3.2.2 Scattering of gold nanoparticles................................................................ 37 
2.3.2.3 Fluorescence of gold nanoparticles........................................................... 38 
2.3.3 Application of gold nanoparticles.................................................................... 39 
2.3.4 Cytotoxicity of gold nanoparticles................................................................... 44 
2.4 References............................................................................................................... 48 
 
CHAPTER 3. An Air-supported Liquid Crystal System for Real-time and Label-free 
Characterization of Phospholipases and Their Inhibitors ................................................. 56 
3.2 Experimental Section .............................................................................................. 59 
3.2.2 Preparation of phospholipid solution ............................................................... 60 
3.2.3 Preparation of the air-supported LC system .................................................... 61 
3.2.4 Formation of phospholipid monolayer............................................................. 62 
3.2.5 Enzymatic activity assay.................................................................................. 62 
3.2.6 Optical examination of LC orientation ............................................................ 62 
3.3 Results and Discussion ........................................................................................... 63 
 iii
3.3.1 Design of the air-supported LC system ........................................................... 63 
3.3.2 Enzymatic hydrolysis of phospholipid monolayer by phospholipases ............ 65 
3.3.3 Inhibition of phospholipase activity................................................................. 71 
3.4 Conclusion .............................................................................................................. 75 
3.5 References............................................................................................................... 76 
 
CHAPTER 4. A Liquid Crystal-based Sensor for Real-time and Label-free Identification 
of Phospholipase-like Toxins and Their Inhibitors........................................................... 78 
4.1 Introduction............................................................................................................. 78 
4.2 Experimental Section .............................................................................................. 80 
4.2.1 Materials .......................................................................................................... 80 
4.2.2 Preparation of the air-supported LC optical cell.............................................. 80 
4.2.3 Formation of phospholipid monolayer............................................................. 81 
4.2.4 LC-based sensor for phospholipase-like toxin testing ..................................... 82 
4.2.5 Optical examination of LC textures................................................................. 82 
4.3 Results and discussion ............................................................................................ 83 
4.3.1 Self-assembly of phospholipid monolayer at aqueous-LC interface ............... 83 
4.3.2 Identification of phospholipase-like toxin ....................................................... 83 
4.3.3 Identification of phospholipase-like toxin inhibitors....................................... 89 
4.3.4 Sensor regeneration.......................................................................................... 90 
4.4 Conclusion .............................................................................................................. 92 
4.5 References............................................................................................................... 94 
 
CHAPTER 5. Decorating Liquid Crystal Surfaces with Proteins for Real-time Detection 
of Specific Protein-Protein Binding.................................................................................. 95 
5.1. Introduction............................................................................................................ 95 
5.2 Experimental Section .............................................................................................. 98 
5.2.1 Materials .......................................................................................................... 98 
5.2.2 Preparation of amphiphile solutions ................................................................ 98 
5.2.3 Preparation of LC optical cells ........................................................................ 99 
5.2.4 Formation of amphiphile monolayers............................................................ 100 
5.2.5 Immobilization of histidine-tagged protein and specific antigen-antibody 
binding events ......................................................................................................... 100 
5.2.6 Optical examination of LC orientation .......................................................... 101 
5.3 Results and Discussion ......................................................................................... 101 
5.3.1 Self-assembly of amphiphiles on LC surface ................................................ 101 
5.3.2 Protein immobilization on LC surface........................................................... 103 
5.3.3 Specific protein-protein binding events on LC surface ................................. 108 
5.4 Conclusion ............................................................................................................ 112 
5.5 References............................................................................................................. 112 
 
CHAPTER 6. Imaging Disruption of Phospholipid Monolayer by Protein-coated 
Nanoparticles Using Ordering Transitions of Liquid Crystals ....................................... 114 
6.1 Introduction........................................................................................................... 114 
6.2 Experimental Section ............................................................................................ 117 
6.2.1 Materials ........................................................................................................ 117 
 iv
6.2.2 Preparation of phospholipid solutio ............................................................... 118 
6.2.3 Preparation of DMOAP-coated glass slides .................................................. 118 
6.2.4 Preparation of optical cells............................................................................. 119 
6.2.5 Optical examination of LC orientation .......................................................... 120 
6.2.6 Formation of phospholipid monolayer........................................................... 120 
6.2.7 Preparation of gold nanoparticle solution ...................................................... 121 
6.2.8 Protein adsorption on gold nanoparticles....................................................... 122 
6.3 Results and Discussion ......................................................................................... 122 
6.3.1 Interaction between citrate-stabilized gold nanoparticles and phospholipid 
monolayer laden on liquid crystals ......................................................................... 122 
6.3.2 Interaction between protein-coated gold nanoparticles and phospholipid 
monolayer ............................................................................................................... 124 
6.3.3 Driving force for the binding of protein-coated gold nanoparticles to 
L-DLPC monolayer ................................................................................................ 126 
6.4 Conclusion ............................................................................................................ 130 
6.5 References............................................................................................................. 131 
 
CHAPTER 7. Effect of cholesterol on nanoparticle binding to liquid crystal-supported 
cell membrane model...................................................................................................... 133 
7.1 Introduction........................................................................................................... 133 
7.2 Experimental Section ............................................................................................ 136 
7.2.1 Materials ........................................................................................................ 136 
7.2.2 Preparation of phospholipid, cholesterol and mixed phospholipid/cholesterol 
solutions .................................................................................................................. 137 
7.2.3 Preparation of DMOAP-coated glass slides .................................................. 138 
7.2.4 Preparation of optical cells............................................................................. 138 
7.2.5 Optical examination of LC orientation .......................................................... 139 
7.2.6 Self-assembly of phospholipid/cholesterol monolayer at aqueous-LC interface
................................................................................................................................. 140 
7.2.7 Oxidation of cholesterol at aqueous-LC interface using cholesterol oxidase 140 
7.2.9 Protein adsorption on gold nanoparticles....................................................... 141 
7.3 Results and Discussion ......................................................................................... 141 
7.3.1 Self-assembly of phospholipids and cholesterol at aqueous-LC interface .... 141 
7.3.2 Interactions between mixed phospholipid-cholesterol monolayer and protein-
coated gold nanoparticles........................................................................................ 145 
7.3.3 Driving force for the disruption of mixed phospholipid/cholesterol monolayer 
by protein-coated AuNPs........................................................................................ 148 
7.3.4 Comparison of specific and non-specific interactions between protein-coated 
gold nanoparticles and LC-supported cell membrane model ................................. 151 
7.4 Conclusion ............................................................................................................ 154 
7.5 References............................................................................................................. 155 
 
CHAPTER 8. Conclusions and Recommendations ........................................................ 157 
8.1 Conclusions........................................................................................................... 157 
8.2 Recommendation .................................................................................................. 159 
8.3 References............................................................................................................. 161 
 v








Liquid crystal (LC)-based system is a promising platform for chemical and 
biological sensing due to the unique properties of LCs. It can potentially be used for real-
time and label-free detection with high sensitivity and without the need of complex 
instrumentation. The research work described in this thesis explores the use of 
thermotropic liquid crystals (LCs) for probing and imaging molecular-scale interactions 
occur at an aqueous-LC interface. The research exploration presented in this thesis is 
organized into two categories. 
The first category focuses on the biomolecule sensing. A novel air-supported LC-
based system that permits real-time and label-free interfacial examination with high-
throughput speed and small sample quantity was first designed and developed. Using this 
system, the enzymatic hydrolysis of phospholipid monolayer self-assembled at aqueous-
LC interface by various phospholipases (PLA2, PLC, PLD) and phospholipase-like toxins 
were characterized. During these enzymatic events, orientational transitions of LCs were 
triggered and the corresponding optical signals reflecting the spatial and temporal 
distribution of phospholipids were generated. The mechanisms of phospholipase-induced 
LC orientational changes were also investigated. Finally, introducing phospholipase 
inhibitors together with the respective phospholipases inhibited the enzymatic activities 
and resulted in no measurable optical response of LCs.  
The air-supported LC system was next used to identify phospholipase-like toxins. 
Beta-bungarotoxin exhibits Ca2+-dependent phospholipase A2 activity whereas alpha-
bungarotoxin and myotoxin II do not exhibit any phospholipase activity. The LC sensor 
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selectively identified beta-bungarotoxin when it hydrolyzed a phospholipid monolayer 
self-assembled at aqueous-LC interface and triggered orientational responses of LCs. The 
sensor was also very sensitive and required less than 5 pg of beta-bungarotoxin for the 
detection. When phospholipase A2 inhibitors were introduced together with beta-
bungarotoxin, no orientational response of LCs could be observed. In addition, the 
regeneration of the sensor could be done without affecting the sensing performance.  
After demonstrating the feasibility of studying enzymatic activities, we further 
employed the air-supported LC-based system to self-assemble nitrilotriacetic acid-
terminated amphiphiles loaded with Ni2+ ions at the aqueous-LC interface. This LC 
surface was capable for immobilizing histidine-tagged proteins in a well-defined 
orientation via complex formation between Ni2+ and histidine. Using histidine-tagged 
ubiquitin as a model protein to decorate LC surface, orientational transitions of LCs was 
observed by exposing the surface to antibody target to induce specific protein-protein 
binding events. The resultant sharp LC optical switching from dark to bright can readily 
be observed under polarized lighting. This work demonstrates that the air-supported LC 
system provides a facile platform for biomolecule characterization including for studying 
enzymatic reaction and inhibition, toxin identification inhibitor screening as well as 
specific protein-protein binding events.  
The second category focuses on the nanomaterial characterization. Protein-coated 
gold nanoparticles were found to disrupt cell membrane model system consisting of 
either phospholipid or mixed phospholipid/cholesterol monolayers self-assembled at 
aqueous-LC interface. The monolayer disruption was found to depend strongly on the 
type of protein (albumin, neutravidin and fibrinogen) adsorbing onto nanoparticle 
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surfaces. Hydrophobic interaction was found to play a major role in the disruption. 
Furthermore, mixed phospholipid/cholesterol monolayers with higher cholesterol 
contents were more susceptible to the disruption by protein-coated AuNPs. Results 
obtained from this study may offer new understanding in the potential nanotoxicity 
pathway, where the biophysical interaction between nanomaterials and cell membrane is 
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CHAPTER 1. Introduction 
 
1.1 Motivation 
In chemical and biological sensing research, liquid crystals (LCs) have become a 
promising tool and have gained considerable attentions, especially in the last decade.[1-3] 
LC-based sensors have exploited some unique properties possessed by LCs. Firstly, 
orientations of LCs are very sensitive to minute changes on surfaces and the orientational 
responses can be amplified to the LC bulk phase up to tens of micrometers away. This 
property allows LCs to detect and amplify the molecular-level information on surfaces 
into micrometer spatial readouts without any need of labelling molecules such as 
fluorophores. Secondly, the elastic force within LC phase and the liquid-like mobility of 
LC molecules can amplify LC responses within tens of milliseconds. This allows the use 
of LCs for fast and real-time detection. Thirdly, LC molecules are birefringent, and the 
orientational changes of LCs can be readily visualized under crossed polarizers. This 
allows the use of LCs for simple optical detection without any use of complex and 
expensive instrumentations.  
In the past, a number of studies have demonstrated the use of LCs to transduce 
and amplify molecular events such as ligand-receptor binding and protein-protein 
interactions occur on the surfaces of solid substrates.[2, 4-7] However, a wide range of 
biological events exist in dynamic fluid environments, such as biomolecular interactions 
at cell membranes and relatively little work has been dedicated to develop LC-based 
system as well as to use LCs to probe these events.[1, 8-10] The research presented in this 
thesis, therefore, focus on the development of LC-based system consisting of a fluid 
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interface in which biomolecules (e.g. phospholipid cell membranes) can adsorb at this 
interface and the organization of these biomolecules correspond to some biomolecular 
interactions is coupled to the orientation of the LCs. The research presented in this thesis 
also focus on the implementation of the LC-based system developed mainly for 
biomolecule characterization but has been expanded for nanomaterial characterization. 
The research described in this thesis, specifically, aims to: 
(1) Design and develop an LC-based system that permits real-time and label-free analysis 
on events at aqueous-LC interface with small sample quantity and high throughput speed: 
In the past, studies have developed a method to prepare a relatively stable and planar 
interface between LC and aqueous phase.[1, 8] This interface allows real-time and label-
free analysis on molecular events at aqueous-LC interface as the events are coupled to the 
orientational transition of LCs. The overall system incorporating the interface, however, 
requires a large amount of sample volume (≥ 250 µL) due to the presence of dead space 
in the system. Such sample requirement greatly hinders the continuous implementation of 
this LC system for detection applications involving precious and limited samples. In 
contrast, we aim to design and develop an LC-based system that requires minimal sample 
volume and involves simpler, faster and safer preparation. This opens the possibility for 
high throughput and cost-effective LC-based analytical sensors. We further aim to use 
this system for investigating enzymatic activities, enzymatic inhibition, toxin 
identification, toxin inhibition, specific and non-specific protein-protein binding events 
and cell-nanomaterial surface interactions. 
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(2) Characterize phospholipases, phospholipase-like toxins and their inhibitors: We aim 
to demonstrate the implementation of our LC-based system for characterizing the 
hydrolytic activities of various phospholipases: phospholipase A2 (PLA2), phospholipase 
C (PLC) and phospholipase D (PLD) towards phospholipid monolayer self-assembled at 
aqueous-LC interface. The mechanisms by which LCs report the enzymatic activities of 
these phospholipases are also investigated. We further demonstrate the potential 
application of our LC-based system for screening phospholipase inhibitors as well as for 
identifying phospholipase-like toxins and their inhibitor. 
 
(3) Develop a LC-based protein sensor: Detection and characterization of specific 
protein-protein and ligand-receptor binding events is widely used as the basis for 
molecular screening of diseases, toxins in food, narcotics in blood, and novel drugs. Most 
of the methods for detecting and characterizing these binding events, including the state 
of the art technology, involve surface immobilization of proteins of interest on solid 
substrate surface.[2, 6, 7, 11-13] In contrast to this approach, herein, we aim to explore the 
feasibility of immobilizing proteins on LC surface. After proving the feasibility, we 
further aim to investigate whether this protein-decorated LC surface can serve as a 
platform for direct real-time detection of specific protein-protein binding without 
multiple experimental steps. Such LC-based protein sensor may find broad applications 
in biomedical diagnostics. 
 
(4) Investigate biophysical interactions between LC-supported cell membrane model 
system and nanomaterials: This research is motivated by an increasing concern on the 
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toxicity and long-term adverse effects of nanomaterials to humans and environment.[14, 15] 
Indeed, at nanometer-size, nanomaterials can exhibit unusually high reactivity owing to 
the large percentage of atoms lie on their surface.[15] While many past studies focused on 
measuring the end-point cytotoxicity of nanomaterials to biological cells, relatively few 
studies have been dedicated to the understanding of biophysical interactions between 
nanomaterials and cell membrane, which may provide the necessary information for 
establishing nanotoxicity pathway as well as for designing better nanomaterials with 
improved performance and minimum toxicity.[16, 17] Here, we aim to investigate the 
biophysical interactions between LC-supported cell membrane model system and 
nanomaterials. The cell membrane model system is specifically either phospholipid or 
mixed phospholipid/cholesterol monolayer self-assembled at aqueous-LC interface. Both 
of phospholipid and cholesterol are two major constituents in biological cell membranes. 
Gold nanoparticle is chosen as a model nanomaterial owing to its widespread use in 
biosensing, in vivo imaging, and catalysis as well as its inertness in bulk form. Results 
obtained from this study may offer new understanding in the potential nanotoxicity 
pathway, where the biophysical interaction between nanomaterials and cell membrane is 
an important step.  
  
The following chapter (Chapter 2) briefly reviews literature relevant to this thesis 
to provide the background for readers to understand better the research work presented in 
subsequent chapters. The results of the research work are presented in Chapters 3-7. 
Because these chapters were originally prepared for manuscript publication, each chapter 
can be read and understood independently. However, Chapters 3-5 and Chapters 6-7 are 
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best appreciated when each set of chapters is read collectively. Chapter 3-5 emphasize on 
the use of LCs for biomolecule characterization including phospholipase enzymatic 
activities, enzymatic inhibition, toxin identification, toxin inhibition, protein-protein 
binding events and cover Aim (1)-(3). Chapters 6-7 emphasize on the use of LCs for 
nanomaterial characterization, specifically biophysical interactions between gold 
nanoparticles and LC-supported cell membrane model system and cover Aim (4). The 
thesis is ended with conclusions and recommendations in Chapter 8. 
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CHAPTER 2. Literature Review 
 
The literature reviewed in this chapter provides the background of as well as 
useful information to understand better the research work presented in this thesis. The 
review is organized into three main sections: (1) liquid crystals, (2) cell membrane and (3) 
gold nanoparticles. 
 
2.1 Liquid Crystals 
In the research presented in this thesis, liquid crystals (LC) have been used 
extensively as a signal-readout medium that transduces and amplifies the events induced 
by biomolecules as well as nanomaterial activities. A brief review on LCs is presented 
below and is divided into three subsections: (1) types of LCs, (2) properties of LCs and (3) 
application of LCs as sensors. 
 
2.1.1 Types of liquid crystals 
Liquid crystals (LCs) are substances that exhibit a phase of matter in between 
liquid phase and solid crystal phase.[1-4] In LC phase, the molecules can freely diffuse like 
liquids while still maintaining some degree of orientational order like crystals. The 
direction of the averaged orientational order of LC molecules is called the director of the 







Figure 2.1. Director of LCs to show the direction of the averaged orientational order of 
LC molecules. 
 
Based on the configuration of LC molecules in LC phases, LCs can be divided 
into three types: (1) smectic, (2) nematic and (3) cholesteric.[1, 2] In smectic LCs, LC 
molecules are structured into distinct strata or layers (Figure 2.2A). The arrangement of 
the molecules within each layer can be either ordered or random. In both cases, the long 
axes of the molecules are parallel to one another. Similarly to smectic LCs, LC molecules 
are still oriented in a parallel fashioned in nematic LCs. However, the existence of 
distinct strata or layers has disappeared (Figure 2.2B). Accordingly, the resulting one-
dimensional order is less than that in the smectic LCs. In contrast to the parallel 
arrangement of LC molecules found in both smectic and nematic LCs, LC molecules in 
cholesteric LCs are structured into a helical configuration (Figure 2.2C). Therefore, the 
director of cholesteric LCs is not fixed, but it spatially rotates around an axis 
perpendicular to itself and confers a helical structure. In the cholesteric LCs, there is, 
however, a local nematic arrangement of the LC molecules. Cholesteric LCs only occur 






   
Figure 2.2. Three types of LCs based on the configuration of LC molecules in LC phases: 
(A) smectic, (B) nematic and (C) cholesteric. Source: Liquid Crystal Technology Group, 
Oxford University.  
 
Based on the shapes of LC molecules, LCs can be divided into two types: 
calamitic and discotic.[1, 2] In calamitic LCs, the molecules have elongated rod-like shape 
where the length of the molecules is significantly longer than their width (Figure 2.3A). 
On the other hand, the molecules in discotic LCs have disc-like shape (Figure 2.3B).  
 
 
Figure 2.3. Two types of LCs based on the shape of LC molecules: (A) calamitic and (B) 
discotic. Source: Liquid Crystal Technology Group, Oxford University. 
 
Based on the driving force for the formation of LC phase, there are two types of 




certain temperature range (Figure 2.4). In lyotropic LCs, LC phases exist within certain 
concentration range. For example, when the concentration of lyotropic molecules is 
above critical micelle concentration (CMC), LC phase exists. The overall structure of 
lyotropic LCs depends strongly on the dimension of the corresponding lyotropic 
molecules such as the length and the width of the molecules (Figure 2.5).  
 
 
Figure 2.4. Different phases in thermotropic LCs: (A) crystalline solid, (B) smectic, 
(C) nematic and (D) isotropic liquid.  The vertical arrows indicate the director of the 
molecules in corresponding phases.  
 
 
Figure 2.5. Different forms of lyotropic LCs.[6]  
 
2.1.2 Properties of liquid crystals 
2.1.2.1 Anisotropic properties of liquid crystals 
As a result of the anisotropic structure of LC molecules, the physical properties of 
LCs are typically anisotropic.[2, 4] That is, the properties exhibit different values when 
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measured along one axial direction and along another direction. Because of this 
anisotropic characteristic, LC molecules can respond to electric and magnetic fields with 
the long-axis of the molecules all pointing in the same direction as of the fields. For 
example, when an electric field passes through a LC phase, LC molecules will orient 
themselves in a way that the axis of the molecules with higher electrical polarization 
parallelly aligns along the direction of the field. Likewise, a magnetic field can also orient 
LC molecules in a way that the axis of the molecules with higher magnetization parallelly 
aligns along the applied field. Furthermore, because of the same anisotropic characteristic, 
LCs also possess an optical anisotropic property so-called birefringence, defined as the 
difference in LC refractive index, n, measured parallel (nll) and perpendicular (n⊥) to the 
director of LCs (double refraction). Therefore, when a light enters a LC phase, the light 
polarized parallel to the LC director will travel at a different velocity from the one 
polarized perpendicular to the LC director. This phenomenon forms a basis for examining 
the optical image of LCs using a simple polarized microscopy (Figure 2.6) where the path 
of linearly-polarized light through LC phase is determined by the orientation of LCs.  
 
 
Figure 2.6. The working principle of crossed-polarizers. The optical output depends on 
the relative alignment between polarizer and analyzer. 
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2.1.2.2 Anchoring angles of liquid crystals 
The anchoring angle of LCs can be described by a polar angle, θ, and an 
azimuthal angle, φ. Polar angle is the angle between the director, d, and the normal to the 
surface, y (Figure 2.7A). Polar anchoring itself can be further classified into three 
categories: (1) planar anchoring (θ = 90°) (Figure 2.7B), (2) homeotropic anchoring (θ = 
0°) (Figure 2.7C) and (3) tilted anchoring (0° < θ < 90°). Azimuthal angle is the angle 
represents the in-plane orientation of the LC director with respect to a reference 
azimuthal axis, x. Two categories of azimuthal anchoring are (1) uniform anchoring 
where an averaged azimuthal orientation exists and (2) degenerate anchoring where all 
azimuthal orientations are equally probable. 
 
2.1.2.3 Optical appearances of liquid crystals 
One simple technique to examine the orientation of LCs is by using a polarized 
light microscopy.[2, 4, 7-12] In this technique, a LC sample is placed in between two 
polarizers where the bottom polarizer linearly polarizes a light from a light source while 
the top polarizer (analyzer) is arranged to orient perpendicular against the bottom one.  
The optical images of LCs observed as well as the intensity of light transmitted through 
the analyzer are a function of the anchoring of the LC molecules within the sample, the 
orientation of the sample between the polarizers, and the orientation of the polarizers 
relative to each other. A variety of anchoring conditions of LCs and their resulting optical 
images are discussed below.  
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Figure 2.7. Anchoring of liquid crystals: (A) Coordinate system used to describe the 
orientation of LCs, (B) Cartoon of planar anchoring of LCs and representative optical 
images of LCs observed in between crossed-polarizers at α = 0° (left) and α = 45° (right) 
where α is the angle between the director and the axis of the analyzer, (C) Cartoon of 
homeotropic anchoring of the LC and representative optical images of LCs observed in 
between crossed-polarizers using orthoscopic (left) and conoscopic (right) examination.[2] 
 
2.1.2.3.1 Planar anchoring 
Planar anchoring of LCs is illustrated by Figure 2.7B (top part). When the 
azimuthal angle (φ) of LCs is perpendicular or parallel to the axis of the polarizer (Figure 
2.6), the linearly-polarized light only encounters one index of refraction of LCs, either n⊥ 
or nll respectively upon passing through the LC phase. Therefore, after passing through 
the LC samples, the emerging light is fully blocked by the analyzer, and the 
corresponding optical texture will appear uniformly dark as can be seen from the right 




in a periodic modulation of the intensity of transmitted light. The periodic transmission of 





sin2sin 22 αI              (2.1) 
where α is the angle between the director and the easy axis of the analyzer and Δ  is the 
retardation in phase of the light upon passage through a birefringent material expressed as 
( ) λπdnn 2|| ⋅−=Δ ⊥               (2.2) 
where d is the thickness of the LC, λ is the wavelength of light, and n|| and n⊥ are the two 
refractive indices of the LC. A minimum in the transmitted light intensity occurs when 
the director is aligned with one of the polarizers, and a maximum occurs when the 
director is at 45° relative to the polarizers.  
If the azimuthal planar anchoring is uniform, α is the same at all points on the 
surface. Hence, the entire optical texture will exhibit a minimum and a maximum in 
transmitted light intensity when α = 0° or 90° and α = 45° respectively. An example of 
this modulation is shown in Figure 2.7B (below part). However, in non-uniform 
azimuthal planar anchoring, α varies continuously over the surface. As a result, this 
variation causes a simultaneous maxima and minima in the transmitted light intensity 
within the optical textures. Rotation of the sample results in essentially no change in the 
overall intensity of transmitted light, although spatial domains on the surface sinusoidally 




2.1.2.3.2 Homeotropic anchoring 
Homeotropic anchoring of LCs is illustrated by Figure 2.7C. When LCs anchor 
homeotropically, linearly-polarized light travels parallel to the LC director and 
encounters only one index of refraction, n⊥. Therefore, after passing through the LC 
samples, the emerging light will be fully blocked by the analyzer, and the corresponding 
LC optical texture appears uniformly dark even upon a 360° rotation of the samples. 
 
2.1.3 Application of liquid crystals as sensor 
In the past decade, LCs have become promising tools in chemical and biological 
sensing area.[9, 12-32] Some unique properties possessed by LCs include: (i) orientations of 
LCs are very sensitive to minute changes on surfaces and LC responses on surfaces can 
be amplified to LC bulk phase up to tens of micrometers away; (ii) the elastic force 
within LC phase and the liquid-like mobility of LC molecules can amplify LC responses 
within tens of milliseconds; (iii) LC molecules are birefringent, and the orientational 
changes of LCs can be readily visualized under crossed polarizers. As a result, LCs 
permit label-free detection with high sensitivity and without any use of complex and 
expensive instrumentations. 
The key to develop LC-based sensors is to control the orientation of LCs, which 
can be achieved either by using substrates onto which LC molecules are contacted with or 
by directly modifying the decorating LC molecules at the interface. Up to date, the first 
approach is the most popular method to control the orientation of LCs. The surface 
chemistry and/or the physical structures of solid substrates can be engineered to obtain 
desirable orientation of LCs. When a LC phase is contacted with a solid phase, the 
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interface between these two phases is created which limits the continuity of the LC 
phase.[33] This limiting interface perturbs the orientational order of the LC phase over a 
length, ζ, from the interface. Approximately, ζ is on the order of a few molecular lengths, 
20-40 Å. The orientational order of the bulk LC phase is recovered at a distance greater 
than ζ. In the absence of magnetic fields, electric fields, flow fields, or other surfaces, 
elastic forces enforce the ordering of the near-surface LC molecules upon the whole bulk 
LC phase. The amplification of this local ordering can be propagated rapidly up to 100 
μm distance from the limiting interface (coherence length). This coherence length 
decreases with increasing temperature to only a few molecular lengths when the material 
enters the isotropic phase. 
When the surface of glass slide is modified using 3-aminopropyl–triethoxysilane 
(APTES) and nematic LCs 4-Cyano-4’-pentyl-1,1’biphenyl (5CB) are contacted onto this 
surface, the optical image of 5CB will appear bright under crossed-polarizers (Figure 
2.8).[28, 34-36] Similar observations can be obtained when the surfaces of glass slides are 
modified using other amine-terminated or aldehyde-terminated silanes.[27, 37] 
In contrast, when the surface of glass slide is modified using octadecyl-
trichorosilane (OTS) and 5CB LCs are contacted onto this surface, the optical image of 
5CB will appear dark under crossed-polarizers (Figure 2.9), indicating homeotropic 
orientation of LCs on this surface.[7, 33] Similar observations can be obtained when the 
surfaces of glass slides are modified using other alkyl-terminated silanes such as [(3-








Figure 2.8. (A) Cartoon of planar anchoring of 5CB on APES-treated glass slide and (B 
and C) the corresponding optical images of 5CB when the orientation of 5CB director to 






Figure 2.9 (A) Cartoon of homeotropic anchoring of 5CB on OTS-treated glass slide and 
(B) the corresponding optical image of 5CB.  
 
Studies have also investigated the orientational behavior of LCs on gold surfaces 
with and without self-assembled monolayer (SAM) modification.[8, 24, 35, 39-47] In the 








preferred direction and angle of incidence (so-called uniformly deposited gold films) 
aligned 5CB azimuthally degenerate whereas films of gold deposited from gold vapours 
shot at preferred direction and angle of incidence from the normal (so-called obliquely 
deposited gold films) aligned 5CB azimuthally uniform with preferred orientation 
perpendicular to the direction of gold deposition.[8, 39-42, 45, 47] In the case of obliquely 
deposited gold films functionalized with SAM of alkanethiols that have an odd number of 
alkane carbons, the azimuthal orientation of 5CB on these gold surfaces was 
perpendicular to the direction of gold deposition.[8, 41] On the other hand, when obliquely 
deposited gold films were functionalized with SAM of alkanethiols that have an even 
number of alkane carbons, the azimuthal orientation of 5CB was parallel to the direction 
of gold deposition.[8, 41] In addition, when mixed SAM of long and short chains of 
alkanethiols was used to functionalize obliquely deposited gold films, the orientation of 
5CB was homeotropic.[8, 41] Although the exact nature of these molecular-scale 
interactions is still unclear, it has been speculated that the orientation of the terminal 
methyl group of the alkanethiols dictates the azimuthal orientation of LCs. 
As a result of LC sensitivity towards minute changes on surfaces, LCs have been 
used to transduce and amplify biologically-relevant binding events (protein-protein and 
ligand-receptor interactions) on surfaces into optical signals. For example, when 
obliquely deposited gold films were decorated with mixed SAM of ~27% biotin-
(CH2)2[(CH2)2O]2NHCO(CH2)11SH (BiSH) and ~73% CH3(CH2)7SH (C8SH), the 
orientation of 5CB on these gold surfaces was azimuthally uniform with preferred 
orientation parallel to the direction of gold deposition.[17, 46, 48-50] When these biotinylated 
surfaces were exposed to two solutions containing proteins that bind strongly to biotin: (1) 
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avidin (KD~10-15 M) and (2) anti-biotin-immunoglobulin G (KD~10-9 M), significant 
amount of proteins were bound on surfaces as measured by ellipsometry.  Subsequent 
contact of these surfaces with 5CB resulted in non-uniform azimuthal orientation of the 
5CB, indicating the disruption of 5CB orientation upon protein binding on surfaces.  In 
contrast, when the biotinylated surfaces were exposed to non-target proteins, the changes 
in the ellipsometry thickness as well as in the optical image of 5CB were minimal. There 
are two plausible mechanisms by which proteins bound on surfaces can influence the 
orientation of 5CB. First, bound proteins (e.g. avidin with size of 4.2 nm by 4.2 nm by 
5.6 nm) can erase the nano-scale gold structures (e.g. ~2 nm amplitude in topography) 
created during the oblique deposition process. Second, bound proteins can mask the 
functional groups of SAM that can influence the orientation of 5CB. 
Furthermore, obliquely deposited gold films functionalized with amine-terminated 
thiols have been used as substrates in affinity microcontact printing protein transfer.[34, 36] 
When polydimethylsiloxane stamps functionalized with biotinylated bovine serum 
albumin were subsequently immersed in anti-biotin-immunoglobulin G solution and 
stamped onto the gold films, the orientation of 5CB on these stamped regions was planar 
but with azimuthal orientations that were distinct from those assumed by the 5CB on the 
amine-terminated surfaces not supporting anti-biotin-immunoglobulin G. These results 
highlight that amine-terminated surfaces can uniformly align LCs and have sufficiently 
high surface free energy to capture proteins delivered to surfaces from affinity stamps.  
 In order to eliminate the need of preparing obliquely deposited gold films, glass 
slides functionalized with bovine serum albumin were used as alternative substrates for 
developing LC-based protein assays.[51, 52] When the surface of this glass slide was 
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mechanically rubbed using a cloth, the azimuthal orientation of LCs was found to be 
parallel to the direction of rubbing. When the same surface was immersed into an 
aqueous solution of anti-BSA IgG, the orientation of LCs changed to azimuthally non-
uniform. In contrast, when the same surface was immersed into aqueous solutions 
containing either, bovine serum albumin, fibrinogen, lysozyme, anti-FITC 
immunoglobulin G, or anti-streptavidin immunoglobulin G, the orientation of LCs was 
found to largely retain its uniform alignment.  
These past studies have demonstrated that many molecular-level events at 
surfaces can be amplified into ordering transitions in thin films of LCs, thus causing 
changes in the optical appearances of the LCs and hence permitting label-free detection 
with high sensitivity and without any use of complex and expensive instrumentations.  
 
2.2 Cell membranes 
The research work presented in this thesis focuses mainly on biomimetic cell 
membrane model system supported on liquid crystals. A basic review on cell membranes 
is presented below. The review is divided into two subsections: biological cell 
membranes and biomimetic cell membranes. 
 
2.2.1 Biological cell membranes 
Cell membranes are lamellar sheets 5-10 nm thick which mainly consist of a 
bilayer of lipids and proteins embedded within or anchored at the bilayer (Figure 2.10).[53] 
Approximately, there are 5 x 106 lipid molecules in 1 μm2 of lipid bilayer. All lipids 
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constructing the bilayer are amphiphilic molecules, in which they have both hydrophilic 
and hydrophobic parts.  
 
 
Figure 2.10. Biological cell membranes. Source: Cell Biology Group, University of New 
South Wales. 
 
The most abundant lipids in the cell membranes are phospholipids. Phospholipids 
have a polar hydrophilic headgroup and two hydrophobic hydrocarbon tails. Four major 
of phospholipids in cell membranes: phosphatidylethanolamine, phosphatidylserine, 
phosphatidylcholine and sphingomyelin (Figure 2.11). These four types of phospholipids 
constitute more than half of the mass of lipid bilayer in cell membranes. At physiological 
pH of 7.4, only phosphatidylserine has a negatively charged polar headgroup while the 
others are neutral.  
The phospholipid composition of the outer and inner leaflets of the lipid bilayer is 
strikingly different. Almost all of the phospholipid molecules which have a primary 
amino headgroup (e.g. phosphatidylethanolamine and phosphatidylserine) are located in 
the inner leaflet whereas almost all of the phospholipid molecules which have a choline 
headgroup (e.g. phosphatidylcholine and sphingomyelin) are located in the outer leaflet 
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of the lipid bilayer. This compositional difference reflects different functions of the two 
leaflets of the lipid bilayer. Furthermore, because negatively-charged phosphatidylserine 
is accumulated in the inner leaflet of lipid bilayer, there is a significant charge difference 
between the two leaflets of the lipid bilayer. Besides phospholipids, another major 
constituent of lipid bilayer is cholesterol. In eukaryotic cell membranes, cholesterol can 
constitute up to one molecule for every phospholipid molecule. 
 
Figure 2.11. Four types of phospholipids: (from left to right) phosphatidylethanolamine, 
phosphatidylserine , phosphatidylcholine and sphingomyelin.[53]  
 
In 1970, lipid molecules were found to be able to diffuse freely within lipid 
bilayer.[53] Using spin-labeled lipids, the motion and orientation of these lipids within the 
bilayer can be monitored by electron spin resonance spectroscopy. It was found that 
lipids within the same leaflet of bilayer have rapid lateral diffusion with a diffusion 
coefficient of about 10-8 cm2/s. In contrast, lipids were found to rarely migrate (flip-flop) 
from one leaflet of bilayer to another, with an occurrence less than a month for an 
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individual lipid molecule. The length of hydrocarbon tails of phospholipids plays a role in 
determining the fluidity of lipid bilayer. For example, the longer the hydrocarbon tails, 
the stronger the interactions among phospholipids and the less fluid lipid bilayer will be. 
The presence of cis-double bonds in the hydrocarbon tails of phospholipids also 
influences the fluidity of the lipid bilayer. These cis-double bonds can create kinks, 
disrupt the packing order among phospholipids and cause the lipid bilayer more fluid. 
Furthermore, the presence of cholesterol is also known to regulate the fluidity and 
permeability of the lipid bilayer. Higher cholesterol content is associated with lower 
fluidity of lipid bilayer. 
 Within this fluidic lipid bilayer matrix, membrane proteins embedded within or 
anchored at the bilayer perform most of cell membrane functions, including signal and 
energy transductions.[53] The entire assembly of lipids and membrane proteins is non-
covalently associated. Therefore, similarly to the lipid molecules in the bilayer, many 
membrane proteins can also laterally diffuse within the bilayer. In the cell membrane of 
eukaryotic cells, most of membrane proteins and some of lipid molecules are decorated 
with sugar residues. This sugar coating can mediate cell adhesion as well as can protect 
the cell surface from mechanical and chemical damages. 
 
2.2.2 Biomimetic cell membranes 
The compositional complexity and dynamic fluid of biological cell membranes 
make it difficult to study certain fundamental aspects of biological system in details. 
Detail analysis of results from cellular studies can lead to inconclusive interpretation. 
Cell membrane model system with well-defined composition can complement the cellular 
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studies and can be useful for probing the details of biomolecular interactions occur at cell 
membranes, e.g. for determining the effect of individual recognition events on the 
functional behaviour of cells. Some experimental systems have been developed to mimic 
the structure and the function of biological cell membranes. Three types of biomimetic 




Vesicle is a small membrane-enclosed liquid compartment. The membrane 
consists of either a bilayer (unilamellar) or several layers (multilamellar) of amphiphilic 
molecules, typically phospholipids. Based on the size and structure, vesicles can be 
divided into four classes: small unilamellar vesicles (SUVs), large unilamellar vesicles 
(LUVs), giant unilamellar vesicles (GUVs) and multi-lamellar vesicles (MLVs) (Figure 
2.12).[54] Unilamellar vesicles consist of a single bilayer of amphiphilic molecules and 
can be classified according to their diameter: ~25 nm for SUVs, ~30-400 nm for LUVs 
and >1 µm for GUVs. In contrast, MLVs comprise of several concentric bilayers of 
amphiphilic molecules, which are separated by a liquid phase, and typically have 
diameters on the order of 1 µm.  
The fluidity of the lipids constructing the vesicles is an important characteristic in 
mimicking biological cell membranes. Using fluorescence correlation spectroscopy 
measurements, L-1,2-dilauryl-sn-glycero-3-phosphocholine (L-DLPC) in GUVs was 
found to have a diffusion coefficient of 3 x 10-8 cm2/s at room temperature.[55] Addition 
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of cholesterol to the DLPC vesicles led to a reduction of the lateral diffusivity by 
approximately 1 order of magnitude. 
 
Figure 2.12. Different types of vesicle assemblies; SUV: small unilamellar vesicle, LUV: 
large unilamellar vesicle, GUV: giant unilamellar vesicle, MLV: multi-lamellar vesicle. 
 
Vesicles have been exploited to investigate protein interactions with lipids. 
Studies have investigated the hydrolysis of zwitterionic phospholipid 1-palmitoyl-2-
oleoyl-sn-glycero-3-phosphocholine (POPC) vesicles with average diameter of 100 nm 
by phospholipase D from Streptomyces sp. at pH 8.0.[56] This hydrolysis produced 
negatively charged 1-palmitoyl-2-oleoyl-sn-glycero-3- phosphatidic acid (POPA). At 
Ca2+ concentration of 1 mM, PLD addition resulted in vesicle aggregation, fusion, and 
precipitation, which was likely due to electrostatic interactions between Ca2+ ions and 
POPA. In contrast, in the absence of Ca2+, the size of the vesicles did not change 
significantly with time upon PLD addition, as judged from turbidity and dynamic light 
scattering measurements. In another study, the hydrolysis of vesicles comprising of 1,2-
dimyristoyl-sn-glycero-3-phosphocholine (DMPC) phospholipids by phospholipase A2 
has been studied by using confocal Raman microscopy.[57] The relative Raman scattering 
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of C-C stretching vibration from the acyl chains of DMPC were correlated directly with 
the extent of DMPC hydrolysis. This technique allowed the determination whether the 
enzymatic products were dissolved into aqueous phase or remained within the vesicles. In 
other studies, polydiacetylene lipids have been used to prepare stable blue colour 
polymerized vesicles.[58] Phospholipids can be mixed with polydiacetylene lipids to form 
vesicles containing mixed lipids. When these vesicles were exposed to phospholipase A2, 
DMPC were hydrolyzed and the colour of the vesicle solution changed from blue to red. 
This colour change was ascribed due to perturbation of the packing order of the lipids 
within the vesicles induced by the hydrolysis. 
Some studies have investigated the incorporation of proteins into vesicles.[59] This 
incorporation can be done by co-sonication of phospholipids and proteins of interest, or 
by mixing phospholipids and membrane proteins in the presence of detergents, which 
then are removed by dialysis, or by freezing and thawing the vesicles in the presence of 
the proteins of interest. Radio-labeled proteins (typically by 125I) have been used in the 
study of protein incorporation into vesicles.[60, 61] After the incorporation, the vesicle 
solution was then centrifuged to separate bound and unbound proteins. The gamma 
emission from free proteins in the supernatant was then measured.  
 
2.2.2.2 Supported lipid bilayer 
Supported lipid bilayer encompasses a wide array of bilayer assemblies of 
phospholipids on solid substrates. The most commonly used material for preparing 
supported lipid bilayer is mica. Glass and silicon wafers are other frequently used 
materials for forming supported lipid bilayer. However, organic contaminants and 
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particles can disrupt the formation of supported lipid bilayer and should be carefully 
removed before use, e.g. by washing in piranha or aqua regia solution followed by 
ultrasonication in water. Gold surfaces may also be functionalized with self-assembled 
monolayer of organic alkanethiols for preparing so-called hybrid alkanethiol/lipid 
bilayers.  
There are essentially two methods to prepare supported lipid bilayer: Langmuir-
Blodgett method and fusion of lipid vesicles (Figure 2.13).[62] In the Langmuir–Blodgett 
technique, lipids are usually first spread at the air–water interface (Figure 2.13A). The 
lipids are then compressed to obtain desired surface density of lipids. At constant surface 
pressure and constant speed, the lipids are transferred onto a solid support. A monolayer 
of lipid interacts with mica surfaces through the polar headgroups, thus exposing the 
hydrophobic tails to the environment. The resulting lipid monolayer is stable in air, not in 
water. Therefore, it should be used in air. The second layer of lipids can be transferred 
onto a mica-supported lipid monolayer through hydrophobic interactions to yield a 
supported lipid bilayer. This supported lipid bilayer is stable in aqueous phase, not in air, 
and therefore should always be kept and analyzed in aqueous solution. Up to date, the 
most popular method for preparing supported lipid bilayer is, however, the fusion of lipid 
vesicles (Figure 2.13B). Vesicle fusion can be achieved by simply contacting mica 
surface to solution containing lipid vesicles for 45–60 min at a temperature between 25 
and 60°C. The resulting supported lipid bilayer is then rinsed thoroughly with buffer 
solution prior to use. Although the exact mechanism of lipid bilayer formation from lipid 
vesicles has not been fully understood yet, the process involves adsorption of the vesicles 





Figure 2.13. Two methods to prepare supported lipid bilayer: (A) Langmuir-Blodgett 
method and (B) fusion of lipid vesicles.[62] 
 
Vesicle fusion approach is simpler than Langmuir-Blodgett one. However, 
Langmuir-Blodgett approach allows the formation of asymmetric lipid bilayer. For both 
methods, membrane proteins can be reconstituted into preformed supported lipid bilayer, 
which is first destabilized by detergents used in membrane biochemistry (dodecyl-b-
maltoside or dodecylb-thiomaltoside).[63] 
Supported lipid bilayer has been used extensively to investigate protein 
interactions with lipids. For example, using acoustic wave device, the interaction of the 
pore-forming cytolytic toxin CytB with a positively charged supported lipid bilayer on 




lipids at all fractional coverages even when the protein-to-lipid ratio was high enough to 
imply that the protein was associating with the external surface of the bilayer. The rate of 
association with the bilayer was found to be directly proportional to the solution 
concentration of CytB at higher concentrations but appeared to be low at a CytB solution 
concentration of 5 μg/mL. In another study, supported lipid bilayer containing 
DMPC/GM1 lipids and bodipy dyes embedded within the bilayer were prepared on gold-
coated surface plasmon resonance chip.[65] When this bilayer was exposed to cholera 
toxins, bodipy dyes were released as detected by surface-plasmon enhanced 
fluoresecence spectroscopy, indicating a bilayer leakage due to toxin binding. This 
bilayer leakage could be blocked by addition of 1 μmol/L of europium chloride.  
 
2.2.2.3 Lipid monolayer 
Lipid monolayer has been used extensively as mimics of one-half of the cell 
membrane lipid bilayer.[66-72] Although lipid monolayer does not fully duplicate the 
structure of the bilayer, the high level of experimental control over the state of the lipid 
interface (e.g. the simplicity, stability and reproducibility) can make their use desirable in 
mimicking biological cell membranes. Studies have demonstrated that many important 
biological phenomena occur at lipid bilayer can also occur at lipid monolayer 
experimentally. The formation of lipid monolayer at air-water and oil-water interfaces 
typically follows one of two approaches, either spreading of lipid from an organic solvent 
or fusion of lipid vesicles.[68, 69, 73, 74] In lipid spreading, lipids are first dissolved in a 
volatile organic solvent.[68, 69] The lipid solution is then spread at either air-water or oil-
water interface. The solvent is allowed to evaporate, leaving non-volatile lipids to 
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organize as a monolayer at the interface. In vesicle fusion, a solution containing lipid 
vesicles is exposed to an interface to allow the vesicles to contact, rupture and fuse as a 
monolayer at the interface.[73, 74] Given enough time, the amount of lipids transferred 
from vesicles to the interface is independent of the vesicles size, although lipids with 
smaller size adsorb more quickly to the interface. The areal density of lipids transferred 
to the interface and the dynamics of lipid adsorption depend strongly on the bulk 
concentration of lipids and the phase state of the vesicles. Increasing the bulk 
concentration of the lipids results in an increased level of lipids transferred to the 
interface. 
The fluidity of the lipids constructing the vesicles is an important characteristic in 
mimicking biological cell membranes. The diffusion coefficient of L-DLPC in a 
monolayer at the air-water interface has been reported to be about ~1.2 x 10-10 m2/s at 0 
mN/m surface pressure.[75] Addition of cholesterol to the monolayer led to a decrease in 
the fluidity of monolayer. At n-heptane-water interface, the diffusion coefficient of L-
DLPC was reported to be about 5 x 10-11 m2/s at 0 mN/m surface pressure.[76]   
Lipid monolayer has been used extensively to investigate protein interactions with 
lipids. For example, studies have investigated the adsorption of bovine serum albumin to 
phospholipid monolayer. Phosphatidylcholine monolayer was found to resist non-specific 
bovine serum albumin adsorption.[13] This result is in agreement with measurements of 
human serum albumin adsorption on phosphatidic acid and phosphatidylcholine 
monolayers. Phosphatidylcholine monolayer was shown to adsorb only 33% as much 
human serum albumin as the negatively charged phosphatidic acid monolayer.[77] Patino 
and co-workers have studied the interactions between β-casein with 1,2-dipalmitoyl-sn-
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glycero-3-phosphocholine (DPPC) monolayer at air-water interface using surface 
pressure-area isotherm measurements.[78] β-casein was found to not only interact with but 
also accumulate at and penetrate the DPPC monolayer. The penetration is facilitated at 
acidic and neutral pH, but is hindered at basic pH. In another study, surface pressure-area 
isotherm measurements were used to investigate the incorporation of alcohol 
dehydrogenase into a negatively charged dimyristoylphosphatidic acid monolayer at air-
water interface.[79, 80] Alcohol dehydrogenase was found to interact strongly with the 
monolayer and to remain at the interface even after one month. The study has also 
demonstrated the use of the dimyristoylphosphatidic acid monolayer containing alcohol 
dehydrogenase as a chemical sensor capable of detecting down to 10 ppb ethanol.  
 
2.3 Gold nanoparticles 
A brief literature review on gold nanoparticles (AuNPs) is presented below. The 
review is divided into four parts: synthesis, properties, application and cytotoxicity of 
AuNPs.  
 
2.3.1 Synthesis of gold nanoparticles 
Various methods for the synthesis of AuNPs have been developed including 
synthesis of water-soluble, organic-soluble, ionic-stabilized and steric-stabilized AuNPs. 
A brief review below on the synthesis of AuNPs is emphasized on green chemistry 
viewpoint and is therefore focused more on water-soluble AuNPs stabilized with either 
ions, thiol ligands, or proteins.  
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One of the most popular methods to synthesize water-soluble AuNPs is Au3+ 
reduction from HAuCl4 to Au0 by citrate.[9, 81-87] This method involves a one-step 
synthesis route and produces spherical AuNPs with high reproducibility and good 
stability over the time. Using this method, the size of AuNPs can be varied from nearly 
10 nm up to 150 nm by simply varying the molar ratio of HAuCl4 to citrate. Recently, 
studies have revealed the relationship between AuNP size and HAuCl4/citrate molar 
ratio.[83] When the HAuCl4/citrate molar ratio is in the range of 3.5-28, the size of AuNPs 
increases when HAuCl4/citrate molar ratio increases, but within a range of HAuCl4/citrate 
molar ratio of 0.3-3.5, the size of AuNPs increases when HAuCl4/citrate molar ratio 
decreases. The plot of AuNP size against HAuCl4/citrate molar ratio has, therefore, 
shown a skewed-U-shaped profile (Figure 2.14). The synthesis of AuNPs with size >30 
nm is usually accompanied by a lower stability and a more heterogeneous shape 
(spherical, imperfect spherical, ellipsoid and triangle) of AuNPs. Regardless of the size, 
citrate-stabilized AuNPs is usually prone to aggregation in high ionic strength, especially 
in the presence of counter ions. The synthesis of AuNPs using citrate is relatively cheap 
and can be scaled-up up to hundreds of milliliters or liters of solution in a single batch 
synthesis. The synthesis can also be categorized as a “green” method since water is used 
as a solvent and trisodium citrate, as the reducing agent, has been used as a food additive 




Figure 2.14. Plot of AuNP size against molar ratio of HAuCl4 to citrate.[83] 
 
Tannic acid has been introduced together with citrate as the co-reducing agent to 
produce water-soluble AuNPs with size range within 5-15 nm.[89-95] The resulting AuNPs 
has relatively narrow size distribution and good stability over the time. As the amount of 
the tannic acid increases, the size of AuNPs synthesized becomes smaller. Tannic acid 
itself is relatively non-toxic as it can be found in food including tea. Indeed, studies have 
used tea and soybean extracts to produce biocompatible AuNPs.[88, 96-98] The 
phytochemicals present in tea and soybean were found not only to reduce Au3+ from 
NaAuCl4 to Au0, but also to stabilize the AuNPs in various high ionic strength solutions 
including ~2% NaCl solution and 25 mM HEPES buffer. The MTT assay revealed that 
these AuNPs were non-toxic and cells treated with these AuNPs showed 90-100% 
viability compared to untreated cells. As a result, the production of AuNPs from natural 
products such as tea and soybean can be categorized as a “green” method. Another 
popular method to synthesize water-soluble AuNPs is using borohydride as the reducing 
agent.[99-106] This method produces spherical AuNPs with size <10 nm and with relatively 
bigger size distribution. As the amount of borohydride increases, the size of AuNPs 
produced is smaller. Using borohydride, it is possible to produce AuNPs with size <1nm. 
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However, the resulting AuNPs is usually susceptible to aggregation in high ionic strength. 
Furthermore, borohydride itself is highly reactive, corrosive and is toxic. Therefore, the 
synthesis of AuNPs using borohydride cannot be considered as a “green” method.  
Biomolecules such as amino acids and proteins have also been used in a “green” 
production of AuNPs.[88, 107-119] Bovine serum albumin (BSA) is one of the most common 
proteins used for AuNPs synthesis since it is readily available in bulk quantity, is 
inexpensive, has mild reduction ability, and has been known to passivate AuNPs 
surface.[110, 115, 118, 120, 121] In the presence of BSA as the stabilizing agent, the use of 
reducing agents such as borohydride, UV irradiation and hydrazine hydrate vapour have 
produced AuNPs with size ranging from <2 nm, ~8 nm and nearly 100 nm 
respectively.[110, 111, 115] However, the use of non-biocompatible reducing agents is not 
desirable when the resulting AuNPs are meant to be used for biological-related 
applications. Using intrinsic reduction ability of BSA and under acidic condition at 37°C, 
prism-shaped and polygon-shaped AuNPs have been produced up to 80% yield.[118] On 
the other hand, using intrinsic reduction ability of BSA but under basic condition at 37°C, 
spherical AuNPs with size <1 nm were successfully produced.[118] The resulting AuNPs 
were stable even when they were dispersed in 1 M of NaCl solution or 50 mM of HEPES 
buffer.  
Synthesis and subsequent coating of AuNPs can be directly accomplished in one-
pot by addition of reducing agents and thiol ligands.[81, 121-141] Brust and Schiffrin have 
introduced a method to synthesize organic-soluble alkanethiol monolayer-protected 
AuNPs in two phase system by first reducing the Au3+ from HAuCl4 to Au0 in H2O using 
borohydride and subsequently transferring the AuNPs produced to dodecanethiol-
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containing toluene using tetraoctylammonium bromide as the phase transfer agent.[122] 
The resulting AuNPs were thermally stable and air-stable. The size of the AuNPs can be 
varied from 1.5-8 nm. This method can be extended to one phase system to produce 
water-soluble ligand monolayer-protected AuNPs by using oligoethylene glycol-, amine-, 
sulfonate- and carboxylic acid- terminated thiols as the ligands.[129, 140, 142, 143] Murray et al. 
have introduced a “ligand exchange” method to produce mixed ligand monolayer-
protected AuNPs by exposing AuNPs, protected by a single type of thiol, to other 
functional thiols present in excess.[127, 128, 144, 145] Although Au-S bond is relatively strong, 
the other functional thiols were able to replace the original thiol ligand initially bonded 
onto AuNP surface. Synthesis of mixed ligand monolayer-protected AuNPs can be 
directly accomplished in a one-step route by simultaneous addition of a mixture of thiol 
ligands.[101, 128, 146-148] The self-assembly of two types of thiols onto AuNP surface led to a 
formation of concentric, ribbon-like domains with alternating composition (Figure 2.15). 
The domain shape and dimension can be controlled by varying the ligand composition 
and the AuNP core size. 
Synthesis of AuNPs with diameter >5 nm can be done by growing smaller seed 
AuNPs via epitaxial addition of Au atoms.[81, 88] These Au atoms can be supplemented by 
reducing additional Au3+ using mild reducing agents. The use of well-defined seeds is 
critical to obtain end-product AuNPs with narrow size distribution. Amphiphiles can be 
used to control the growth of the AuNP seeds into different shapes as well as to stabilize 
the AuNPs produced.[81] Sodium citrate and hydroxylamine have been widely used in 
seeding growth Au seeds to produce bigger 30-100 nm AuNPs.[142, 149] Instead of 
spherical AuNPs, Jana and Murphy have successfully grown 3.5 nm Au seeds to 5-40 nm 
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gold nanorods (AuNRs) with narrow size distribution using ascorbic acid and 
cetyltrimethylammonium bromide (CTAB).[144]  
 
   
Figure 2.15. (A) Scanning tunneling image and (B) the corresponding schematic drawing 
of a single AuNP protected by mixed thiol monolayer.[99] 
  
2.3.2 Properties of gold nanoparticles 
 AuNPs have many unique physicochemical properties that are not found in their 
bulk counterparts.[81, 146, 147, 150-157] Three properties are reviewed here: surface plasmon 
resonance, scattering and fluorescence of AuNPs. 
 
2.3.2.1 Surface plasmon resonance of gold nanoparticles 
An interesting physical property of AuNPs is surface plasmon resonance (SPR).[81, 
153-158] SPR is a coherent excitation of all free electrons existing in the conduction band 
by visible light. In SPR, the electric field of light induces polarization of free negative 
electrons relative to cationic lattice of metal nanoparticles, and generates a dipolar 
oscillation of electrons at a certain frequency. The maximum wavelength (λmax) and 
bandwidth of SPR are influenced by the AuNP shape and shell, environment dielectric 
A B 
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constants and refractive index, and temperature.[81, 153] One of the manifestations of SPR 
can be seen from the colour of AuNP solution. For example, an SPR absorption band in 
the visible region around 520 nm corresponds to a red-wine colour of AuNP in water. 
Aqueous AuNPs with the average diameter of 9, 15, 22, 48 and 99 nm have 
corresponding SPR λmax at 517, 520, 521, 533 and 575 nm respectively.[81] At constant 
particle concentration, the intensity of SPR sharply decreases with decreasing the size of 
AuNPs.[81, 156, 159] This decrease of SPR intensity is accompanied by the broadening of the 
SPR bandwidth.[81, 156, 159] At diameter less than 2-3 nm and at bulk form, SPR of AuNPs 
vanish.[81, 156, 159] The energy of SPR is also influenced by the shape of nanoparticles. At 
an elliptical shape, the SPR of AuNPs is shifted to higher wavelength.[81, 156]  
All AuNPs are protected by stabilizing agents, and thus the SPR energy is rarely 
exactly as predicted by Mie theory, especially if the shift by stabilizing agents is not 
considered.[81, 156, 160] This shift can be significant with thiolate ligands, which are 
responsible for a strong ligand field interacting with the surface electron cloud of AuNPs. 
The charge of the stabilizing agents surrounding AuNP surfaces also influences the 
SPR.[81, 160] Excess electron charge causes SPR to shift to the higher energy level, 
whereas electron deficiency causes shifts to the lower energy level. The SPR of AuNPs is 
also shifted to lower energy level (higher wavelength) when the spacing between 
particles is reduced.[81, 159, 160] This red shift correlates exponentially with the gap between 
two AuNPs and is negligible when the gap is larger than approximately 2.5 times the 
short-axis length of AuNP. SPR is also affected by the refractive index of environment 
surrounding AuNPs. Solutions of dodecanethiolated AuNPs with average size of 5.2 nm 
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show an 8-nm shift in SPR λmax as the solvent refractive index varies from 1.33 to 
1.55.[161]  
 
2.3.2.2 Scattering of gold nanoparticles 
The scattering intensities of AuNPs are high enough to be seen with naked eyes or 
to be quantitated with simple spectroscopic and photonic instrumentation. For example, 
at particle concentration as low as 1 nM, 20 nm AuNP solution shows a strong red-wine 
colour visible to naked eyes. The scattering properties of AuNPs have been exploited in 
sensor applications using surface-enhanced Raman scattering (SERS) and dark-field 
microscopy.[154, 162-175] Studies have reported that AuNPs can enhance SERS signal up to 
1010-1018 fold.[167, 168, 176] Nie and co-workers have demonstrated that PEGylated AuNPs 
with average size of 60 nm enhanced the signal of Raman dyes by as much as 1014 – 1015 
fold with light emission in the near-infrared window and in in vivo conditions.[171] On a 
particle-to-particle comparison basis, this signal was > 200 times brighter than what can 
be obtained from a single near-infrared-emitting quantum dot (Figure 2.16). 
 A single AuNP can be observed under dark-field microscopy.[166, 176] When an 
AuNP has a size dimension much smaller than the wavelength of excitation, a resonance 
can occur at which the elastic scattering cross section of the AuNP increases significantly 
and the local electromagnetic fields are greatly enhanced. Although the particle 
dimension is smaller than the diffraction limit of light, the plasmon resonance of 
nanoparticles can, nevertheless, be readily observed individually in a microscope under 
appropriate illumination conditions where background scattering is minimized. The 
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intensity of scattered light from a single 60 nm Au particle was reported to be 
approximately equivalent to 3 x 105 fluorescein molecules.[175] 
 
   
Figure 2.16. (A,B) Images and (C) brightness intensity of (A) gold nanoparticle SERS 
and (B) quantum dots fluorescent dispersed on glass slides and acquired under the same 
conditions (633 ± 3 nm excitation and 655 nm emission).[171] 
  
2.3.2.3 Fluorescence of gold nanoparticles 
AuNPs with diameter <1 nm have size regime comparable to the Fermi 
wavelength of the conduction electrons. The spatial confinement of free electrons in this 
size regime results in discrete and size-tunable electronic transitions, leading to unique 
charging and luminescence properties. Thiol-protected AuNPs with size <1.2 nm can 
exhibit fluorescence in the blue to near-IR regimes with relatively low quantum yields 
(0.001%-0.1%).[168, 176-178] Recently, poly(amidoamine) dendrimer has been used as a 
template to synthesize AuNPs with a quantum yield >10%.[178-180] More recently, Ying 
and co-workers reported a simple, one-pot, and “green” synthetic route based on the mild 
reduction capability of BSA to reduce Au3+ from HAuCl4 into Au0 at 37°C with red 
emission (λem max = 640 nm, QY ≈ 6%).[119] In contrast, larger AuNPs have been shown to 
effectively quench fluorescence dyes adsorbed onto AuNP surface.[180-183] For example, 
20 nm AuNPs can effectively quench the fluorescence signals of fluorescein and its 
A B C 
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derivatives. However, when AuNPs were coated with shell e.g. silica with thickness 
around 15-30 nm, it was found that AuNPs can enhance the signals of fluorescence dyes 
by approximately 2-30 folds.[181, 184-186] The fluorescence enhancement by metallic 
nanoparticles depends on the size and shape of the nanoparticles, the distance between 
the dye molecules and the core of metallic nanoparticles, the orientation of the dipole 
with respect to the dye-nanoparticle axis, and the wavelength overlap of the dye emission 
with the nanoparticle absorption spectrum.[186-189]  
 
2.3.3 Application of gold nanoparticles 
AuNPs have been widely used as sensors.[81, 150, 153, 155, 157, 190] Mirkin and co-
workers first demonstrated that hybridization between oligonucleotides conjugated on 
AuNPs and complementary DNA in solution induces AuNP aggregation and results in a 
red shift in the surface plasmon of AuNPs from 520 to ~600 nm that changes the solution 
from red to blue.[191, 192] By heating the solution for DNA dehybridization, the AuNP 
aggregates redisperse and the colour of AuNP solution changes back from blue to red. 
This method permits a simple colorimetric detection for DNA hybridization. Furthermore, 
conjugating oligonucleotide to AuNPs rather than fluorophores dramatically alters the 
melting profiles of the nucleotides.[192] In the case of AuNP-conjugated oligonucleotides, 
the melting profiles allow the discrimination of target oligonucleotide sequences with 
single nucleotide mismatches and with three-fold selectivity when compared to 
fluorophore-conjugated oligonucleotides. Moreover, upon AuNP-induced reduction of 
silver ions (silver enhancement), the detection limit of the hybridization events is 
amplified by two orders of magnitude compared to that of the fluorophore system (5 fM 
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vs 5 pM). The silver enhancement has further been coupled to surface-enhanced Raman 
scattering to develop microarray-based DNA detection with single nucleotide mismatch 
discrimination and up to 20 fM detection limit.[193] Because each Raman-active dye has a 
specific narrow-band spectroscopic fingerprint, multiplexed detection of oligonucleotide 
targets is possible when AuNPs are conjugated with both DNA targets and Raman-active 
dyes. Oligonucleotides can also be used to control the crystallization of oligonucleotide-
conjugated AuNPs.[194] Different oligonucleotide sequences have been shown to guide 
the assembly of AuNPs into micrometer-sized crystal structures with different crystalline 
states such as face-centered-cubic and body-centered-cubic crystal.  
The use of AuNPs to detect proteins usually relies on the specific interactions 
between antibody-conjugated AuNPs with the target protein, which result in distinct 
optical signals of the AuNPs. Mirkin and co-workers have used the combination of 
magnetic microparticles and AuNPs to develop an ultrasensitive method for detecting 
protein analytes.[195, 196] In this study, magnetic microparticles were conjugated to 
monoclonal antibody whereas AuNPs were conjugated to polyclonal antibody and 
double-stranded DNA. The double-stranded DNA comprised of a single-stranded thiol-
modified DNA linked to surfaces of AuNPs and its complementary DNA as a bio-bar-
code. In the presence of specific protein antigens (e.g. prostate specific antigen), complex 
structures consisting of magnetic microparticles, protein targets and AuNPs were formed. 
These complex structures were then exposed to a condition which allowed 
dehybridization and release of bio-bar-code DNA from the structures. The dehybridized 
bar-code DNA were separated from the complex structures by the help of magnetic 
separator. The bar-code DNA were then detected using DNA detection methods 
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described above. Because each complex structure contains a large number of 
oligonucleotides conjugated to AuNPs per protein binding event, substantial 
amplification is achieved and protein target can be detected at 30 aM concentration 
(Figure 2.17 inset). Alternatively, a polymerase chain reaction on the bar-code DNA can 
boost the detection limit up to 3 aM (Figure 2.17). In comparison, clinically existing 
assays for detecting the same protein target only have detection limits of ~ 3 pM.  
 
Figure 2.17. Scanometric detection of prostate specific antigen-bar-code DNA. Prostate 
specific antigen concentration (sample volume of 10 μL) was varied from 300 fM to 3 
aM and a negative control sample where no prostate specific antigen was added (control) 
is shown. For all seven samples, 2 μL of antidinitrophenyl (10 pM) and 2 μL of β-
galactosidase (10 pM) were added as background proteins. Also shown is PCR-less 
detection of PSA (30 aM and control) with 30 nm NP probes (inset).[196] 
 
The AuNP-based colorimetric detection can be expanded to detect wide varieties 
of analytes. Lu and co-workers used AuNPs conjugated with oligonucleotides for 
colorimetric detection of Pb (II) ions in aqueous media and lead-containing paint samples 
at concentrations as low as 100 nM.[197, 198] The middle part of this oligonucleotide was a 
substrate to a DNAzyme that requires Pb as cofactor. In the presence of Pb (II), the 
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DNAzyme hydrolyzed the substrate, causing AuNP aggregates to disassemble and 
resulting in a change in the colour of AuNP solution from blue to red. In another work, 
AuNPs conjugated with oligonucleotides have been used to detect the mercury ions 
(Hg2+).[199, 200] This detection took advantage of the Hg2+ affinity toward T-T mismatches 
in oligonucleotides. When the mercury ions bridged the AuNPs, the colour of the 
corresponding AuNP solution changed from red to blue.   
AuNPs have been used in plasmonic nanoparticle-enhanced SPR 
immunoassays.[201, 202] In these assays, gold surfaces immobilized with primary antibody 
were sequentially exposed to antigen and secondary antibody-conjugated AuNPs. The 
presence of the AuNPs enhanced the SPR shift measurements. With the secondary 
antibody alone, the shift of the SPR peak was relatively small. The size, composition, 
surface coverage of AuNPs as well as the SPR substrate and the distance between the 
AuNPs and the substrate can affect the observed signal enhancement.[202-204] This method 
has been used not only in immunoassays but also in detecting DNA hybridization, protein 
conformational changes, small molecule binding interactions, and single nucleotide 
polymorphisms.[205-208]  
The high scattering intensity, the possibility to tailor the scattered wavelength, the 
biocompatibility, and the well-established surface chemistry make AuNPs suitable as 
contrast agents for imaging applications. Such optical imaging provides a promising route 
for noninvasive, high-resolution diagnostic imaging of tissues and cells with high 
sensitivity and specificity. For example, AuNPs, functionalized with antibodies that can 
target proteins overexpressed on cancerous cells have been used to image cancer 
cells.[209-215] Anti-HER and anti-EGFR antibodies have been widely used for targeting 
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epidermal growth factor receptors overexpressed in many types of cancers such as 
cervical, bladder, breast, lung, and oral cancers. After incubating the cancer cells or 
tissues with the antibody-conjugated AuNPs, the labeled cells or tissues can then 
examined using optical imaging instruments such as dark field microscopy and two 
photon luminescence.  
Because the optical properties of gold nanorods (AuNRs), especially their 
longitudinal plasmon resonances, are very sensitive to small changes in the aspect ratio of 
the particles, AuNRs with different aspect ratios have been used for multiplexed 
bioanalytical sensing measurement in solution.[215] Three AuNRs with different aspect 
ratios (length/width of 2.1, 4.5 and 6.5, annotated as AuNR 1, 2 and 3 respectively) and 
functionalized with different recognition molecules in a single solution showed three 
absorption spectra corresponding to three longitudinal localized SPR of the three AuNRs. 
When an analyte specifically recognized by the recognition molecule on AuNR 1 was 
added, a red shift in the longitudinal peak corresponding to AuNR 1 spectrum occurred 
with minimal shifts in the peaks corresponding to AuNR 2 and 3 spectra. When two 
analytes specifically recognized by the recognition molecules on AuNR 1 and 2 were 
added, red shift in the peaks corresponding to AuNR 1 and 2 spectra occurred, whereas 
only minimal shift in the peak associated with AuNR 3 occurred. Expectedly, red shift in 
all three SPR peaks of AuNRs occurred when their corresponding targets were added to 





2.3.4 Cytotoxicity of gold nanoparticles 
AuNPs with their novel and tunable physicochemical properties are of great 
interest for use in diverse fields including in sensor, medicine, chemical manufacturing 
and catalysis.[81, 153, 216-218] As more AuNP-based applications are being developed, there 
is an increasing concern on the toxicity and long-term adverse effects of these 
nanomaterials to humans and environment. Indeed, at nanometer-size, nanomaterials can 
exhibit unusually high reactivity owing to the large percentage of atoms lie on their 
surface.[216-218] Therefore, over the past 5-6 years, AuNPs and other engineered 
nanomaterials have been a focus of evaluation on their adsorption, distribution, 
metabolism, excretion and toxicity (ADMET) prior to their validity for applications.[216-
232]  
 AuNPs have been found to enter living cells (Figure 2.18).[85, 220, 221, 227] Feldheim 
and co-workers have used AuNPs functionalized with receptor-mediated endocytosis and 
nuclear-localization oligopeptides to penetrate HepG2 cells and transfect the nucleus 
effectively.[231] However, the successful nuclear transfection did not appear to cause cell 
death since the cell viability was greater than 95% after 12 hours of transfection. In 
addition, they found that the number of AuNPs inside the cells decreased at 4°C, 
indicating that the cell entry was energy dependent.  
In another study, Rotello and co-workers investigated the effect of surface charge 
on the cytotoxicity of AuNPs in COS-1 cells, red blood cells and Escherichia coli 
cultures for 24 hours.[225] Within particle concentration of 0.38 - 3 µM, the cationic 
AuNPs were more cytotoxic than anionic ones. However, for the cationic AuNPs, a small 
cytotoxicity variation was observed among the cell types, suggesting that different cell 
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types experienced similar toxicity. The authors proposed that the AuNPs interact with the 
cells passively rather than through energy-dependent processes. This contradicts the 
findings obtained by Feldheim and co-workers; however, this difference could be due to 
different surface functionalization used.  
 
Figure 2.18. A transmission electron microscopy image of lung fibroblasts after being 
treated with 1 nM of AuNPs for 72h. The image shows the presence of AuNPs in vesicles 
which cluster around the nucleus (N).[85] 
 
Wyatt and co-workers investigated the effect of surface functionalization of 
AuNPs on the uptake and cytotoxicity in human leukemia cells.[223] At particle 
concentration up to 25 µM, AuNPs coated with citrate, biotin, glucose and cysteine did 
not cause cytotoxicity even after three days exposure. However, AuNPs coated with 
cetyltrimethylammonium bromide (CTAB) displayed significant cytotoxicity. Indeed, 
both of CTAB and AuCl4 salts alone were found to cause 90% cell death. Within the first 
hour of exposure, the AuNP concentration dropped significantly, indicating rapid uptake 
of AuNPs by the cells. The uptaked AuNPs were found maintained their size and 
clustered in endocytic vesicles. 
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Although cationic CTAB was reported to cause cytotoxicity, Park and co-workers 
have used positively-charged primary amine-functionalized AuNPs as intracellular 
delivery vehicles for therapeutic small interfering RNA (siRNA).[233] These AuNPs 
effectively inhibited the expression of cancer gene target while maintaining cell viability 
> 85%. In another study, Klibanov and co-workers found that when monkey kidney cells 
were exposed to positively-charged polyethylenimine (PEI)-functionalized AuNPs, 80% 
of the cells were still viable.[234] Moreover, PEI-functionalized AuNPs were found to 
transfect the cells six folds better compared to PEI only. For AuNPs functionalized with 
dodecyl-PEI, the cell tranfection was better but the cell viability decreased to 70%. The 
study suggested that the internalization was a factor in cytotoxicity. 
 Synthetic nanomaterials including dendrimers have been shown to enter the cells 
through transient-poration induced penetration, a process associated with cytotoxicity.[9, 
228, 235-240] Recently, AuNPs functionalized with subnanometer striations of alternating 
anionic and hydrophobic groups have been shown to penetrate the plasma membrane of 
the dendritic and fibroblast cells without bilayer disruption.[105] Following the exposure, 
~90% cell viability was recorded. In contrast, when similar AuNPs were coated with 11-
mercaptoundecane-tetramethylammonium chloride, the cell viability decreased to 34%.  
 The presence of AuNPs in biological system can trigger immunological 
responses. Sastry and co-workers studied the effect of AuNPs on the proliferation, 
reactive oxygen species and nitric oxide of RAW264.7 macrophage cells.[240] After 
exposing the cells to 100 µm of AuNPs for 48 hours, more than 90% cell viability was 
recorded with no increase in pro-inflammatory cytokines TNF-α and IL-1β. After 72 
hours exposure, the cell viability decreased to 85%. The authors attributed this 
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observation to the depletion of nutrients in media since it was not changed in those 72 
hours. Studies have also investigated the influence of AuNPs on the proliferation, 
spreading and migration of living cells. Rafailovich and co-workers found that citrate-
stabilized AuNPs affected dermal fibroblast cell proliferation and migration.[229] The 
surface density of cells and actin fibers decreased with increasing concentration of 
AuNPs, indicating cytotoxic effects. Yung and co-workers found that 1 nM of serum-
coated AuNPs caused significant reduction in total number of viable lung fibroblast cells 
after 72 hours exposure.[85] The decrease in total cell number with no increase in non-
viable cells implies that cell proliferation was inhibited at this concentration. The 
depletion of serum protein in media by AuNPs as the cause of the decrease in total cell 
number was ruled out since AuNPs used were already coated with serum. They also 
found oxidative DNA damage after exposing the cells to AuNPs. The genes 
downregulated included genes associated with the cell cycle and with maintaining 
genomic integrity.  
 It appears that the interactions between nanomaterials and biological cells depend 
strongly on the type and surface functionalization of nanomaterials. The latter can make 
toxic nanomaterials less toxic or relatively non-toxic nanomaterials more toxic. A 
particular attention should be given to protein adsorption onto nanomaterial surface, 
which is inevitable in in vivo condition and can alter the surface properties of 
nanomaterials. As a result, it is likely that biological cells interact with protein-coated 
nanomaterials instead of bare ones. Therefore, interactions between engineered 
nanomaterials and proteins should be taken into consideration when nanomaterials with 
minimum toxicity are designed for in vivo application. 
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CHAPTER 3. An Air-supported Liquid Crystal System for Real-time 
and Label-free Characterization of Phospholipases and Their Inhibitors 
 
3.1 Introduction 
Phospholipases are an important class of interfacial membrane enzymes that 
catalyze the hydrolysis of cellular L-phospholipid molecules. Based on the position of the 
cleaving sites, phospholipases can be divided into four subclasses – phospholipase A, 
phospholipase B (PLB), phospholipase C (PLC), and phospholipase D (PLD) (Figure 3.1). 
PLA1 and PLA2 hydrolyze phospholipids into acyl lysophospholipids and free fatty acids 
at the sn-1 and sn-2 position respectively of the glycerol backbone of the phospholipids. 
PLB is a phospholipase that possesses both PLA1 and PLA2 activities. PLC hydrolyzes 
phospholipids into diacylglycerols and phosphate-containing compounds whereas PLD 
hydrolyzes phospholipids into phosphatidic acids and alcohol. Phospholipases play key 
roles in diverse biochemical processes including lipid metabolism and cellular signal 
transduction.[1] In addition to these important functions, phospholipases also take parts in 
the development of some diseases and inflammatory responses. For example, PLA2 is 
involved in the arachidonic acid cascade leading to the biosynthesis of eicosanoids 
(including thromboxanes, leukotrienes, and prostaglandins) which are responsible for a 
range of inflammatory diseases such as asthma, Prinzmetal’s angina, Raynaud’s 
phenomenon, pancreatitis, and rheumatoid arthritis.[2] Furthermore, lysophospholipids not 
only participate in stimulating cell proliferation, migration, and survival but also play a 
role in cancer initiation, progression, and metastasis.[3] Indeed PLA2 has been found to be 
overexpressed in certain tumor cells.[4, 5] Other studies have shown that PLC and PLD are 
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potential tumor promoters and their hydrolytic products, particularly diacylglycerols and 
phosphatidic acids, are likely to be involved in promoting tumor growth.[3, 6, 7] Therefore, 
characterizations of phospholipase activities as well as the identification of new 
compounds that can modulate these activities are of great and continuous interests in 
pursuing novel therapeutic strategies as well as deeper understanding in diverse 
biochemical processes involving these enzymes. 
`  
Figure 3.1. A model of phospholipid structure indicating the cleavage points by various 
phospholipases including PLA1, PLA2, PLC and PLD. 
 
Existing methods of characterizing phospholipase activities include colorimetric, 
radiochemical and fluorescent assays.[8-11] In these methods, labelled phospholipids are 
used as substrates in the form of liposomes or phospholipid monolayer, and the 
phospholipase activities are characterized by measuring the absorbance, radioactivity, or 
fluorescence signals of the cleaved products. Colorimetric assays are less sensitive than 
the radiochemical method. However, the need for labelling the phospholipids by 
fluorescent and radiochemical tags hinder them from being used in high-throughput 
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applications. Moreover, the changes in the chemical structure of phospholipids due to 
labelling may decrease the extent of substrate-enzyme hydrolysis.  
Recently, a new method to characterize PLA2 activities by using phospholipid 
monolayer self-assembled at the aqueous-liquid crystal (LC) interface has been 
reported.[12] In this system, the orientations of LCs are coupled to the presence of 
phospholipids, therefore, they are able to transduce and amplify the enzymatic events 
acting on the phospholipids. This approach permits a real-time and label-free imaging of 
spatial and temporal distribution of the phospholipids during the enzymatic reactions. The 
use of complex instrumentations can also be avoided since LC molecules are birefringent 
and the orientational transition of LCs can be readily visualized under crossed 
polarizers.[13] This approach, however, requires a large amount of sample volume (≥ 250 
µL) due to the presence of dead space in the system. Such sample requirement greatly 
hinders the continuous implementation of this LC system for detection applications 
involving precious samples.  
Herein, we report an air-supported LC system for analysing interfacial 
phenomena occurred due to molecular interaction between LCs and adsorbed molecules 
of interest at aqueous-LC interface (Figure 3.2). Compared with the existing LC system, 
the system reported here requires less sample volume and involves simpler, faster and 
safer preparation. This opens the possibility for high throughput and cost-effective LC-
based analytical assays. We used this system to characterize the hydrolytic activities of 
various phospholipases and demonstrated the potential application of this system for 
screening phospholipase inhibitors. The hydrolysis of L-α-dilauroyl phosphatidylcholine 
(L-DLPC) monolayer self-assembled at aqueous-LC interface induced the orientational 
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responses of LCs. As a result, optical signals that reflect the spatial and temporal 
distributions of phospholipids during the enzymatic reactions can therefore be obtained. 
When the phospholipase was introduced together with a known inhibitor, no orientational 
response of LCs was observed. In some cases, cross-inhibitions of phospholipases by 
other inhibitors were observed. This work suggests that air-supported LCs combined with 
phospholipid monolayer self-assembled at aqueous-LC interface provide a facile assay 
for characterizing phospholipase activities and for screening potential phospholipase 
inhibitors.  
 
3.2 Experimental Section 
3.2.1 Materials  
Tris(hydroxymethyl)aminomethane (Tris), sodium chloride, calcium chloride, 
hydrochloric acid, sodium hydroxide, chloroform, ethanol, methanol, acetone, capillary 
tubes, Eukitt mounting medium, PLA2 (Naja mossambica mossambica) were purchased 
from Sigma-Aldrich (U.S.). PLC (Bacillus cereus) and PLD (Streptomyces) were 
purchased from Calbiochem (U.S.). L-α-dilauroyl phosphatidylcholine (L-DLPC) was 
purchased from Avanti Polar Lipids (U.S.). 4'-pentyl-4- cyanobiphenyl (5CB) was 
purchased from Merck (U.S.). Veco gold grids 200 mesh (20-μm thickness, 85-μm grid 
spacing, and 50-μm bar width) was purchased from Electron Microscopy Science (U.S.). 
Glass slides were purchased from Marienfeld (Germany). Nickel grid-coating plate was 
purchased from Ted Pella (U.K.). Ultrapure water, with a resistivity of 18.2 MΩ cm, was 




    








Figure 3.2. (A) Top view of the gold grid (top) and cross-sectional view of the gold grid 
impregnated with LCs and exposed to aqueous sample confined in the nickel support 
plate (bottom). (B) Top view of the experimental setup. (C) and (D) are the 
corresponding orientational profiles of air-supported LCs before (C) and after (D) the 
phospholipid adsorb to the aqueous-LC interface. A planar orientation of LCs at the 
aqueous-LC interface is found in (C) and a homeotropic orientation of LCs at the 
aqueous-LC interface is found in (D).  
 
3.2.2 Preparation of phospholipid solution 
Phospholipid solutions were prepared following standard procedures published in the 




Aqueous phase Suspension of phospholipid
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and placed under vacuum for at least 3 h. The dried phospholipid was resuspended with 
Tris-buffered saline (TBS, consisting of 10 mM Tris, 150 mM NaCl at pH 8.9) to a final 
concentration of 100 µM. The resulting solution was cloudy indicating the presence of 
large multilamellar vesicles (MLV). The phospholipid suspension was then sonicated 
(VCX 130pb, Sonics and Materials Inc., U.S.) three times each for 5 min at T > Tm (Tm 
of L-DLPC is 1°C) to obtain a clear solution. This solution was filtered twice using a 
0.22-μm filter (Millipore, U.S.) and typically used within 2 days after the preparation.  
 
3.2.3 Preparation of the air-supported LC system 
Glass slides were cleaned by sonication in a 5 % Decon-90 solution for 15 min. The 
slides were then rinsed with deionized water, dried under a stream of nitrogen gas, and 
heated in a 100°C oven for 30 min. The slide was then immersed into a chloroform 
solution containing 10 % (w/v) Eukitt mounting medium. Subsequently, a nickel plate 
support with holes (diameter 2.4 mm and depth 0.42 mm) was placed onto the slide and 
secured using binder clips on both sides of the plate (Figure 3.2). This system was then 
placed inside a vacuum oven at 65°C for 2 h. Meanwhile, 200-mesh gold grids (width ~ 
85 μm; depth ~ 20 μm) were cleaned sequentially in ethanol, methanol, and acetone with 
sonication, and then heated at 100°C for at least 3 h.[12] The gold grid was then 
impregnated with ~ 0.5 μL of 5CB using a capillary tube. Excess 5CB was removed by 
contacting the LC with the other end of the capillary tube. The grids containing LCs were 
then put on the wells of the plate containing samples of interest. This optical cell was 
then ready for examination under cross-polarized lighting. 
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3.2.4 Formation of phospholipid monolayer 
Prior to the formation of L-DLPC monolayer, 0.1 mM of L-DLPC solution was added to 
one of the wells of the plate support. L-DLPC monolayer was then prepared by 
contacting gold grid impregnated with 5CB to the L-DLPC solution in the well. Fusion of 
L-DLPC vesicles was allowed to occur for 2 h.[14] At the end of the equilibration, the grid 
containing 5CB laden with L-DLPC was transferred and contacted to fresh TBS buffer to 
remove excess L-DLPC and to ensure the formation of L-DLPC monolayer at 5CB 
interface.[14]  
 
3.2.5 Enzymatic activity assay 
Prior to the characterization of phospholipase activity, various types and concentrations 
of phospholipase solutions (in 10 mM Tris, 150 mM NaCl, pH 8.9) in the presence of 5 
mM Ca2+ were added to the wells of the plate support. The grids containing 5CB laden 
with L-DLPC monolayer were then transferred and contacted to these phospholipase 
solutions. For the phospholipase inhibition and cross-inhibition experiments, before 
exposing to L-DLPC monolayer, known inhibitor was first added to phospholipase 
solution in the presence of 5 mM Ca2+. 
 
3.2.6 Optical examination of LC orientation  
The optical orientation of LCs was examined using a Nikon eclipse LV100 POL 
microscope equipped with crossed polarizers in a transmission mode. The optical cell 
was placed on a rotating stage between two polarizers. Orthoscopic examination was 
performed with light intensity of ~ 70% full illumination and the aperture of ~ 40% full 
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opening in order to collimate the incident light. Homeotropic optical textures were 
determined by observing the absence of transmitted light during a 360° rotation of the 
sample. Planar optical textures were determined by the birefringence of LCs when the 
sample was observed between crossed polarizers. A reference for the description of the 
LC textures can be found elsewhere.[13, 15] All images were captured using a digital 
camera (Nikon, Japan) mounted on the microscope. 
 
3.3 Results and Discussion 
3.3.1 Design of the air-supported LC system  
The geometry of air-supported LC system shown in Figure 3.2 exploits air to 
provide a boundary condition that aligns LCs homeotropically.[16] The LC films are 
confined within gold grids that provide capillary forces for confining LC between the air 
and aqueous phases with a good stability (Figure 3.2A).[17] The gold grids containing LCs 
are then put onto a metal plate comprising holes filled with aqueous samples to create a 
miniature closed system (Figure 3.2B). Following this design, the amount of the samples 
required can be reduced to as little as 2 µL and more than 100 samples can be loaded 
onto each plate. Overall, since air is homogeneous and readily available, a uniform 
anchoring of the LCs can be obtained without preparing homogeneous hydrophobic glass 
substrate (Figure 3.2C and D). Thus, a simple and cost-effective LC-based system that 
permits the imaging of interfacial phenomena at aqueous-LC interface can be achieved.  
The working principle of this system was demonstrated using water-immiscible 
nematic liquid crystal 4-cyano-4’-pentylbiphenyl (5CB). When the grid containing 5CB 
was contacted with aqueous buffer, a colourful image associated with near planar 
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orientation of 5CB at the aqueous interface was observed (Figure 3.3A).[17-19] When the 
grid was transferred to a 0.1 mM L-α-dilauroyl phosphatidylcholine (L-DLPC) solution, 
the self-assembly of L-DLPC at the aqueous-LC interface induced a rapid orientation 
change of 5CB from planar to homeotropic and yielded a uniformly dark image (Figure 
3.3B). This observation is in good agreement with past studies where the orientation 
change of LCs reflects the formation of the phospholipid monolayer at aqueous-LC 
interfaces.[12, 14] Next, we placed the grid containing 5CB laden with L-DLPC under 100 
% relative humidity condition at room temperature to investigate the stability of this 
system towards the humidity in air. Our result shows that the dark appearance of 5CB 
was still intact after 10 h of exposure to humid air (Figure 3.3C). This observation leads 
us to propose that the water does not condense on the surface of liquid crystals even in an 
environment with a high humidity, probably because of the hydrophobic nature of 5CB. 





           
Figure 3.3. (A-C) Cross-polarized optical images of 5CB confined within a gold grid 
when exposing to (A) TBS buffer containing no L-DLPC, and (B) TBS buffer containing 
0.1 mM of L-DLPC. (A) and (B) after preparation; (C) after exposed to 100% relative 




A B C 
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3.3.2 Enzymatic hydrolysis of phospholipid monolayer by phospholipases 
For the enzymatic hydrolysis study, we exposed the L-DLPC monolayer self-
assembled at the aqueous-LC interface (Figure 3.2D) to various phospholipases. Figure 
3.4A-E shows the optical images of air-supported 5CB laden with L-DLPC monolayer as 
a function of PLA2 concentration. It has been reported the enzymatic hydrolysis of L-
DPLC monolayer self-assembled at aqueous-LC interface by PLA2 induces the 
orientational response of LCs.[12] The enzymatic events trigger changes in the orientation 
of LCs from homeotropic to planar giving visible optical signals from dark to bright 
respectively. At PLA2 concentrations of 10 pM or above, we observed the bright optical 
image of 5CB in the presence of 5 mM Ca2+ (Figure 3.4A-D). When the bulk 
concentration of PLA2 was decreased to 1 pM, however, the optical image of LCs 
remained dark, indicating the detection limit of PLA2 (Figure 3.4E). To seek the 
enzymatic activities of PLC and PLD on the L-DLPC monolayer at aqueous-LC interface, 
the same experiment was repeated. Bright optical images were observed at PLC 
concentrations of greater than 10 nM (Figure 3.4F). At 10 nM concentration, however, 
only patches of bright domains in the optical image was observed (Figure 3.4G). No 
measurable optical response of LCs was observed at the bulk concentrations of PLC of 1 
nM or lower (Figure 3.4H). Similarly, these partial and full bright optical images of LCs 
were observed with PLD at 10 nM concentrations and greater than 10 nM respectively 
(Figure 3.4I-J). Decreasing the concentration of PLD to 1 nM or less resulted in dark 
optical images as well (Figure 3.4K). PLA2 (Naja mossambica mossambica) has 
enzymatic activity of 1900 units/mg, PLC (Bacillus cereus) has 58 units/mg and PLD 
(Streptomyces) has 76 units/mg. In the case of PLA2, the enzymatic detection reported 
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here requires less than 1 pg due to the small sample volume needed in this system. Based 
on the above results, the phospholipid monolayer self-assembled at aqueous-LC interface 







                       
 
 
                     
 
 
                                                          
 
 
Figure 3.4. Cross-polarized optical images of 5CB laden with L-DLPC when exposed to 
various concentrations of (A-E) PLA2, (F-H) PLC, (I-K) PLD in the presence of Ca2+. 
Scale bar = 85 μm. 
 
To monitor whether the non-specific adsorption of phospholipases onto 
phospholipid monolayer at aqueous-LC interface triggers the orientational response of 
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containing no Ca2+. Under a range of phospholipases (PLA2, PLC and PLD) 
concentrations in which the orientational responses of LCs was observed in the presence 
of Ca2+, no optical response of LCs was detected in the absence of Ca2+ (Figure 3.5A-F). 
When the bulk concentration of phospholipases was increased to greater than 500 nM, 
however, we observed optical responses of LCs from dark to bright, indicating non-
specific adsorption of phospholipases onto L-DLPC monolayer indeed can occur in the 
absence of Ca2+ (Figure 3.5G-I). A similar degree of non-specific adsorption was found 
for all three phospholipases since more than 500 nM of each enzyme were required to 
induce bright optical LC images. In addition, the degree of non-specific adsorptions 
shown by these three phospholipases does not correlate with the level of their enzymatic 
activities. Since the enzyme concentration required to exhibit orientational changes of 
LCs via non-specific adsorption is substantially higher (> 500 nM), the results here 
further support that the optical images of LCs shown in Figure 3.4 reflect the enzymatic 
hydrolysis of L-DLPC monolayer by phospholipases (PLA2, PLC and PLD) in the 
presence of Ca2+.  
In the case of PLA2, the effect of PLA2 hydrolysis on LC-supported phospholipid 
monolayer depends on the aliphatic chain length of phospholipids.[12, 20] For L-DLPC, 
which has two saturated C12 aliphatic chains, the enzymatic hydrolysis causes desorption 
of the enzymatic product, 1-lauroyl-2-hydroxy-sn-glycero-3-phosphocholine, from the 
aqueous-LC interface. This is because 1-lauroyl-2-hydroxy-sn-glycero-3-phosphocholine 
has only a single C12 aliphatic chain which, in turn, may result in weak hydrophobic and 
Van der Waals interaction with 5CB at the interface.[12, 21] The desorption consequently 
lowers the surface density of phospholipid monolayer and creates phospholipid-depleted 
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regions, where the contact between LCs and aqueous phase occurs. This results in a 
change in the optical appearance of LCs from dark to bright that reflects the spatial 
organization of the phospholipids at the interface. For L-1,2-dipalmitoyl-sn-glycero-3-
phosphocholine (L-DPPC), which has two saturated C16 aliphatic chains, the enzymatic 
product, 1-palmitoyl-2-hydroxy-sn-glycero-3-phosphocholine, does not desorb from the 
aqueous-LC interface. This is because 1-palmitoyl-2-hydroxy-sn-glycero-3-
phosphocholine has a long C16 aliphatic chain which, in turn, may result in stronger 
hydrophobic and Van der Waals interaction with 5CB at the interface.[21] However, 
hydrolysis of L-DPPC monolayer by PLA2 at the aqueous-LC interface can still lead to 
the formation of small bright domains in the optical image of LCs. It is possible that these 
domains are triggered by the adsorption of enzymes onto lipid and fatty acid enzymatic 
products at the interface. 
Unlike PLA2, no studies have investigated the enzymatic activity of PLC and 
PLD acting on LC-supported phospholipid monolayer. To understand more on this, we 
first tested whether the enzymatic products 1,2-dilauroyl-sn-glycerol (DLG) and 1,2-
dilauroyl-sn-glycero-3-phosphate (DLPA), generated from the hydrolysis of L-DLPC by 
PLC and PLD respectively, could self-assemble at the aqueous-LC interface. Exposing 
5CB to a solution containing either DLG (Figure 3.6A) or DLPA (Figure 3.6B) resulted 
in uniform dark optical images, indicating the self-assembly of DLG or DLPA at the 
aqueous-LC interface. The 5CB films laden with DLG or DLPA were then exposed to 
fresh buffer containing no enzymatic products or phospholipids. In both cases, no 
measurable change in the optical images of 5CB could be observed even after 24h. These 
results suggest that the hydrophobic and Van der Waals interaction between the self-
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assembled enzymatic products, DLG and DLPA, and 5CB is sufficient to hold the 
enzymatic products intact stably at the aqueous-LC interface. This is in good agreement 
with past studies showing both diacylglycerol and phosphatidic acid compounds, such as 
DLG and DLPA, do not desorb from vesicles, oil-water, or air-water interface.[10, 22, 23] In 
addition, because the self-assembly of L-DLPC, DLG, and DLPA at the 5CB-aqueous 
interface all cause 5CB to become uniformly dark, the generation of the enzymatic 






   
 
 
   
 
 
   
 
 
Figure 3.5. Cross-polarized optical images of 5CB laden with L-DLPC when exposed to 
various concentrations of (A,D,G) PLA2, (B,E,H) PLC, (C,F,I) PLD in the absence of 










To investigate whether Ca2+ present in the buffer during the enzymatic reaction 
can interact with the enzymatic products, we exposed 5CB films laden with either DLG 
or DLPA to buffers containing various Ca2+ concentrations. We found that the optical 
images of 5CB laden with DLG remained uniformly dark at 500 mM Ca2+ (Figure 3.6C). 
For 5CB laden with DLPA, however, the optical image changed from dark to bright at 
the same Ca2+ concentration (Figure 3.6D). This indicates some degree of interaction 
between DLPA and Ca2+. Previous studies have reported that the negatively-charged 
DLPA can attract positively-charged Ca2+ and induce the formation of Ca2+-bridged 
DLPA complexes.[23] In our case, clustered DLPA-Ca2+ complexes may destabilize the 
monolayer and permit direct contact between LCs and aqueous phase, which may result 
in a change in the optical appearance of LCs from dark to bright. No bright LC image 
was observed in the case of 5 mM Ca2+, the concentration used in the phospholipase 
hydrolysis of L-DLPC monolayer (data not shown). This indicates that although clustered 
DLPA-Ca2+ complexes may destabilize the monolayer at 500 mM Ca2+, it is unlikely the 
cause of the bright images upon the hydrolysis of L-DPLC. 
To investigate whether PLC and PLD themselves can interact with the DLG and 
DLPA monolayers respectively, we exposed 5CB laden with either DLG or DLPA to a 
solution of PLC or PLD containing no Ca2+. The absence of the enzyme cofactor Ca2+ 
eliminates the possibility of DLG and DLPA hydrolysis by enzymes during our 
experiments. At 100 nM of PLC (the same concentration used for our enzymatic 
hydrolysis study earlier), the optical image of 5CB laden with DLG changed from dark to 
bright (Figure 3.6E). Same phenomenon was observed when exposing the same 
concentration of PLD to DLPA (Figure 3.6F). These results suggest that there is non-
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specific adsorption of PLC (or PLD) onto the DLG (or DLPA) layer. The concentration 
of PLC (or PLD) causing the non-specific adsorption on the DLG (or DLPA) layer is less 
than that required for the case of L-DLPC (> 500 nM, see Figure 3.5). This is likely due 
to the different abilities to resist non-specific protein adsorption. L-DLPC has a 
zwitterionic phosphocholine headgroup that is well-known to resist non-specific protein 
adsorption.[24, 25] In contrast, DLG is relatively non-polar and DLPA is anionic. No 
studies have ever reported that any of DLG or DLPA can resist non-specific protein 
adsorption. On the basis of the results mentioned above, we believe that the change of the 
optical appearance of LC laden with L-DLPC monolayer from dark to bright after 
PLC/PLD hydrolysis is due to the non-specific adsorption of enzymes on the digested 
DLG/DLPA. Further investigation is currently conducted to confirm this. 
 
3.3.3 Inhibition of phospholipase activity 
After investigating the detection limits and non-specific adsorptions of phospholipases 
towards L-DLPC monolayer at aqueous-LC interface, a range of phospholipase 
concentrations was established for studying the phospholipase inhibition phenomena. In 
these experiments, 100 nM of phospholipase and known phospholipase inhibitors (1-
hexadecyl-3-trifluoroethylglycero-2-phosphomethanol (MJ33) for PLA2, compound 
48/80 for PLC, and ethylene glycol-bis(2-aminoethylether)-N,N,N’,N’-tetraacetic acid 
(EGTA) for PLD) were used. MJ33 and compound 48/80 are known to inhibit PLA2 and 
PLC respectively by forming enzyme-substrate analogue complexes whereas EGTA is 
known to inhibit phospholipases through binding with their cofactors, Ca2+.[25-27] 
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Figure 3.6. Cross-polarized optical images of 5CB laden with (A, C, E) DLG and (B, D, 
F) DLPA after being exposed to either (C, D) 500 mM of Ca2+, or 100 nM of (E) PLC or 
(F) PLD. Scale bar = 85 μm. 
 
In the presence of 5 mM Ca2+ and 0.5 mM inhibitors, exposing L-DLPC monolayer to a 
mixture of either PLA2 and MJ33 or PLC and compound 48/80 resulted in dark optical 
images (no responses) of LCs (Figure 3.7A and B). Similarly, PLD mixed with EGTA (> 
5 mM) in the presence of 5 mM Ca2+ yielded the same optical response of LCs (Figure 
3.7C). The concentrations of MJ33 and compound 48/80 needed to inhibit PLA2 and PLC 
respectively could be much lower than the concentration of Ca2+ in the bulk phase 
(Figure 3.8A and B). However, at MJ33 and compound 48/80 concentrations of 5 μM, 
there were much less inhibition effects can be observed (Figure 3.8C and D). When 
decreasing the concentrations of MJ33 and compound 48/80 to 1 μM or less, there were 






inhibition by EGTA, the concentrations of EGTA needed strongly depend on the 
concentration of Ca2+ in the bulk phase (Figure 3.8G and H). When the concentration of 
EGTA was slightly lower than Ca2+ one, there was almost no inhibition effect of PLD 
activities can be observed (Figure 3.8H). 
 
 
   
 
 
Figure 3.7. Cross-polarized optical images of 5CB laden with L-DLPC when exposed to 
a mixture of (A) PLA2 and MJ33, (B) PLC and compound 48/80, (C) PLD and EGTA. 
Scale bar = 85 μm. 
 
To the best of our knowledge, the cross-inhibition among phospholipases was 
often performed in a cellular system but not in a model system.[26, 27] The compositional 
complexity encountered in those cellular studies usually leads to inconclusive 
interpretation. Here, using a system with well-defined composition, we attempted to 
determine cross-inhibition effect of the three inhibitors used above by testing each 
inhibitor with the other two phospholipases. Incubating MJ33 with either PLC or PLD 
resulted in dark optical images (Figure 3.9A and B), suggesting that MJ33 cross-inhibits 
PLC and PLD. The observation of PLC inhibition by MJ33 is consistent with past study 
that showed slight inhibition of PLC at low concentration of MJ33.[28] While incubating 
compound 48/80 with PLA2 led to bright optical images (Figure 3.9C), dark optical 
images were obtained with PLD (Figure 3.9D). These results suggest that compound 
48/80 cross-inhibits PLD but not PLA2. The observation of no PLA2 inhibition by 
A B C
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compound 48/80, however, contradicts with a past study that showed a dose-dependent 
inhibition of PLA2 by compound 48/80 at concentration above 1 µg/mL.[26] We do not 
know yet the reasons behind this difference but it may be due to the difference of the 
experimental system. Inhibitions of PLA2 and PLC by EGTA were observed when the 
concentrations of EGTA were above the concentrations of Ca2+ (Figure 3.9E and F). This 
is expected since EGTA binds with Ca2+. Without the presence of free Ca2+, both PLA2 
and PLC should be inhibited.  
 
 
                        
 
 






                       
 
 
Figure 3.8. Cross-polarized optical images of 5CB laden with L-DLPC showing the 
effects of inhibitors on the enzymatic activities of phospholipases. (A, C, E) PLA2 in the 
presence of various concentrations of MJ33; (B, D, F) PLC in the presence of various 
concentrations of compound 40/80; (G, H) PLD in the presence of various concentrations 
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Figure 3.9. Cross-inhibition among phospholipases by (A, B) MJ33, (C, D) compound 
48/80, (E, F) EGTA. Scale bar = 85 μm. 
 
3.4 Conclusion 
We have designed a new air-supported LC system for analysing interfacial 
phenomena based on molecular interaction between LCs and adsorbed molecules of 
interest at aqueous-LC interface. Compared with the existing LC system, the system 
reported here requires much less sample volume, involves much simpler and safer 
preparation, and is recyclable. This system offers a LC-based analytical platform for 










characterize the hydrolytic activities of various phospholipases including PLA2, PLC and 
PLD. The enzymatic hydrolysis of phospholipid monolayer self-assembled at aqueous-
LC interface induces an orientational response of LCs after exposing to the three 
phospholipases. When introducing known phospholipase inhibitors, no orientational 
response of LCs was observed. In some cases, cross-inhibitions on the other 
phospholipases were also observed. This work suggests that air-supported LCs combined 
with phospholipid monolayer self-assembled at aqueous-LC interface provide a facile 
label-free assay for characterizing phospholipase activities, and screening compound 




1. Waite, M., The Phospholipases, Plenum, New York, 1987. 
2. Dennis, E. A.; Wong, P. Y. K., Phospholipase A2: Role and Function in 
Inflammation, Plenum, New York, 1990. 
3. Mills, G. B.; Moolenaar, W. H., Nature 2003, 3, 582. 
4. Graff, J. R.; Konicek, B. W.; Deddens, J. A.; Chedid, M.; Hurst, B. M.; Colligan, 
B.; Neubauer, B. L.; Carter, H. W.; Carter, J. H., Clin Cancer Res 2001, 7, 3857. 
5. Yamashita, S.; Yamashita, J.; Ogawa, M., Br J Cancer 1964, 69, 1166. 
6. Daniel, L. W.; Sciorra, V. A.; Ghosh, S., Biochim Biophys Acta 1999, 1439, 265. 
7. Kassis, J.; Moellinger, J.; Lo, H.; Greenberg, N. M.; Kim, H. G.; Wells, A., Clin 
Cancer Res 1999, 5, 2251. 
8. Bayburt, T.; Yu, B. Z.; Street, I.; Ghomashchi, F.; Laliberte, F.; Perrier, H.; Wang, 
Z. Y.; Homan, R.; Jain, M. K.; Gelb, M. H., Anal Biochem 1995, 232, 7. 
9. Ehnholm, C.; Kuusi, T., Methods Enzymol 1986, 129, 716. 
10. Jelinek, R.; Okada, S.; Norvez, S.; Charych, D., Chem Biol 1998, 5, 619. 
11. Reynolds, L. J.; Hughes, L. L.; Dennis, E. A., Anal Biochem 1992, 204, 190. 
12. Brake, J. M.; Daschner, M. K.; Luk, Y. Y.; Abbott, N. L., Science 2003, 302, 
2094. 
13. Collings, P. J., Liquid crystals: nature's delicate phase of matter, Princeton 
University Press, 2002. 
14. Brake, J. M.; Daschner, M. K.; Abbott, N. L., Langmuir 2005, 21, 2218. 
15. Woltman, S. J.; Crawford, G. P.; Jay, G. D., Liquid crystals: frontiers in 
biomedical applications, World Scientific Publishing Company, 2007. 
16. Nazarenko, V.; Nych, A., Phys Rev E 1999, 60, 3495. 
 77
17. Brake, J. M.; Abbott, N. L., Langmuir 2002, 18, 6101. 
18. Brake, J. M.; Mezera, A. D.; Abbott, N. L., Langmuir 2003, 19, 8629. 
19. Price, A. D.; Schwartz, D. K., J Phys Chem B 2007, 111, 1007. 
20. Brake, J. M.; Abbott, N. L., Langmuir 2007, 23, 8497. 
21. Brake, J. M.; Mezera, A. D.; Abbott, N. L., Langmuir 2003, 19, (16), 6436-6442. 
22. Kondo, T.; Kakiuchi, T.; Senda, M., Bioelectroch Bioener 1994, 34, 93. 
23. Kondo, T.; Kakiuchi, T.; Shimomura, M., Thin Solid Films 1994, 244, 887. 
24. Chen, S.; Yu, F.; Yu, Q.; He, Y.; Jiang, S., Langmuir 2006, 22, 8186. 
25. Cornell, D. G.; Patterson, D. L.; Hoban, N., J Colloid Interf Sci 1990, 140, 428. 
26. Bronner, C.; Wiggins, C.; Monte, D.; Marki, F.; Capron, A.; Landry, Y.; Franson, 
R. C., Biochim Biophys Acta 1987, 920, 301. 
27. Ellisdavies, G. C. R.; Kaplan, J. H., P Natl Acad Sci USA 1994, 91, 187. 




CHAPTER 4. A Liquid Crystal-based Sensor for Real-time and Label-
free Identification of Phospholipase-like Toxins and Their Inhibitors 
 
4.1 Introduction 
Phospholipase-like toxins are protein toxins that exhibit phospholipase enzymatic 
activity. This activity enables the toxins to hydrolyze phospholipid cell membranes. 
These toxins are usually found in venoms of certain types of animals especially snakes. 
For example, beta-bungarotoxin is a 21.8 kDa Bungarus snake venom which exhibits 
Ca2+-dependent phospholipase A2 (PLA2) activity.[1] Many phospholipase-like toxins are 
considered among the most potent toxins. Studies have reported that beta-bungarotoxin 
can induce more potent cytotoxic effects than other toxins such as alpha-bungarotoxin, 
cardiotoxin and melittin.[2]  
Several studies have reported the development of assays for identifying and 
characterizing phospholipase-like toxins.[3-6] Applications of these assays include (1) 
selective screening of new toxins and compounds that exhibit phospholipase activity, (2) 
screening for toxin antidotes, (3) diagnosis for snake envenomation which is a serious 
problem in many tropical and subtropical countries, (4) detection against the use of these 
toxins as biological warfare. Van Dong et al. used horse-peroxidase-induced precipitation 
of tetramethylbenzidine to detect the presence of beta-bungarotoxin.[6] They also 
exploited optical changes of gold-coated silicon chips for detecting the same toxin.[5] 
Selvanayagam et al. used changes in the electrical current of field-effect transistor to 
detect beta-bungarotoxin.[4] Gao et al. used quantum dots as fluorescence labels to detect 
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the presence of beta-bungarotoxin on polystyrene beads.[3] All of these existing immuno-
based detection require time-consuming and expensive labeling of antibodies.   
In Chapter 3, we have applied a novel air-supported LC system to characterize 
phospholipase activity using phospholipid monolayer self-assembled at the aqueous-
liquid crystal (LC) interface. The orientation of LCs is coupled to the presence of 
phospholipids such that it can be used to transduce and amplify enzymatic events acting 
on the phospholipids. This approach permits a label-free and real-time detection of 
phospholipase. The use of complex instrumentations can also be avoided since LC 
molecules are birefringent and the orientational transition of LCs can be readily 
visualized under crossed polarizers.[7]  
In this chapter, we report the air-supported LC system for real-time and label-free 
identification of phospholipase-like toxins. To the best of our knowledge, LC has never 
been used to report the activity of phospholipase-like toxins such as beta-bungarotoxin 
before. In the present study, we sought to investigate the activities of beta-bungarotoxin 
towards L-α-dilauroyl phosphatidylcholine (L-DLPC) monolayer at aqueous-LC interface 
and their coupling to the orientational responses of LCs. We also investigated the effects 
of phospholipase A2 inhibitors to the activities of beta-bungarotoxin. This work 
demonstrates the development of a facile and cost-effective LC-based sensor for 
identifying phospholipase-like toxins and for screening their potential antidotes. 
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4.2 Experimental Section 
4.2.1 Materials 
Tris(hydroxymethyl)aminomethane (Tris), sodium chloride, calcium chloride, 
hydrochloric acid, sodium hydroxide, chloroform, ethanol, methanol, acetone, capillary 
tubes, Eukitt mounting medium, beta-bungarotoxin (B. multicinctus), alpha bungarotoxin 
(B. multicinctus), myotoxin II (C. viridis) were purchased from Sigma-Aldrich (U.S.). L-
α-dilauroyl phosphatidylcholine (L-DLPC) was purchased from Avanti Polar Lipids 
(U.S.). Liquid crystal 4'-pentyl-4- cyanobiphenyl (5CB) was purchased from Merck 
(U.S.). Veco gold grids 200 mesh (20-μm thickness, 85-μm grid spacing, and 50-μm bar 
width) was purchased from Electron Microscopy Science (U.S.). Glass slides were 
purchased from Marienfeld (Germany). Nickel grid-coating plate was purchased from 
Ted Pella (U.K.). Ultrapure water, with a resistivity of 18.2 MΩ cm, was obtained from a 
Milli-Q system.  
 
4.2.2 Preparation of the air-supported LC optical cell 
An air-supported LC optical cell can be prepared following our previous 
published procedure.[8] Briefly, glass slides were cleaned by sonication in a 5 % Decon-
90 solution for 15 min. The slides were then rinsed with deionized water, dried with N2 
gas, and heated in a 100°C oven for 30 min. The slide was then immersed into a 
chloroform solution containing 10 % (w/v) Eukitt mounting medium. Subsequently, a 
nickel plate support with holes (diameter 2.4 mm and depth 0.42 mm) was placed onto 
the slide and secured using binder clips on both sides of the plate. This optical cell was 
then placed inside a vacuum oven at 65°C for 2 h. Meanwhile, 200-mesh gold grids 
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(width ~ 85 μm; depth ~ 20 μm) were cleaned sequentially in ethanol, methanol, and 
acetone with sonication, and then heated at 100°C for at least 3 h. The gold grid was then 
impregnated with ~ 0.5 μL of 5CB using a capillary tube. Excess 5CB was removed by 
contacting the LC with the other end of the capillary tube. The grids containing LCs were 
then put on the wells of the plate containing samples of interest. 
 
4.2.3 Formation of phospholipid monolayer 
LCs laden with phospholipid monolayer were prepared from L-DLPC 
phospholipid solution following standard procedures published in the literatures.[9] 
Briefly, phospholipids dissolved in chloroform was dried with N2 gas and placed under 
vacuum for at least 3 h. The dried phospholipid was resuspended with Tris-buffered 
saline (TBS, consisting of 10 mM Tris, 150 mM NaCl at pH 8.9) to a final concentration 
of 100 µM. The cloudiness of resulting solution indicated the presence of large 
multilamellar vesicles. The phospholipid suspension was then sonicated three times each 
for 5 min at T > Tm (Tm of L-DLPC is 1°C) to obtain a clear solution. This solution was 
filtered twice using a 0.22-μm filter and typically used within 2 days after the preparation. 
Prior to the formation of L-DLPC monolayer, 0.1 mM of L-DLPC solution was added to 
one of the wells of the plate support. L-DLPC monolayer was then formed by contacting 
gold grid impregnated with 5CB to the L-DLPC solution in the well. Fusion of L-DLPC 
vesicles was allowed to occur for 2 h. At the end of the equilibration, the grid containing 
5CB laden with L-DLPC was transferred to fresh TBS buffer. This procedure ensures that 
there was no excess L-DLPC in the buffer solution.  
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4.2.4 LC-based sensor for phospholipase-like toxin testing 
Prior to the identification of beta-bungarotoxin, 2 µL of solution containing each 
toxin (in 10 mM Tris, 150 mM NaCl, 5mM Ca2+, pH 8.9) were added to individual wells. 
5CB (confined in gold grids) laden with L-DLPC monolayers were then immersed in 
these toxin solutions. In our inhibition experiments, phospholipase A2 (PLA2) inhibitors 
were also added to beta-bungarotoxin solution before the immersion of 5CB. 
 
4.2.5 Optical examination of LC textures  
Optical textures of LCs were examined using a Nikon eclipse LV100 POL 
microscope equipped with crossed polarizers in a transmission mode. The optical cell 
was placed on a rotating stage between two polarizers. Orthoscopic examination was 
performed with a light intensity of ~ 70% of maximum illumination and the aperture of ~ 
40% full opening in order to collimate the incident light. Homeotropic orientations were 
determined by observing the absence of transmitted light during a 360° rotation of the 
sample. Planar orientations were determined from bright optical textures of LCs when 
samples were rotated between crossed polarizers. A reference for the description of the 
LC textures can be found elsewhere.[7, 10] All images were captured using a CCD camera 
(Nikon, Japan) mounted on the microscope. Tilt angles of 5CB were determined by 


























The refractive indexes, IIn and ⊥n , of 5CB are 1.711 and 1.5296. The effective 
birefringence, effnΔ , was determined by matching the colour of 5CB optical images to 
Michel-Levy chart at a thickness, d, of 20 μm. For each value of effnΔ , the tilt angle of 
5CB, θ , at aqueous-5CB interface was then determined numerically. 
 
4.3 Results and discussion 
4.3.1 Self-assembly of phospholipid monolayer at aqueous-LC interface  
In this LC-based sensor, phospholipid monolayer at aqueous-LC interface was 
used as the toxin substrate. This monolayer was prepared by exposing the 5CB-filled 
grids to aqueous solution containing 100 µM of L-DLPC. Following the exposure, the 
initially bright optical images of 5CB (Figure 4.1A) changed to uniformly dark (Figure 
4.1B), indicating the self-assembly of L-DLPC at aqueous-LC interface. This observation 
is in good agreement with past studies showing that orientational changes of LCs reflect 
the formation of the phospholipid monolayer at aqueous-LC interfaces (Figure 4.1C and 
D).[9] Films of 5CB laden with L-DLPC were then washed with TBS buffer at pH = 8.9 
and exposed to a variety of toxins. 
 
4.3.2 Identification of phospholipase-like toxin 
Three toxins were used in this study: (1) beta-bungarotoxin, a Bungarus snake 
venom exhibits Ca2+-dependent phospholipase A2 (PLA2) activity, (2) alpha-
bungarotoxin, a Bungarus snake venom binds irreversibly to the acetylcholine receptor, 
and (3) myotoxin II, a rattlesnake venom causes muscle necrosis and leads to 
instantaneous paralysis of bitten prey.[11, 12] The last two toxins do not exhibit any 
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phospholipase activity. When exposing the 5CB films laden with L-DLPC to 100 nM of 
beta-bungarotoxin in the presence of 5 mM Ca2+, the optical images of 5CB evolved from 
dark to bright (Figure 4.2A), indicating the interfacial hydrolysis of L-DLPC by the toxin. 
In contrast, when we exposed 5CB laden with L-DLPC to 100 nM of either alpha-
bungarotoxin or myotoxin II in the presence of 5 mM Ca2+, the optical image of 5CB 
remained dark (Figure 4.2B and C). These findings highlight the specificity of this LC 
sensor to report only the toxin that exhibit phospholipase activity.  
 
 
















Figure 4.1. (A,B) Cross-polarized optical images and (C,D) the corresponding 
schematics of 5CB (A,C) before and (B,D) after laden with L-DLPC. The schematic 
below each optical image represents the respective 5CB orientation. Scale bar = 85 µm. 
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Past studies have reported the orientational responses of LCs were induced by the 
PLA2 enzymatic hydrolysis of L-DPLC monolayer at the aqueous-LC interface.[8, 13] The 
enzymatic products of L-DLPC were found to desorb from the aqueous-LC interface, 
resulting in the orientational changes of LCs located underneath.[14] In the case of beta-
bungarotoxin, the changes in the optical images of 5CB began with the appearances of 
small bright domains (Figure 4.3A). Subsequently, the number and the size of these small 
bright domains increased (Figure 4.3B). These domains then grew and coalesced until the 
whole regions became fully bright (Figure 4.3C and D). These observations are supported 
by the previously reported formation of bright domains that correspond to the 
phospholipid-depleted regions when L-DLPC monolayer at aqueous-LC interface was 
hydrolyzed by PLA2.[13] We also observed the formation of these bright domains using 
normal lighting instead of cross-polarized one (Figure 4.3E-H). These results suggest the 
feasibility of using ambient lighting to image beta-bungarotoxin activity. In addition, the 
continuous color changes in the optical images of LCs indicate orientational changes of 
5CB tilt angle and an increase in the birefringence level. In the absence of beta-
bungarotoxin, the phospholipid monolayer was intact at the interface and the 5CB 
supported the monolayer assumed homeotropic orientation (0o angle to normal). In the 
presence of beta-bungarotoxin, the phospholipid monolayer was hydrolyzed and the 5CB 
supported these phospholipid-depleted regions was tilted towards planar orientation (> 0o 
angle to normal). The progression of these 5CB tilt angles from homeotropic to planar 
orientation, which was manifested in changes in the color and birefringence of 5CB, can 
be quantified using a Michel-Levy chart. The details of the quantification are given in 














Figure 4.2. (A-C) Cross-polarized optical images of 5CB laden with L-DLPC after being exposed to 100 nM of (A) beta-
bungarotoxin, (B) alpha-bungarotoxin, and (C) myotoxin II, in the presence of 5 mM Ca2+. (D-H) Cross-polarized optical images of 
5CB laden with L-DLPC after being exposed beta-bungarotoxin at various concentrations: (D) 100 nM (E) 10 nM, (F) 1 nM, (G) 100 
pM and (H) 10 pM. Scale bar = 85 µm. 
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Figure 4.3. Comparison between (A-D) cross-polarized and (E-H) unpolarized optical images of 5CB laden with L-DLPC after being 
exposed to 100 nM of beta-bungarotoxin in the presence of 5 mM Ca2+. Scale bar = 85 µm. 
A B C D
E F G H
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~42° (tilted) using the images shown in Figure 4.3. The quantification of the color 
changes has been shown by Abbott and coworkers to be a potential way of quantifying 
the interfacial event accompanying the LC orientational changes, in our case, the 
enzymatic hydrolysis of L-DLPC monolayer by beta-bungarotoxin. 
To determine the sensitivity of this LC sensor, 5CB films laden with L-DLPC 
monolayer were exposed to beta-bungarotoxin solution at various concentrations. In the 
presence of 5 mM Ca2+, 1 nM or above beta-bungarotoxin concentration yielded a bright 
optical image of 5CB (Figure 4.2D-F). At 100 pM concentration, however, only partial 
bright domains in the optical images of 5CB were observed (Figure 4.2G). When the bulk 
concentration of beta-bungarotoxin decreased to 10 pM or lower, no obvious optical 
response of LCs was observed (Figure 4.2H), indicating that the detection limit of beta-
bungarotoxin is approximately 100 pM. In the case of 100 pM of beta-bungarotoxin, the 
total amount of toxin sample required was less than 5 pg. This high sensitivity is 
comparable or even better to other methods reported in the past studies on beta-
bungarotoxin detection. For example, Gao et al. reported an immunofluorescence assay 
that can detect 1-10 ng of beta-bungarotoxin.[3] Selvanayagam et al. reported a field-
effect transistor immunosensor that can detect as low as 1 ng.[4] Van Dong et al. reported 
an optical immunoassay that can detect approximately 5 pg.[6] In addition, compared to 
these existing assays which require time-consuming and expensive labeling of antibodies, 
the LC-based sensor reported here does not use antibody and does not involve any 
























Figure 4.4. Plot of changes in the tilt angles of 5CB during the enzymatic hydrolysis of 
L-DLPC monolayer by beta-bungarotoxin. 
 
4.3.3 Identification of phospholipase-like toxin inhibitors 
1-hexadecyl-3-trifluoroethylglycero-2-phosphomethanol (MJ33) is known to 
inhibit PLA2 activity by forming enzyme-substrate analogue complexes whereas ethylene 
glycol-bis(2-aminoethylether)-N,N,N’,N’-tetraacetic acid (EGTA) to inhibit PLA2 
activity through binding with their cofactors, Ca2+.[15, 16] To the best of our knowledge, 
there is no previous report on whether these inhibitors can inhibit beta-bungarotoxin 
activity or not. To test whether MJ33 can inhibit beta-bungarotoxin activity, 5CB films 
laden with L-DLPC were exposed to 100 nM of beta-bungarotoxin in the presence of 
MJ33 and 5 mM Ca2+. As shown in Figure 4.5A-C, the optical images of 5CB remained 
dark when the MJ33 concentrations were above 100 nM, suggesting that MJ33 can 
inhibit beta-bungarotoxin activity. However, when the MJ33 concentrations were below 
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100 nM, the optical images of 5CB became bright (Figure 4.5D and E), indicating MJ33 
at this concentration is insufficient to inhibit the beta-bungarotoxin activity. These results 
also suggest that the molar inhibition ratio of beta-bungarotoxin by MJ33 is 
approximately 1:1. Furthermore, This equimolar ratio indicates that MJ33 may inhibit 
beta-bungarotoxin with a mechanism similar to the PLA2 inhibition, i.e. by forming 
toxin-substrate analogue.[16] Further investigation is needed to confirm this. 
To test whether EGTA can also inhibit beta-bungarotoxin activity, 5CB films 
laden with L-DLPC were exposed to 100 nM of beta-bungarotoxin in the presence of 
EGTA and 5 mM Ca2+. When EGTA concentration was 5 mM or above, we observed the 
dark optical image of 5CB (Figure 4.5F), suggesting that EGTA can inhibit beta-
bungarotoxin activity. However, when the EGTA concentration was 2.5 mM, the optical 
image of 5CB became bright (Figure 4.5G). This result is in good agreement with a past 
study in which the binding of EGTA to Ca2+ ions was shown to be 1:1.[15] As a control 
experiment, 5CB films laden with L-DLPC were exposed to 100 nM of beta-
bungarotoxin in the absence of Ca2+. Dark optical image was observed (Figure 4.5H), 
indicating that Ca2+ is needed for beta-bungarotoxin to hydrolyze L-DLPC.  
 
4.3.4 Sensor regeneration 
 Facile regeneration of a sensor while maintaining its performance is important. In 
the case of antibody-based toxin sensors, such as surface plasmon resonance sensors, the 
renewal of the sensing surface is usually accomplished either by breaking the antigen- 
antibody bond using low pH and high ionic strength or by eliminating the antigen-








    
 
 
Figure 4.5. Cross-polarized optical images of 5CB laden with L-DLPC after being exposed to 100 nM of beta-bungarotoxin in the 
presence of (A) 5 μM MJ33, (B) 500 nM MJ33, (C) 150 nM MJ33, (D) 75 nM MJ33, (E) 50 nM MJ33 (F) 5 mM EGTA, (G) 2.5 mM 





latter requires regenerating the expensive antibody layer that involves multiple chemical 
steps. In addition, the sensitivity of the regenerated sensor is often compromised. 
Compared to the antibody-based toxin sensors, the LC-based sensor used here can befully 
reused. The gold grids for LC confinement can be washed thoroughly and reused without 
leaving any trace that can affect the sensor performance for the next detection. Only 
approximately 200 nL of LCs and less than 1 nanomole of L-DLPC are required for each 
testing. The recycled gold grid was tested for 5 times and the performance of this LC-
based sensor was not affected by the regeneration (Figure 4.6). These results exhibit the 
potential of developing a cost-effective LC-based sensor. 
For real life device applications, the stability of sensor is particularly important. In 
Chapter 3, we demonstrated that air-supported LCs system was stable even in 100% 
relative humidity at room temperature for at least 10h. However, 5CB-based sensor 
reported here should be used within 24-35°C since 5CB phase will lose its birefringence 
properties outside this temperature range. For higher temperature working ranges, other 
thermotropic LCs should be used. Furthermore, our sensor design does not involve the 
use of delicate antibody molecules known to have thermal stability problems. Thus, the 
adoption of our LC sensors may reduce the stringent storage and shipping conditions 
normally required for antibody-based sensors and assays. 
 
4.4 Conclusion 
We have demonstrated a LC-based sensor for real-time and label-free 
identification of phospholipase-like toxin. Beta-bungarotoxin which exhibits Ca2+-
dependent PLA2 activity was used in this study as a toxin model. The hydrolysis of 
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Figure 4.6. Cross-polarized optical images of 5CB films confined within regenerated gold grids which have been exposed to 
(A,C,E,G) 100 µM of L-DLPC and subsequently to (B,D,F,H) 100 nM of beta-bungarotoxin. The gold grids have been regenerated 
(A,B) two times, (C,D) three times, (E,F) four times, (G,H) five times. Scale bar = 85 µm. 
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phospholipid monolayer self-assembled at aqueous-LC interface by beta-bungarotoxin 
induces orientational responses of LCs. As a result, optical signals that reflect the 
hydrolysis of  phospholipids can therefore be generated in a real-time manner. Whenwell-
known PLA2 inhibitors were introduced together with beta-bungarotoxin, no orientational 
response of LCs was observed. This work demonstrates the development of a simple and 
cost-effective LC-based sensor for identifying phospholipase-like toxins and for 
screening compound libraries to find potential toxin inhibitors. 
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CHAPTER 5. Decorating Liquid Crystal Surfaces with Proteins for 
Real-time Detection of Specific Protein-Protein Binding 
 
5.1. Introduction 
 Detection and characterization of specific protein-protein and ligand-receptor 
binding events is widely used as the basis for molecular screening of diseases, toxins in 
food, narcotics in blood, and novel drugs. Most of the methods for detecting and 
characterizing these binding events, including the state of the art technology, involve 
surface immobilization of proteins of interest.[1-3] The immobilized proteins can be of 
random orientation or well-defined orientation, depending on the physical 
binding/chemical linkage between the functionalized surfaces and the proteins. 
Immobilization with well-defined orientation is generally more preferable in preventing 
denaturation and preserving biological functions of the immobilized proteins.[1-4] There 
are a number of techniques to immobilize proteins on functionalized surfaces with well-
defined orientation. These techniques include (1) chemoselective immobilizations via 
Staudinger ligation, Diels-Alder cycloaddition reactions, or native chemical ligation, and 
(2) fusion protein immobilization via popular fusion tags such as glutathione S-
transferase, FLAG and histidine oligopeptides.[1] The use of natural amino acids as tag 
for well-defined immobilization of proteins is advantageous because this type of tag can 
be incorporated into proteins of interest via genetic engineering. Histidine tag is among 
the most widely used tags, which is originally developed for protein purification by 
metal-affinity chromatography.[5] 
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 Detection of the binding between surface-immobilized proteins and their 
complementary protein or targets can be accomplished through various methods such as 
fluorescence imaging, enzyme-substrate colorimetry, western blotting, surface plasmon 
resonance spectroscopy, quartz crystal microbalance, and liquid crystal (LC) imaging. In 
the past decade, LCs have become promising tools in biological sensing area.[4, 6-18] Some 
unique properties possessed by LCs include: (i) orientations of LCs are very sensitive to 
minute changes on surfaces and LC responses on surfaces can be amplified to LC bulk 
phase up to 100 μm away; (ii) LC molecules exhibit liquid-like mobility and can amplify 
LC responses within tens of milliseconds; (iii) LC molecules are birefringent, and the 
orientational changes of LCs can be readily visualized under crossed polarizers. As a 
result, LCs permit label-free detection with high sensitivity and without any use of 
complex and expensive instrumentations. 
A number of studies have used LCs to report protein capturing and protein-protein 
binding events on solid surfaces.[4, 8, 9, 13, 17, 18] For example, Gupta et al. reported a LC-
based bioassay where nematic LCs switch from uniform to non-uniform azimuthal 
orientation on functionalized gold films after incubating with protein solution.[9] In 
another study, Luk et al. designed a LC-based protein assay that differentiate between 
random and well-defined protein orientation.[4, 13] In the presence of target proteins, LCs 
adopt non-uniform azimuthal orientation on surfaces immobilized with proteins with 
well-defined orientation and uniform alignment on random-oriented proteins. These types 
of LC-based assays, however, are not real-time detection and require multiple 
experimental steps before the readout signals can be observed. Recently, a number of 
research groups, including our group, have developed LC-based sensors that permit real-
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time reporting of various biological events.[10, 19, 20] These sensors have been used in 
enzymatic hydrolysis of phospholipids by phospholipases, specific phospholipid-protein 
binding and DNA hybridization.[6, 7, 10, 12, 15] The use of LC-based sensors for real-time 
and label-free detection of protein-protein binding, however, has not yet demonstrated. 
In contrast to the previous works where proteins of interest are immobilized on 
solid substrate surface, herein, we explored the feasibility of immobilizing proteins on LC 
surface. This subsequently allowed direct real-time detection of specific protein-protein 
binding without multiple experimental steps. In the current strategy, LC functions not 
only as a signal-readout medium that transduces and amplifies the events occur on LC 
surface but also as a substrate to immobilize proteins with well-defined orientation. As a 
model, we used histidine-tagged ubiquitin and its antibody. Immobilization of ubiquitin 
with well-defined orientation on LC surface was achieved via nickel-histidine 
coordination chemistry where Ni2+ ion induced complex formation between histidine-
tagged ubiquitin and nitrilotriacetic acid (NTA)-functionalized amphiphiles self-
assembled at aqueous-LC interface. Subsequent specific binding of antibody to ubiquitin 
triggered orientational transitions of LCs. As a result, the spatial and temporal of this 
antigen-antibody binding event switched the optical appearances of LCs from dark to 
bright visible under crossed polarizers. This work demonstrates a simple strategy to 
immobilize proteins on LC surfaces with well-defined orientation and the development of 
a LC-based sensor for real-time and label-free detection of specific protein-protein 
binding events, which may find broad applications in biomedical field. 
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5.2 Experimental Section 
5.2.1 Materials 
HEPES, sodium chloride, hydrochloric acid, sodium hydroxide, chloroform, acetone, 
ethanol, methanol, capillary tubes, nickel nitrate, chambered coverslips, histidine-tagged 
ubiquitin, anti-ubiquitin antibody and bovine serum albumin (BSA) were purchased from 
Sigma-Aldrich (Singapore). 1,2-dioleoyl-sn-glycero-3-{[N(5-amino-1-carboxypentyl) 
iminodiacetic acid] succinyl} (nickel salt) (DOGS-NTA-Ni) and 1,2-dioleoyl-sn-glycero-
3-{[N(5-amino-1-carboxypentyl) iminodiacetic acid] succinyl} (ammonium salt) 
(DOGS-NTA) were purchased from Avanti Polar Lipids (U.S.A.). 4'-pentyl-4- 
cyanobiphenyl (5CB) was purchased from Merck (Singapore). Veco gold grids 200 mesh 
(20-μm thickness, 85-μm square spacing, and 50-μm bar width) was purchased from 
Electron Microscopy Science (U.S.A.). Ultrapure water with a resistivity of 18.2 MΩ cm 
was obtained from a Milli-Q system.  
 
5.2.2 Preparation of amphiphile solutions 
Two types of amphiphiles were used in our experiments: nitrilotriacetic acid (NTA)-
functionalized amphiphile loaded with Ni2+ ion (DOGS-NTA-Ni) and not loaded with 
Ni2+ ion (DOGS-NTA) (Figure 5.1A and B). Amphiphile solutions containing either 
DOGS-NTA-Ni or DOGS-NTA were prepared following standard procedures published 
in the literatures.[10, 21] Briefly, amphiphiles dissolved in chloroform were dried with N2 
gas and placed under vacuum for at least 3 h. The dried amphiphiles were resuspended in 
buffer solution (10 mM HEPES and 150 mM NaCl at pH 7.5) to a final concentration of 
100 µM. The resulting solutions were cloudy, indicating the presence of large 
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multilamellar vesicles (MLV). The amphiphile suspensions were then sonicated (VCX 
130pb, Sonics and Materials Inc., U.S.A.) 5 min for three times in an ice bath to obtain a 






Figure 5.1. The chemical structures of (A) DOGS-NTA-Ni and (B) DOGS-NTA. 
 
5.2.3 Preparation of LC optical cells 
The LC optical cells were prepared following the procedures reported in Chapter 3. 
Briefly, 200-mesh gold grids (width ~ 85 μm; depth ~ 20 μm) were cleaned sequentially 
in chloroform, acetone, ethanol, methanol, and then heated at 65°C for overnight.[7, 10] 
The gold grid was then impregnated with ~ 0.5 μL of 5CB using a capillary tube. Excess 
5CB was removed by contacting the LC with the other end of the capillary tube. The 
grids containing LCs were then put on the wells of the chambered coverslips containing 
samples of interest. This optical cell was then ready for examination under crossed 
polarizers. In this study, chambered coverslips made of polydimethylsiloxane, instead of 
A 
B 
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nickel plate support used in Chapter 3, were used to house samples in order to eliminate 
the possibility of nickel contamination. 
 
5.2.4 Formation of amphiphile monolayers 
Prior to the formation of amphiphile monolayers, 0.1 mM of either DOGS-NTA-Ni or 
DOGS-NTA solution was added to one of the wells of the chambered coverslips. 
Amphiphile monolayers were then prepared by contacting gold grid impregnated with 
5CB to either DOGS-NTA-Ni or DOGS-NTA solution in the well. Fusion of DOGS-
NTA-Ni or DOGS-NTA vesicles was allowed to occur for 2 h. At the end of the 
equilibration, the grids containing 5CB films laden with either DOGS-NTA-Ni or DOGS-
NTA were transferred to fresh buffer solution to remove excess amphiphiles and to 
ensure the formation of amphiphilic monolayers at aqueous-5CB interface. 
 
5.2.5 Immobilization of histidine-tagged protein and specific antigen-antibody 
binding events 
Prior to immobilization, 5 μL of histidine-tagged ubiquitin solutions at various 
concentrations were first added into the wells of the chambered coverslips. Films of 5CB 
laden with either DOGS-NTA-Ni or DOGS-NTA were then exposed to these histidine-
tagged ubiquitin solutions. Films of 5CB containing immobilized histidine-tagged 
ubiquitin were then washed with fresh buffer and exposed to 5 μL of anti-ubiquitin 
antibody solutions at various concentrations in the wells for specific antigen-antibody 
binding. For the dissociation of histidine-tagged ubiquitin from aqueous-LC interface, 
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films of 5CB containing immobilized histidine-tagged ubiquitin were exposed to buffer 
solution containing 100 mM of Ni2+ ions. 
 
5.2.6 Optical examination of LC orientation  
The optical orientation of LCs was examined using a Nikon eclipse LV100 POL 
microscope equipped with crossed polarizers in a transmission mode. The optical cell 
was placed on a rotating stage between two polarizers. Orthoscopic examination was 
performed with light intensity of ~ 70% full illumination and the aperture of ~ 40% full 
opening in order to collimate the incident light. Homeotropic optical textures were 
determined by observing the absence of transmitted light during a 360° rotation of the 
sample. Planar optical textures were determined by the birefringence of LCs when the 
sample was observed between crossed polarizers. A reference for the description of the 
LC textures can be found elsewhere.[22] All images were captured using a digital camera 
(Nikon, Japan) mounted on the microscope. 
 
5.3 Results and Discussion  
5.3.1 Self-assembly of amphiphiles on LC surface 
 Two types of amphiphiles were used in our experiments: 1,2-dioleoyl-sn-glycero-
3-{[N(5-amino-1-carboxypentyl) iminodiacetic acid] succinyl} (nickel salt) (DOGS-
NTA-Ni) and 1,2-dioleoyl-sn-glycero-3-{[N(5-amino-1-carboxypentyl) iminodiacetic 
acid] succinyl} (ammonium salt) (DOGS-NTA) (Figure 5.1A and B). One NTA chelates 
one Ni2+ ion at four coordination sites, leaving two other vacant sites of Ni2+ ion available 
for chelating histidine residues of fusion proteins (Figure 5.1A). DOGS-NTA is NTA-
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functionalized amphiphile without Ni2+ ion (Figure 5.1B). The Ni2+-free NTA cannot 
chelate histidine residues.  
Studies by other researchers and by us (in previous chapters) have reported that 
LC surfaces can be decorated with amphiphile monolayers forming spontaneously 
through hydrophobic interactions between hydrocarbon chains of amphiphiles and LC 
molecules.[7, 10, 19, 21, 23] The orientation of LCs at these surfaces is very sensitive to spatial 
and temporal organizations of the amphiphiles. To create LC surfaces capable of 
immobilizing histidine-tagged proteins, films of a nematic LC 5CB were exposed to 
buffer solution containing 100 μM of DOGS-NTA-Ni. Initially, contacting 5CB films 
with the buffer resulted in bright and colourful optical image of 5CB (Figure 5.2A). 
Within a 2 h period, the optical image of 5CB evolved from bright to dark, reflecting the 
self-assembly of DOGS-NTA-Ni at the aqueous-LC interface (Figure 5.2B). When these 
5CB films laden with DOGS-NTA-Ni were washed with fresh buffer, the optical image 
of 5CB remained dark (same as Figure 5.2B), even after more than 24h. These results 
suggest that the DOGS-NTA-Ni layer does not desorb from aqueous-LC interface after 
being washed with fresh buffer and this phospholipid layer is stable at this interface along 
the time. Similar observations were also obtained for the case of DOGS-NTA, suggesting 
that DOGS-NTA can also self-assemble and form stable monolayer at aqueous-LC 
interface (Figure 5.2C). In these experiments, HEPES buffer (10 mM HEPES and 150 
mM NaCl at pH 7.5) was used because it minimizes interactions with metal ions. 
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Figure 5.2. Cross-polarized optical images of 5CB after being exposed to (A) HEPES 
buffer, (B) DOGS-NTA-Ni, (C) DOGS-NTA. The corresponding schematic illustrations 
of LC orientation are shown below each image. Scale bar = 85 μm. 
 
5.3.2 Protein immobilization on LC surface 
We next studied the complex formation between DOGS-NTA-Ni and histidine-
tagged ubiquitin, and its coupling to the orientational responses of LCs. Ubiquitin is an 
8.5 kDa regulatory protein ubiquitously expressed in eukaryotes. It plays an important 
HEPES Buffer DOGS-NTA-Ni DOGS-NTA 
A B C 
DOGS-NTA-Ni DOGS-NTA 
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role in mediating selective degradation of regulatory proteins via ubiquitin-proteasome 
pathway. In immunohistochemistry, ubiquitin recognition by its antibody has been used 
to identify abnormal accumulation of certain proteins inside cells which are biomarkers 
of diseases, including Parkinson’s disease, Alzheimer’s disease, Huntington’s disease and 
Angelman syndrome.[24-27] When films of 5CB laden with DOGS-NTA-Ni were exposed 
to 500 nM of histidine-tagged ubiquitin, we observed that the optical image of 5CB 
changed from dark to bright (Figure 5.3A). In contrast, no measurable optical response of 
5CB was detected when 5CB films laden with DOGS-NTA were exposed to the same 
concentration of histidine-tagged ubiquitin solution (Figure 5.3B). These results suggest 
that the complex formation between DOGS-NTA-Ni and histidine-tagged ubiquitin not 
only occurs but also triggers the orientational transition of LCs from homeotropic (dark) 
to planar (bright). The change in the optical image of 5CB upon exposure to histidine-
tagged ubiquitin was irreversible even upon transfer the 5CB films to fresh buffer 
solution. Moreover, when films of 5CB laden with DOGS-NTA-Ni were exposed to 500 
nM of bovine serum albumin (BSA) solution, no orientational transition of LCs was 
observed (Figure 5.3C). This shows that proteins without histidine tags do not bind 
specifically onto DOGS-NTA-Ni layers. This result also highlights the ability of LCs 
laden with DOGS-NTA-Ni to differentiate proteins with histidine tags from those without 
histidine tags. From Figure 5.3B and C, it is evident that the absence of either histidine or 
Ni2+ resulted in no orientational response of LCs. Therefore, the mechanism by which 
LCs report the immobilization of histidine-tagged ubiquitin onto DOGS-NTA-Ni should 
involve interactions between Ni2+ and histidine. It is likely that one molecule of ubiquitin 
with its six histidine tags binds with more than one molecule of DOGS-NTA-Ni since six 
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histidine residues can bind with up to three NTA-Ni moieties. Studies have reported that 
chemical and biological interactions with unique spatial patterns at aqueous-LC interface 
can perturb the orientations of LCs.[12, 14, 15] For example, complex formation between 
negatively-charged single-stranded DNA and octadecyltrimethylammonium bromide at 
aqueous-LC interface resulted in orientational transition of LCs corresponding to spatial 
electrostatic patterns.[15] When oligopeptides with only three reactive amines reacted with 
carboxylic acid at aqueous-LC interface, the orientational transition of LCs 
corresponding to spatial reaction patterns was observed.[14] In our present case, binding of 
histidine-tagged ubiquitin on DOGS-NTA-Ni through multiple anchoring sites can create 
spatial patterns and trigger the orientational transition of LCs.  
 
   
 
 
Figure 5.3. Cross-polarized optical images of 5CB laden with (A,C) DOGS-NTA-Ni, (B) 
DOGS-NTA after being exposed to (A,B) 500 nM of histidine-tagged ubiquitin (C) 500 
nM of bovine serum albumin (BSA). Scale bar = 85 μm. 
 
 We further investigated the reversibility of the complex formation between 
DOGS-NTA-Ni and histidine-tagged ubiquitin. By contacting films of 5CB containing 
immobilized histidine-tagged ubiquitin to buffer solution containing 100 mM of Ni2+ ions, 
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the optical images of 5CB changed from bright to dark (Figure 5.4A and B). This 
observation suggests the dissociation of histidine-tagged ubiquitin from DOGS-NTA-Ni 
layers. When these regenerated DOGS-NTA-Ni layers were re-exposed to histidine-
tagged ubiquitin solution, the optical image of 5CB returned to bright (Figure 5.4C), 
reflecting the re-attachment of histidine-tagged ubiquitin onto DOGS-NTA-Ni. 
Introduction of 100 mM of Ni2+ ions the second time to these DOGS-NTA-Ni layers 
resulted in the dark optical image of 5CB again (Figure 5.4D). These results show that 
Ni2+ ion in solution can compete with DOGS-NTA-Ni for histidine-tagged ubiquitin 
binding. The association/dissociation reversibility also demonstrates that the DOGS-NTA 
monolayer (with or without Ni) is intact and DOGS-NTA-Ni does not desorb from 
aqueous-LC interface upon binding with histidine-tagged ubiquitin. Depending on which 
compound the histidine-tagged proteins want to be replaced from Ni layers, several past 
studies have reported that other competitors such as imidazole and EDTA can also 
effectively replace the histidine-tagged proteins, thus providing a simple way to 
regenerate the Ni layers.[28, 29] 
Studies have reported that the orientational responses of LCs towards interfacial 
events are sensitive to the surface concentrations of analytes at aqueous-LC interface.[6, 7, 
10, 17, 18] To examine the effect of histidine-tagged ubiquitin concentrations to the 
orientational responses of LCs, films of 5CB laden with DOGS-NTA-Ni were exposed to 
solutions containing histidine-tagged ubiquitin at various concentrations. When 
concentrations of histidine-tagged ubiquitin solutions were 150 nM or above, we 
observed the optical image of 5CB to become bright (Figure 5.5A-C). However, when the  
 





Figure 5.4. Cross-polarized optical images of 5CB laden with DOGS-NTA-Ni after 
sequentially being exposed to (A) 500 nM histidine-tagged ubiquitin, (B) 100 mM of Ni2+, 
(C) 500 nM histidine-tagged ubiquitin for the second time and finally to (B) 100 mM of 
Ni2+ for the second time. Scale bar = 85 μm. 
 
bulk concentrations of histidine-tagged ubiquitin were decreased to 90 nM or below, the 
optical image of 5CB remained dark (Figure 5.5D and E). These results indicate that a 
bulk concentration of histidine-tagged ubiquitin of > 90 nM is the critical concentration 
to induce a change in the orientation of the LCs. We also noticed that the sharp dark-to-
bright orientational transition of LCs during the immobilization of histidine-tagged 
ubiquitin occurred within a narrow ubiquitin concentration range (90 to 150 nM, or 
approximately 50 nM range) during the immobilization of histidine-tagged ubiquitin. 
A B 
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This abrupt optical response of LCs is in good agreement with the dual-easy-axis model 
that predicts the discontinuous orientational transition of LCs at critical surface 
condition.[17, 18, 30] 
  




Figure 5.5. Cross-polarized optical images of 5CB laden with DOGS-NTA-Ni after 
being exposed to histidine-tagged ubiquitin solutions at concentrations of (A) 350 nM, (B) 
250 nM, (C) 150 nM, (D) 90 nM, (E) 50 nM. Scale bar = 85 μm. 
 
 
5.3.3 Specific protein-protein binding events on LC surface 
The principle of using critical analyte concentration to induce orientational 
transition of LCs is very useful to design an ultrasensitive LC-based detection method. 
When the concentrations of analytes exceed the critical value, the orientational transition 
A B C 
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of LCs is triggered, leading up to a sharp change in the optical image of LCs from dark to 
bright. To exploit this principle for real-time detection of specific protein-protein 
interactions, films of 5CB laden with DOGS-NTA-Ni were first exposed to 90 nM of 
histidine-tagged ubiquitin solution for 2h. This concentration was below the critical 
concentration, and therefore the corresponding optical LC image appeared dark. After 
exposing to 20 μg/mL of anti-ubiquitin antibody, we observed the formation of small 
bright domains within seconds (Figure 5.6A). These bright domains grew until the whole 
square of LC films became fully bright (Figure 5.6B and C). In contrast, 20 μg/mL of 
anti-biotin antibody did not perturb the orientation of LCs under similar conditions during 
the time of observation (Figure 5.6D). In addition, exposing the DOGS-NTA-Ni layers 
without histidine-tagged ubiquitin to 20 μg/mL of anti-ubiquitin antibody gave no 
detectable optical response of LCs (Figure 5.6E). These results suggest that the bright 
optical image observed in Figure 5.6A-C can be attributed to the specific binding of 
ubiquitin to its antibody. We further found that anti-ubiquitin antibody at as low as ~5 
μg/mL can trigger the orientational transition of LCs. This concentration corresponds to 
approximately 50 nanogram of the antibody. The fast LC orientational transition in 
Figure 5.6A-C upon exposing to unlabelled anti-ubiquitin antibody demonstrates the 
feasibility of developing real-time and label-free biosensors for detecting protein-protein 
binding. In the previous LC systems for detecting protein-protein binding on solid 
substrates, the binding is not readily observed when the surface-immobilized proteins are 
incubated in solutions containing their target proteins. After the incubation, the surface 
needs to be washed, dried and sandwiched into an LC-optical cell before the optical 
readout can be observed.[9] 
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Figure 5.6. (A-C) Cross-polarized optical images of 5CB containing immobilized 
histidine-tagged ubiquitin after being exposed to 20 µg/mL anti-ubiquitin antibody for (A) 
< 30 s, (B) 1.5 min, (C) 6 min. (D) Cross-polarized optical images of 5CB containing 
immobilized histidine-tagged ubiquitin after being exposed to 20 µg/mL anti-biotin 
antibody. (E) Cross-polarized optical images of 5CB laden with DOGS-NTA-Ni after 
directly being exposed to 20 µg/mL of anti-ubiquitin antibody. Scale bar = 85 μm. 
 
The orientational responses of LCs observed during this specific protein-protein 
binding event is different from the ones observed during DNA hybridization.[15] 
Hybridization between single-stranded DNA and its complementary DNA on LC surfaces 
caused the optical responses of LCs to change from bright to dark due to local 
condensation of cationic amphiphile-DNA complexes on LC surfaces.[15] In contrast, 
specific binding events between histidine-tagged proteins on LC surfaces with its 
A B C 
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antibody caused the optical responses of LCs to change from dark to bright. This may be 
due to the binding of an antibody molecule to one or two ubiquitin molecules, and 
subsequently causing the 5CB molecules underneath tilted. The formation of other 
complex molecular structures at the interface may also cause the orientational transition 
of LCs and should not be ruled out. Further investigation is required to gain more 
understanding in this. 
Because a threshold point of the dark-to-bright transition observed in the system 
depends on both the surface density of histidine-tagged ubiquitin and the anti-ubiquitin 
concentration, we measured several threshold points by varying both variables. Table 1 
tabulates the correlation between the degree of histidine-tagged ubiquitin immobilization 
and LC optical response triggered by antigen–antibody binding. As the concentrations of 
histidine-tagged ubiquitin were lowered, higher concentrations of anti-ubiquitin antibody 
were needed to trigger orientational transitions of LCs. When the concentration of 
histidine-tagged proteins was at 90, 50, 10, and 5 nM, the minimum antibody 
concentration required to trigger orientational transitions of LCs increased to 5, 10, 40 
and 80 μg/mL respectively. However, at 1 nM ubiquitin concentration, the optical image 
of 5CB remained dark even after being exposed to 100 μg/mL of anti-ubiquitin antibody. 
These results suggest that the sharp threshold point of dark-to-bright transition of LCs 
can be exploited to report the dynamic of specific protein-protein binding events at 
different concentration ranges. 
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Table 5.1. Concentrations of anti-ubiquitin antibody detected as a function of 
concentrations of histidine-tagged ubiquitin exposed to 5CB films laden with DOGS-
NTA-Ni 
 













We end this chapter by concluding that surface of LC films, when decorated with 
well-oriented proteins, can function as a platform for real-time and label-free imaging of 
specific protein-protein binding events. Immobilization of proteins on LC surfaces with 
well-defined orientation can be achieved via coordination chemistry between histidine-
tagged proteins and DOGS-NTA-Ni self-assembled at aqueous-LC interface. Using 
histidine-tagged ubiquitin and its antibody as a model system, we demonstrated that the 
spatial and temporal of protein immobilization and specific protein-protein binding 
events can be detected through LC ordering transitions. These transitions can be easily 
visualized under crossed polarizers as sharp LC switching from dark to bright. This work 
demonstrates the development of a simple and low cost liquid crystal-based imaging tool 
for real-time and label-free reporting of specific protein-protein binding events, which 
may find diverse important applications within biomedical needs. 
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CHAPTER 6. Imaging Disruption of Phospholipid Monolayer by 




Engineered nanomaterials have become increasingly important in recent years 
because of their unique physical and chemical properties. These new properties have also 
led to the novel applications of these nanomaterials in catalysts, semiconductors, sensors, 
drug carriers, and personal care products.[1-4] Commercial products that contain synthetic 
nanomaterials are expected to grow significantly in the coming years. Consequently, both 
occupational and consumer exposures to engineered nanomaterials are likely to increase 
in proportion to their use in the society. However, these nanomaterials can be potentially 
harmful to human and environment due to the large percentage of atoms lie on their 
surface and unusually high reactivity.[5] Over the past 3-4 years, engineered 
nanomaterials have been a focus of study on their adsorption, distribution, metabolism, 
excretion, and toxicity (ADMET) prior to their validity for applications and the attention 
on the interactions between engineered nanomaterials and biological systems has been 
raised increasingly.[6-8] 
In the past few years, a number of studies have been carried out in order to 
elucidate the potential toxic effects and fates of nanomaterials in biological cells.[9-12] For 
example, Bhatia and co-workers found that the uncapped quantum dot nanoparticles 
(QDs) liberate free Cd2+ ions and induce heavy metal toxicity on liver cells, and capping 
with ZnS and bovine serum albumin (BSA) reduces but does not eliminate the toxicity of 
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QDs.[10] Using in vitro human lymphoma cells, Hoshino et al. showed that carboxylic-
modified QDs cause slightly more cell death than hydroxyl-modified ones.[11] Colloidal 
gold is widely considered biocompatible due to the inertness of gold in bulk form. 
Nevertheless, Goodman et al. observed that 2 nm cationic gold nanoparticles (AuNPs) are 
moderately toxic to mammalian and E. coli cells.[9] Recently, we have reported that 
AuNPs can induce DNA damage and inhibit cell proliferation in human embryonic lung 
fibroblasts. Furthermore, the genes associated with regulation of the cell cycle and DNA 
repair were also downregulated.[12] 
While many past studies focused on measuring the end-point cytotoxicity of 
nanomaterials to biological cells, relatively few studies have been dedicated to the 
understanding of molecular interactions between nanomaterials and cell membrane, 
which may provide the necessary information to understand how nanomaterials bind and 
enter cells.[13-15] The interaction between nanomaterials and cells is believed to strongly 
depend on the type and surface modification of nanomaterials. The latter can make toxic 
nanomaterials less toxic, or relatively non-toxic nanomaterials more toxic. Understanding 
the interaction between nanomaterials and cell membrane through cellular studies is not 
an easy task because (1) various components present in the biological fluids or culture 
media can adsorb onto nanoparticle surface, alter the surface properties of nanoparticles 
and affect nanoparticle interaction with cell membranes; (2) the cell membrane is a 
complex surface with various compositions and fluidity characteristics. Therefore, 
analyzing the interaction between nanoparticles and cell membranes by exposing the cells 
directly to nanoparticles usually leads to inconclusive interpretation. A model system of 
cell membranes and nanoparticles with well-defined composition is useful for studying 
 116  
the interactions between nanoparticles and cell membrane. Recently, Peetla et al. have 
reported the use of surface pressure-area isotherm measurements (Langmuir monolayer 
model system) and atomic force microscopy to systematically study the interaction 
between phospholipid monolayer at aqueous-air interface and polystyrene nanoparticles 
with different surface chemistry. It was found that aminated and plain polystyrene 
nanoparticles could interact with and reorganize the phospholipid monolayer. However, 
carboxylated ones showed a negligible interaction with phospholipid monolayer.[14] In 
another study, Banerji et al. showed that simple diffusion of gold nanoparticles across 
phospholipid vesicles was unlikely to occur.[13] 
In reality, protein adsorption on foreign particle surface is inevitable when the 
particles enter human body. Although it is known that proteins can interact with 
phospholipids through a variety of hydrophobic and electrostatic interactions, to the best 
of our knowledge, it is relatively unknown whether proteins are able to mediate the 
interaction between nanoparticles and phospholipids.[16, 17] Therefore, in this study, we 
seek more understanding on whether nanoparticles, when coated with different proteins, 
behave differently in their interactions with cell membrane as well as the key driving 
force in determining the disruption of the phospholipid monolayer by protein-coated 
nanoparticles via the orientational changes of the liquid crystals (LCs).  
Several recent studies have demonstrated the spontaneous formation of 
phospholipid monolayer at the aqueous-LC interface to create a biomimetic cell 
membrane model system, including the self-assembly of phospholipid at the interface 
between nematic liquid crystal 4'-pentyl-4-cyanobiphenyl (5CB) and aqueous buffer.[18, 19] 
The spatial and temporal organization of phospholipid monolayer at the aqueous-LC 
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interface is coupled to the orientation of LC, allowing the dynamic characteristics of the 
phospholipid layer to be observed directly with the naked eye. This cell membrane model 
system has been used to investigate enzymatic events and binding of proteins to the 
phospholipid monolayer.[19] In our experiment, after phospholipid monolayer self-
assembled at the aqueous-LC interface, gold nanoparticles (AuNPs) coated with different 
proteins were then added into the system to investigate their effects on the integrity of the 
monolayer. The orientation of LCs that corresponds to the disruption of the monolayer 
was examined by monitoring the optical images of LCs under crossed polarizers. 
 
6.2 Experimental Section 
6.2.1 Materials 
Tris(hydroxymethyl)aminomethane (Tris), HEPES, sodium acetate, sodium chloride 
(NaCl), hydrochloric acid (HCl), sodium hydroxide (NaOH), ethanol, methanol, acetone, 
capillary tubes, N,N-dimethyl-N-octadecyl-3-aminopropyl trimethoxysilyl chloride 
(DMOAP), bovine serum albumin (BSA), human fibrinogen, HAuCl4.3H2O and sodium 
citrate were obtained from Sigma-Aldrich (St. Louis, U.S.A.). L-α-dilauroyl 
phosphatidylcholine (L-DLPC) was obtained from Avanti Polar Lipids (Alabaster, 
U.S.A.). NeutrAvidin was obtained from Invitrogen (Maryland, U.S.A.). All chemicals 
were used as obtained. Ultrapure water (resistivity of 18.2 MΩ cm) was obtained using a 
Milli-Q system. Liquid crystal 4’-pentyl-4-cyanobiphenyl (5CB) and Veco gold grids 75 
mesh (20-μm thickness, 283-μm grid spacing, and 50-μm bar width) were obtained from 
Electron Microscopy Sciences (New York, U.S.A.). The glass microscope slides were 
obtained from Marienfeld (Germany). 
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6.2.2 Preparation of phospholipid solution 
Phospholipid solution was prepared following standard procedures in the literatures.[18, 19] 
Briefly, L-DLPC in chloroform (20 mg/mL) was dried with N2 gas and placed under 
vacuum for at least 3 h. The dried phospholipid was resuspended with Tris-buffered 
saline (TBS, consisting of 10 mM Tris, 150 mM NaCl at pH 8.9) to a final concentration 
of 0.1 mM. The resulting solution was cloudy, indicating the presence of large 
multilamellar vesicles (MLV). The phospholipid suspension was then sonicated (VCX 
130pb, Sonics and Materials Inc.) subsequently three times for 5 min each at T > Tm (Tm 
of L-DLPC is 1°C) to obtain a clear solution. This solution was then filtered twice using a 
0.22 μm filter (Millipore) and typically used within 2 days after preparation. 
 
6.2.3 Preparation of DMOAP-coated glass slides 
DMOAP-coated glass slides were prepared according to published procedure.[20] Briefly, 
the slides were cleaned in piranha solution (70% (v/v) sulfuric acid and 30% (v/v) 
hydrogen peroxide) for 1 h at ~80°C (warning: piranha solution reacts strongly with 
organic compounds and should be handled with extreme caution; do not store the solution 
in closed containers). The slides were then rinsed thoroughly with water. A 0.1% v/v of 
DMOAP solution in ultrapure water was prepared and the clean glass slides were dipped 
into this solution for 5 min at room temperature. The DMOAP-coated glass slides were 
then rinsed with ultrapure water and dried under a stream of nitrogen gas. Finally, they 
were put into 100°C oven for at least 3 h to allow for crosslinking of the DMOAP 
molecules onto the surface of glass through Si-O-Si covalent bonds. 
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6.2.4 Preparation of optical cells  
An optical cell was prepared as a platform for the formation of a supported phospholipid 
monolayer at the aqueous-LC interface (Figure 6.1). Gold specimen grids were cleaned 
sequentially in ethanol, methanol, and acetone, dried under nitrogen gas, and then heated 
at 100°C overnight.[18, 19] The gold grids were then placed on DMOAP-treated glass slide 
and impregnated with ~0.2 μL of 5CB using a capillary tube. Excess 5CB was removed 
by blotting it with the other end of capillary tube. The optical textures of 5CB supported 
on DMOAP-treated slides were examined using polarized light to confirm homeotropic 
anchoring. Any sample not exhibiting homeotropic anchoring of 5CB was rejected. The 
optical cells were then immersed into a piranha-cleaned petri dish containing an aqueous 
sample and the petri dish was sealed by its cover and parafilm.  
        
 
Figure 6.1. (A) Schematic illustration and (B) photograph of the optical cell used in 
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6.2.5 Optical examination of LC orientation  
The optical orientation of 5CB was examined using a Nikon eclipse LV100 POL 
microscope equipped with crossed polarizers in a transmission mode. The optical cell 
was placed on a rotating stage between two polarizers. Orthoscopic examinations were 
performed with light intensity of ~70% full illumination and the aperture of ~30% full 
opening in order to collimate the incident light. Homeotropic orientation was determined 
by observing the absence of transmitted light during a 360° rotation of the sample. Planar 
orientation was determined by a bright and birefringence appearance of 5CB when the 
sample was observed between crossed polarizers. A reference for the description of the 
LC orientation can be found elsewhere.[21] All images were captured using a digital 
camera (Nikon’s 5MegaPixel) mounted on the microscope. 
 
6.2.6 Formation of phospholipid monolayer  
The formation of phospholipid monolayer at the aqueous-LC interface was conducted by 
immersing the optical cell into an L-DLPC solution. L-DLPC was used in this study 
because phospholipids with the phosphocholine head group are a major constituent at the 
outer cell membrane. Immediately after immersion, the optical appearance of 5CB 
observed under crossed polarizers was bright, which corresponds to a planar orientation 
of LC at the aqueous-LC interface (Figure 6.2A). Changes in the optical appearance from 
bright to dark were observed over time, which corresponds to the change in the 
orientation of 5CB at the aqueous-LC interface from planar to homeotropic (Figure 6.2B). 
These changes reflect the self-assembly of L-DLPC monolayer at aqueous-LC interfaces 
via interaction between hydrophobic tails of L-DLPC and LC.[18] At the end of self-
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assembly process, the optical cell was flushed with fresh Tris-buffered saline (TBS) 
containing no phospholipid to remove excess L-DLPC. The resulting phospholipid 
monolayer was stable in TBS for at least five days in our experiments (Figure 6.2C). 
 
 









Figure 6.2. Crossed polarized optical images of 5CB confined to 75 mesh gold grids 
supported on DMOAP-coated glass (top) and schematics of the aqueous-LC interface 
(bottom) when immersed into 0.1 mM L-DLPC (A) within 5 min (B) after 2 h (C) after 
flushed by fresh TBS. Scale bar = 283 µm. 
 
6.2.7 Preparation of gold nanoparticle solution 
Citrate-stabilized gold nanoparticle (AuNP) solution with 20 nm diameter was prepared 
using published procedure.[22] Briefly, 10 mg of HAuCl4.3H2O was dissolved into 95 mL 
of ultrapure water. This chloroauric solution was heated to boiling, and 5 mL of 1% 
sodium citrate solution was then introduced. The solution was refluxed for 30 min and 
then left to cool to room temperature. 
A B C 
Initial state Equilibrium L-DLPC Monolayer
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6.2.8 Protein adsorption on gold nanoparticles 
The protein adsorption and saturation on AuNPs was prepared following procedures in 
the literatures.[23] In brief, AuNPs solution was first centrifuged to remove the supernatant. 
Protein solution was then mixed with AuNPs at a ratio of 375 (number of protein 
molecules/number of AuNPs). The mixture was then incubated for ~10 h. Subsequently, 
the AuNPs were rinsed with TBS buffer twice and reconstituted with the same buffer. 
The protein-coated AuNPs were stable for more than a month in the buffer solution. 
Time-series dynamic light scattering (DLS) experiments showed that the size of protein-
coated AuNPs exhibited negligible change after 2 h protein coating (data not shown). 
Thus the 10 h incubation time used here assured a state of saturated coating on AuNPs. 
The size of the coated AuNPs was found to be the same for at least 3 days after the initial 
DLS measurement, indicating no or negligible protein desorption from the AuNP surface. 
Additional desorption experiment with FITC-labeled proteins also showed negligible 
protein ٛ esorption from AuNPs using fluorescent measurement. 
 
6.3 Results and Discussion 
6.3.1 Interaction between citrate-stabilized gold nanoparticles and phospholipid 
monolayer laden on liquid crystals 
In our study, we prepared citrate-stabilized AuNPs (20 ± 2 nm) in TBS buffer. 
Before the injection of AuNPs into the liquid cell containing L-DLPC monolayer 
supported on LCs, the LCs appeared dark as shown in Figure 6.3A. However, after the 
injection of AuNPs, dark blue images with black dots, which corresponded to aggregated 
AuNPs, were observed under crossed polarizers (Figure 6.3B). The instability of AuNPs 
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was due to the electrical double layer compression by the ions present in the TBS 
buffer.[24] TEM image revealed that the aggregated AuNPs consist of heterogeneous size 
distribution with hundreds of nanometer-sized particles as the major component (Figure 
6.3C). The optical appearance of 5CB, however, was still homeotropic, indicating that the 
integrity of the L-DLPC molecules anchored at the aqueous-LC interface was not 
disrupted by the presence of the AuNPs. This dark appearance of LC was stable for more 
than 3 days. The persistent homeotropic appearance suggests that even with the direct 
deposition of aggregated AuNPs, the integrity of the L-DLPC monolayer was still 
maintained. Since LCs are known to be sensitive for molecular level interactions[25-27], 
our results suggest that the interaction between negatively-charged gold nanoparticles and 
zwitterionic L-DLPC molecules is minimal. Zeta potential measurement of negatively-
charged citrate-stabilized AuNPs and zwitterionic L-DLPC showed -39.5 and -2.4 mV 
respectively (Table 6.1). The relatively low and negative zeta potential of L-DLPC may 
explain the minimal electrostatic interaction with AuNPs. These results are in good 
agreement with the recent study by Peetla and Labhasetwar, who found minimal 
interactions between carboxylated polystyrene nanoparticles and phospholipids.[14] Since 
the ionic-stabilized gold nanoparticles are unstable in buffer conditions, we used protein-
coated gold nanoparticles in our next study. 
 
Table 6.1. Zeta potential of L-DLPC, citrate-stabilized AuNPs and protein-coated AuNPs. 
 
Species Zeta Potential (mV) 
L-DLPC -2.4 ±  0.5 
Citrate-AuNPs -39.5 ±  4.9 
BSA-AuNPs -12.9 ±  0.8 
Neutravidin-AuNPs -9.0 ±  2.8 
Fibrinogen-AuNPs -10.6 ±  1.9 
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Figure 6.3. (A-B) Crossed polarized optical images of 5CB laden with L-DLPC 
monolayer (A) before and (B) after exposing to 20 nm AuNPs. (C) TEM image of 
aggregated AuNPs after being exposed to TBS buffer. Scale bar = 283 µm. 
 
6.3.2 Interaction between protein-coated gold nanoparticles and phospholipid 
monolayer 
Adsorption of protein on the surface of nanoparticles is expected to occur when 
nanoparticles contact body fluids. Consequently, cells are likely to interact with protein-
coated nanoparticles instead of bare nanoparticles. In addition, stabilization of 
nanoparticles using proteins is a common method used in immunochemistry, cell 
targeting, and development of biochips, making the likelihood of exposing protein-coated 
nanoparticles to a biological body even higher[2, 28]. Although past studies have reported 
that proteins can mediate the cellular uptake of nanoparticles, it is not clear how proteins 
can mediate the interactions between nanoparticles and cells.[29, 30] The adsorbed protein 
on nanoparticles may bind to transmembrane receptors and induce specific receptor-
mediated endocytosis. The protein-coated nanoparticles may also bind onto cell 
membrane non-specifically, and subsequently be internalized through normal metabolic 
endocytosis (i.e. not receptor-mediated endocytosis). In addition, it is not known whether 
A B C
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direct penetration of nanoparticles through cell membrane can occur if the binding of 
nanoparticles elicits sufficient disruption on the phospholipid membrane.  
To understand further the interaction between protein-coated nanoparticles and 
cell membrane, we coated AuNPs with different proteins and exposed them to the L-
DLPC monolayer supported on LCs. We first prepared 20 nm BSA-coated AuNPs at a 
particle concentration of 50 nM. Because the desorption of proteins from AuNP surface 
was not observed (See the Experimental Section for details), we assumed that there was 
no free protein available in the solution for binding with the L-DLPC monolayer. Initially, 
upon AuNP exposure, no change in the homeotropic anchoring of LCs was observed 
(Figure 6.4A). However, planar orientation of LCs appeared after approximately 40 hours 
(Figure 6.4B), indicating disruption of the L-DLPC by the BSA-coated AuNPs. As 
shown in Figure 6.4C and D, 20 and 2 nM of BSA-coated AuNPs still can disrupt the 
monolayer and trigger the orientational change of LCs after 60 hours and 90 hours 
respectively. Compared with the case when citrate-stabilized AuNPs (protein-free) were 
used, L-DLPC molecules were more susceptible to the binding of BSA-coated AuNPs. 
While 50 nM of BSA-coated AuNPs could disrupt the monolayer, no disruption was 
observed in the case of uncoated AuNPs at the same concentration. This result provides 
direct evidence that the proteins are able to mediate the interactions between AuNPs and 
L-DLPC.  
To further investigate whether the type of protein coating affects the phospholipid 
monolayer integrity, we performed similar experiments using AuNPs coated with 
fibrinogen and neutravidin. Neutravidin-coated AuNPs triggered an orientational 
transition of 5CB from homeotropic to planar in approximately 32 hours (Figure 6.4E); 
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however, fibrinogen-coated AuNPs were able to trigger a similar homeotropic-to-planar 
orientation in approximately 1-2 hours (Figure 6.4F). These results suggest that the 
disruption of the phospholipid monolayer may depend on the type of proteins adsorbing 
onto the nanoparticle surface. The reason for the faster interaction between phospholipid 
monolayer and fibrinogen-coated AuNPs is currently unknown. It may be due to the more 
adhesive nature of fibrinogen compared to BSA and neutravidin.[31-33] Further studies are 
needed to gain more understanding on this phenomenon. 
 
6.3.3 Driving force for the binding of protein-coated gold nanoparticles to L-DLPC 
monolayer 
We next investigated the driving force in the interactions between protein-coated 
AuNPs and zwitterionic L-DLPC monolayer. Based on the zeta potential measurement 
(Table 6.1) the charge of uncoated AuNPs (-39.5 mV) was significantly higher than the 
charges of all protein-coated AuNPs measured. BSA, neutravidin and fibrinogen-coated 
AuNPs exhibited the zeta potentials of -12.9, -9.0, and -10.6 mV respectively. There was 
no significant difference when comparing zeta potential of these three protein-coated 
AuNPs. Since all components exhibited negative zeta potential, electrostatic interaction is 
unlikely to play a major role in the different degree of L-DLPC disruption by the three 
protein-coated AuNPs shown here.  
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Figure 6.4. Interaction of L-DLPC monolayer self-assembled at the aqueous-LC 
interface with solutions containing protein-coated AuNPs. Optical images of 5CB 
(crossed polarizers) captured (A) within 5 min after immersion of L-DLPC monolayer 
into AuNPs, (B) after 40 hours contact of the L-DLPC with 50 nM of BSA-coated 
AuNPs, (C) after 60 hours contact of the L-DLPC with 20 nM of BSA-coated AuNPs, (D) 
after 90 hours contact of the L-DLPC with 2 nM of BSA-coated AuNPs, (E) after 32 
hours contact of the L-DLPC with 50 nM of neutravidin-coated AuNPs, (F) after 2 hours 
contact of the L-DLPC with 50 nM of fibrinogen-coated AuNPs. Scale bar = 283 µm. 
 
To further investigate whether hydrophobic interactions can be the main driving 
force in the disruption of the phospholipid monolayer by protein-coated AuNPs, we 
exposed 5CB laden with L-DLPC to various buffer solutions containing 50 nM BSA / 
neutravidin / fibrinogen-coated AuNPs at pH equal to isoelectric point (pI) of the 
respective proteins. Sodium acetate buffers at pH of 4.8 and 5.5 were used to prepare the 
BSA and fibrinogen solutions respectively, and HEPES buffer at pH of 6.3 was used to 
prepare neutravidin solution. For all three cases, we observed changes in the optical 
images of 5CB from homeotropic to planar (Figure 6.5) at the rates faster than the ones 
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orientation of 5CB was observed within an hour. For BSA and neutravidin, the changes 
occurred within 8 and 6 h respectively. In the control experiments where sodium acetate 
buffers (pH of 4.8 and 5.5) and HEPES buffer (pH of 6.3) were used, the phospholipid 
monolayer remained intact and 5CB remained homeotropic for more than 24 hours. 
These results, when combined, suggest that hydrophobic interaction plays a dominant 
role in the binding and disruption of the zwitterionic L-DLPC monolayer. This 
observation is in good agreement with the previous work on protein interaction with 
phospholipid monolayer at the air-water interface, where the hydrophobic interaction 
contributes significantly to the protein binding.[16, 17] Our results are also in agreement 
with past studies by Chern et al. who reported the adsorption of BSA onto monomethoxy 
polyethylene glycol surface was maximum at pH closer to the pI of BSA.[34] 
 
       
 
Figure 6.5. Cross-polarized optical images of 5CB laden with L-DLPC after being 
exposed to 50 nM of AuNPs coated with (A) BSA after 8 hours, (B) neutravidin after 6 
hours, (C) fibrinogen after 1 hours at pH equal to the pI of the corresponding proteins. 
Scale bar = 283 µm. 
 
To confirm that the disruption of the phospholipid monolayer was mediated by 
the types of protein adsorbed on AuNPs and not the overall size of the nanoparticles, we 
conducted size measurements of protein-coated AuNPs and proteins alone via dynamic 
light scattering Table 6.2 shows that each protein and its respective coated AuNPs 
A B C
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exhibited substantially different size. Among the three proteins, fibrinogen exhibited the 
largest size (25.5 nm) due to its high molecular weight (>320kDa). Consequently, 
fibrinogen-coated AuNPs also exhibited the largest size among all nanoparticles. Based 
on this result, it appears that larger size protein-coated nanoparticles can induce more 
disruption to the L-DLPC monolayer. However, since the structural and physical 
properties of each protein are different, the size of fibrinogen may only contribute to the 
monolayer disruption to some extent. The local hydrophobic and hydrophilic domains of 
the protein molecule may also have substantial contribution. A better comparison requires 
two proteins with similar structural and physical properties but different in size, and this 
will be conducted in a separate study.  
 
Table 6.2. Size measurement of citrate-stabilized AuNPs, protein-coated AuNPs and 
proteins alone via dynamic light scattering. 
 
Species Size (nm) 
Citrate-AuNPs 21.2 ±  2.3 
BSA-AuNPs 28.3 ±  0.8 
Neutravidin-AuNPs 49.7 ±  3.8 
Fibrinogen-AuNPs 135.7 ±  14.5 
BSA 8.6 ±  0.9 
Neutravidin 17.3 ±  0.4 
Fibrinogen 25.5 ±  2.3 
 
Overall, the results on protein-coated AuNPs presented in this work can be 
relevant to the real events when nanoparticles enter human body since protein adsorption 
inevitably occurs onto the surface of foreign particles. At this stage, however, it is 
premature to speculate whether the observed interaction can lead to other adverse 
consequences such as membrane integrity compromise, transmembrane protein 
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disruption, or nanoparticle penetration into the cytoplasm observed in other studies.[12] 
More work is required to confirm the effects of nanoparticle binding on cell membranes. 
 
6.4 Conclusion 
We have demonstrated an easily-visualized model system, consisting of a thin 
layer of LC and a monolayer of zwitterionic L-DLPC self-assembled at the aqueous-LC 
interface, to study the physical interactions between phospholipid monolayer and AuNPs 
in a well-defined composition. Based on the optical appearance of LCs, we observed that 
the disruption of the L-DPLC monolayer by negatively-charged AuNPs was minimal. In 
contrast, the monoalyer was more susceptible to disruption by protein-coated AuNPs. 
The type of protein used for AuNP coating was found to affect the monolayer disruption. 
Furthermore, our results suggest that hydrophobic interaction plays a major role in the 
disruption of the L-DLPC monolayers by protein-coated AuNPs. Non-specific 
interactions are often overlooked when considering the interactions between 
nanoparticles and phospholipid cell membrane but they may offer unexplored pathway 
for nanoparticle uptake by biological cells. This study offers a useful platform to 
investigate physical interaction between nanoparticles and phospholipid membrane, 
where LC is used as a signal-readout medium to reflect the molecular interaction between 
phospholipids and nanoparticles. Results obtained from this study may offer new 
information to understand the potential cytotoxicity of nanomaterials, where the 
interaction between nanoparticles and cell membrane is an important step.  
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CHAPTER 7. Effect of cholesterol on nanoparticle binding to liquid 
crystal-supported cell membrane model 
 
7.1 Introduction 
Engineered nanomaterials with their novel and tunable physicochemical 
properties are of great interest for use in diverse fields including in chemical 
manufacturing, medicine, personal care, electronics, sensor and catalysis.[1-4] Commercial 
products that contain engineered nanomaterials, such as cosmetics, sunscreens, sporting 
goods, automotive components and semiconductors, are already being used and are 
expected to grow significantly in the coming years. Moreover, engineered nanomaterials 
are also increasingly used in medical applications in vivo, such as in imaging, diagnosis 
and therapeutics. With the hikes in such uses, there is an increasing concern on the 
toxicity and long-term adverse effects of these nanomaterials on humans and 
environments.[2, 4-6] In addition, it has been found that nanomaterials can exhibit 
unusually high reactivity because of the high percentage of surface atoms in these 
materials.[2] Therefore, over the past 5-6 years, engineered nanomaterials have been a 
focus of evaluation on their adsorption, distribution, metabolism, excretion and toxicity 
(ADMET) prior to their validity for applications.[2, 4-12]  
The biophysical interactions between engineered nanomaterials and cell 
membrane play key roles in determining the nanomaterial binding, which can trigger 
subsequent penetration and internalization of nanomaterials by the cells.[9, 13-17] The 
information on the details of these interactions can be crucial in establishing nanotoxicity 
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pathway as well as in designing better nanomaterials with improved performance and 
minimum toxicity. Up to date, however, this information is still very limited.  
Understanding the biophysical interactions between nanomaterials and cell 
membrane through cellular studies is not an easy task because (1) various components 
present in the biological fluids or culture media can adsorb onto nanomaterial surfaces, 
alter the surface properties of nanomaterials and affect nanomaterial interactions with cell 
membrane; (2) the cell membrane is a complex surface with various compositions and 
fluidity characteristics. As a result, analyzing the details of interactions between 
nanomaterials and cell membrane by exposing the cells directly to nanomaterials usually 
leads to inconclusive interpretation. A model system of cell membrane and nanomaterials 
with well-defined composition can complement the cellular studies and is useful for 
studying the details of interactions between nanomaterials and cell membrane.   
Recently, Peetla et al. have systematically studied the interactions between a 
monolayer of phospholipid cell membrane at aqueous-air interface and polystyrene 
nanoparticles with different surface chemistry using surface pressure-area isotherm 
measurements and atomic force microscopy.[15] They found that aminated and plain 
polystyrene nanoparticles interact with and reorganize the phospholipid monolayer. 
However, carboxylated particles exhibit negligible interaction with the phospholipid 
monolayer. The same group also showed that phospholipids interact more strongly with 
polystyrene nanoparticles coated with dichained cationic surfactants than the ones coated 
with single-chained cationic surfactants.[16] In another study, Banerji et al. showed that 
simple diffusion of gold nanoparticles (AuNPs) across phospholipid vesicles is unlikely 
to occur.[18] 
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The interaction between nanomaterials and cells is believed to strongly depend on 
the type and surface modification of nanomaterials.[8, 14, 17] The latter can make toxic 
nanomaterials less toxic or relatively non-toxic nanomaterials more toxic. In reality, 
protein adsorption on foreign particle surface is inevitable when the particles enter human 
body.[7, 9, 11, 13, 19-22] As a result, it is likely that cells interact with protein-coated 
nanomaterials instead of bare ones. Recently, we have reported an easily visualized liquid 
crystal (LC)-based system to study the interactions between protein-coated AuNPs and 
LC-supported cell membrane model. The model consisted of a phospholipid monolayer 
self-assembled at the aqueous-LC interface.[13] Protein-coated AuNPs were found to 
disrupt the L-α-dilauroyl phosphatidylcholine (L-DLPC) phospholipid monolayer, 
leading to the orientational transitions of LCs that support the phospholipid layer. The 
degree of monolayer disruption depends on the types of proteins adsorbed on the AuNP 
surface. The monolayer disruption is likely caused by hydrophobic interaction and not 
electrostatic forces. 
Besides phospholipid, cholesterol is another main constituent of cell 
membranes.[23, 24] In eukaryotic cell membranes, cholesterol can constitute up to one 
molecule for every phospholipid molecule. Furthermore, cholesterol is known to regulate 
the fluidity and permeability of membrane phospholipid bilayer.[23, 24] For example, 
incorporation of cholesterol into phospholipid liposome has been shown to decrease the 
rate of water permeability into the liposome[25], and the addition of cholesterol to 
phospholipid monolayer has been found to restrict the penetration of hydrophobic 
paclitaxel drug.[26] In contrast, other studies have reported that amphiphilic polymer 
Pluronic F68 and amphiphilic oligopeptide model of apolipoprotein A-I have higher 
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binding affinity to mixed phospholipid/cholesterol monolayers than pure 
phospholipids.[27, 28] In addition, cholesterol has also been shown to reduce the free 
energy barrier for crossmembrane transport of anesthetic molecules, such as CHCl3.[24] 
These past studies suggest that the presence of cholesterol in cell membrane does block 
the insertion of certain molecules into the cell membrane, but it can also facilitate binding 
of some other molecules to the cell membrane. To the best of our knowledge, however, 
the effect of cholesterol on the binding of nanomaterials to cell membrane has not been 
studied yet.  
Building on the findings shown in Chapter 6, here we investigated the biophysical 
interactions between supported phospholipid/cholesterol monolayer self-assembled at 
aqueous-LC interface and protein-coated AuNPs. After the phospholipid/cholesterol 
monolayer was self-assembled at the aqueous-LC interface, protein-coated AuNPs were 
then added into the system to investigate their effects on the integrity of the monolayer. 
The orientation of LCs that corresponds to the disruption of the monolayer was examined 
by monitoring the optical images of LCs under crossed-polarizers.  
 
7.2 Experimental Section 
7.2.1 Materials 
Tris(hydroxymethyl)aminomethane (Tris), phosphate-buffered saline (PBS), 
sodium acetate, sodium chloride (NaCl), hydrochloric acid (HCl), sulfuric acid (H2SO4), 
hydrogen peroxide (H2O2), sodium hydroxide (NaOH), ethanol, chloroform, acetone, 
methanol, capillary tubes, chambered coverglass system, N,N-dimethyl-N-octadecyl-3-
aminopropyl trimethoxysilyl chloride (DMOAP), cholesterol, bovine serum albumin 
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(BSA), human fibrinogen, horseradish peroxidase (HRP), tetramethylbenzidine (TMB), 
HAuCl4.3H2O and sodium citrate were obtained from Sigma-Aldrich (St. Louis, U.S.A.). 
L-α-dilauroyl phosphatidylcholine (L-DLPC) and 1,2-dipalmitoyl-sn-glycero-3-
phosphoethanolamine-N-(cap biotinyl) (biotin-capped phospholipid) were obtained from 
Avanti Polar Lipids (Alabaster, U.S.A.). Liquid crystal 4’-pentyl-4-cyanobiphenyl (5CB) 
and Veco gold grids 75 mesh (20-μm thickness, 283-μm grid spacing, and 50-μm bar 
width) were obtained from Electron Microscopy Sciences (New York, U.S.A.). The glass 
microscope slides were obtained from Marienfeld (Germany). All chemicals were used as 
obtained. Ultrapure water (resistivity of 18.2 MΩ cm) was obtained using a Milli-Q 
system.  
 
7.2.2 Preparation of phospholipid, cholesterol and mixed phospholipid/cholesterol 
solutions 
Phospholipid, cholesterol and mixed phospholipid/cholesterol solutions were 
prepared following standard procedures in the literatures.[13, 29-32] Briefly, L-DLPC, or 
cholesterol or L-DLPC/cholesterol mixture at various cholesterol molar compositions (5, 
10, 20, 30, 50%) were dissolved in chloroform, dried under a stream of nitrogen gas and 
placed under vacuum for at least 3 h. The dried films of either L-DLPC, or cholesterol, or 
mixed L-DLPC/cholesterol were resuspended with Tris-buffered saline (TBS, consisting 
of 10 mM Tris, 150 mM NaCl at pH 8.9) to a final concentration of 0.1 mM. The 
resulting solution was cloudy, indicating the presence of large multilamellar vesicles 
(MLV). The L-DLPC, or cholesterol or mixed L-DLPC/cholesterol suspensions were 
then sonicated (VCX 130pb, Sonics and Materials Inc.) subsequently three times for 5 
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min each to obtain a clear solution. The solution was typically used within 2 days after 
preparation.  
 
7.2.3 Preparation of DMOAP-coated glass slides 
DMOAP-coated glass slides were prepared according to published procedure.[13, 
33] Briefly, the slides were cleaned in piranha solution (70% (v/v) H2SO4 and 30% (v/v) 
H2O2) for 1 h at ~80°C (warning: piranha solution reacts strongly with organic 
compounds and should be handled with extreme caution; do not store the solution in 
closed containers). The slides were then rinsed thoroughly with ultrapure water. A 0.1% 
v/v of DMOAP solution in ultrapure water was prepared and the clean glass slides were 
dipped into this solution for 5 min at room temperature. The DMOAP-coated glass slides 
were then rinsed with ultrapure water and dried under a stream of nitrogen gas. Finally, 
they were put into 100°C oven for at least 3 h to allow for cross-linking of the DMOAP 
molecules onto the surface of glass through Si-O-Si covalent bonds. 
 
7.2.4 Preparation of optical cells  
An optical cell was prepared as a platform for the formation of a supported lipid 
monolayer at the aqueous-LC interface (Figure 7.1). Gold specimen grids were cleaned 
sequentially in ethanol, chloroform, acetone and methanol, and were heated at 100°C 
overnight. The gold grids were then placed on DMOAP-coated glass slide and 
impregnated with ~0.2 μL of 5CB using a capillary tube (Figure 7.1A). Excess 5CB was 
removed by blotting it with the other end of capillary tube. The optical textures of 5CB 
supported on DMOAP-coated slides were examined using polarized microscopy to 
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confirm the homeotropic anchoring of 5CB. Any sample not exhibiting homeotropic 
anchoring was rejected. The optical cells were then immersed into a chambered 
coverglass system containing aqueous samples of interest (Figure 7.1B). The system was 









Figure 7.1. (A) Schematic illustration and (B) photograph of the optical cell used in 
nanoparticle interaction experiments. Scale bar ~ 1.5 cm. 
 
7.2.5 Optical examination of LC orientation  
The optical images of 5CB were examined using a Nikon eclipse LV100 POL 
microscope equipped with crossed-polarizers in a transmission mode. The optical cell 
was placed on a rotating stage between two polarizers. Orthoscopic examinations were 
performed with light intensity of ~70% full illumination and the aperture of ~30% full 
opening in order to collimate the incident light. Homeotropic orientation was determined 
by observing the absence of transmitted light during a 360° rotation of the sample. Planar 
orientation was determined by a bright and birefringence appearance of 5CB when the 
sample was observed between crossed-polarizers. A reference for the description of the 
LC orientation can be found elsewhere.[34, 35] All images were captured using a digital 
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7.2.6 Self-assembly of phospholipid/cholesterol monolayer at aqueous-LC interface 
The self-assemblies of phospholipid, cholesterol, mixed phospholipid/cholesterol 
at the aqueous-LC interface were conducted by immersing the optical cell into an 
aqueous solution containing 100 μM of either L-DLPC, or cholesterol, or mixed L-
DLPC/cholesterol respectively for 2 h.[13, 29, 30] At the end of the self-assembly process, 
the optical cell was flushed with fresh buffer containing no phospholipid and cholesterol 
to remove any excess of L-DLPC and cholesterol. In the case of L-DLPC and mixed L-
DLPC/cholesterol, samples which did not show homeotropic anchoring of the 5CB were 
discarded. The resulting L-DLPC and mixed L-DLPC/cholesterol monolayers were stable 
in TBS buffer for at least five days in our experiments.[13]  
 
7.2.7 Oxidation of cholesterol at aqueous-LC interface using cholesterol oxidase 
Films of 5CB were exposed to PBS solution (pH of 7.4) containing 100 μM of 
mixed L-DLPC/cholesterol at equimolar ratio for 2 h. The films were then washed and 
exposed to another PBS solution containing 100 nM of cholesterol oxidase for 1 h. As 
much as 245 μL of sample was taken from this solution and was mixed with 1.5 mL of 
TMB (0.09 mg) and 20 μL of HRP (5 μg).[36] The reaction was stopped by adding 20 μl 
of 1M H2SO4. The colour change was photographed and the corresponding optical 
absorbance was measured using UV-Vis spectroscopy.  
 
7.2.8 Preparation of gold nanoparticle solution 
Citrate-stabilized gold nanoparticle (AuNP) solution with 20 nm diameter and 2 
nM concentration was prepared using published procedure.[37] Briefly, 20 mg of 
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HAuCl4.3H2O was dissolved into 95 mL of ultrapure water. This chloroauric solution 
was heated to boiling, and 5 mL of 2% sodium citrate solution was then introduced. The 
solution was refluxed for 30 min and then left to cool to room temperature. 
 
7.2.9 Protein adsorption on gold nanoparticles 
The protein adsorption and saturation on AuNPs was prepared following 
procedures in the literatures.[13, 22] In brief, AuNPs solution was first centrifuged to 
remove the supernatant. Protein solution was then mixed with AuNPs at a ratio of 375 
(number of protein molecules/number of AuNPs). The mixture was then incubated for 
~10 h. Subsequently, the AuNPs were rinsed with TBS buffer twice and reconstituted 
with the same buffer. The protein-coated AuNPs were stable for more than a month in the 
buffer solution. Time-series dynamic light scattering (DLS) experiments showed that the 
size of protein-coated AuNPs exhibited negligible change after 2 h protein coating (data 
not shown). Thus the 10 h incubation time used here assured a state of saturated coating 
on AuNPs. The size of the coated AuNPs was found to be the same for at least 3 days 
after the initial DLS measurement, indicating no or negligible protein desorption from the 
AuNP surface. Additional desorption experiment with FITC-labeled BSA also showed 
negligible BSA desorption from AuNPs. 
 
7.3 Results and Discussion 
7.3.1 Self-assembly of phospholipids and cholesterol at aqueous-LC interface 
Studies have reported that amphiphiles can be self-assembled at aqueous-LC 
interface through hydrophobic interactions between hydrocarbon chains of amphiphiles 
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and LC molecules.[13, 30, 31, 38, 39] The orientation of LCs at the interface is very sensitive to 
spatial and temporal organization of the amphiphiles. When 5CB films were immersed 
into TBS solution containing 100 μM of L-DLPC, the optical appearance of 5CB was 
initially bright (Figure 7.2A top), which corresponds to a planar (parallel to the interface) 
orientation of 5CB at the aqueous-LC interface (Figure 7.2A bottom schematic). Changes 
in the optical appearance of 5CB from bright to dark were observed over time (Figure 
7.2B top), which corresponds to changes in the orientation of 5CB at the aqueous-LC 
interface from planar to homeotropic, i.e. perpendicular to the interface (Figure 7.2B 
bottom schematic). These changes are in good agreement with past studies and reflect the 
self-assembly of L-DLPC monolayer at aqueous-LC interfaces.[13, 30-32] When these 5CB 
films laden with L-DLPC monolayer were washed with fresh TBS solution, the optical 
appearance of 5CB remained dark (same as Figure 7.2B top) even after 5 days. These 
results suggest that the L-DLPC monolayer does not desorb from aqueous-LC interface 
after being washed with fresh buffer and this phospholipid monolayer is stable at the 
interface. L-DLPC was used in this study because phospholipids with the 
phosphorylcholine head group are the major constituents at the outer cell membrane. 
To investigate the self-assembly of amphiphilic cholesterol at aqueous-LC 
interface and its coupling to the orientational transition of LCs, we exposed 5CB films to 
TBS solution containing 100 μM of cholesterol. As shown in Figure 7.3A, we observed 
the optical appearance of 5CB to contain a mixture of dark and bright domains, 
suggesting that there is some degree of self-assembly of cholesterol at aqueous-5CB 
interface. The mixture of dark and bright domains remained even after subsequently 
incubating the films to fresh TBS solution containing no cholesterol (Figure 7.3B), 
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suggesting that the self-assembled cholesterol is still intact at aqueous-LC interface upon 
exchanging the solution.  
 












Figure 7.2. Cross-polarized optical images of 5CB confined within gold grids supported 
on DMOAP-coated glass (top) and the schematic of the aqueous-5CB interface (bottom) 
after being immersed into 100 μM of L-DLPC solution for (A) < 30s and (B) 60 min. 
Scale bar = 283 μm. 
 
 To further confirm the presence of cholesterol at aqueous-LC interface, we 
performed an oxidation reaction of the cholesterol catalyzed by cholesterol oxidase. This 







   
 
 





     
 
 






           
          




    
 
 
     







      






~20µm 5CB Film 
     
 
   
       
 
  
           
 
 
        






     
   



























 144  
catalyzed by HRP to produce a distinct coloured product. Two films of 5CB, one was  
 
 
    
 
Figure 7.3. Cross-polarized optical images of 5CB (A) after being exposed to 100 μM of 
cholesterol and (B) after subsequently being flushed with fresh buffer. Scale bar = 283 
μm.   
 
laden with mixed L-DLPC/cholesterol and the other with L-DLPC only, were exposed to 
100 nM of cholesterol oxidase. Samples from each solution were subsequently mixed 
with TMB and HRP. For the sample from mixed L-DLPC/cholesterol, we observed a 
blue colour solution (Figure 7.4, inset A, left vial).[36] In contrast, the sample from L-
DLPC only was colourless (Figure 7.4, inset A, right vial). UV-Vis spectroscopy 
measurements of these two solutions showed absorbance at 650 nm (Figure 7.4, red line) 
for mixed L-DLPC/cholesterol sample but no measurable absorbance (Figure 7.4, green 
line) for L-DLPC sample. Addition of H2SO4 into the mixed L-DLPC/cholesterol sample 
further oxidized TMB and changed the solution colour from blue to yellow (Figure 7.4, 
inset B left vial) and shifted the absorbance peak to 450 nm (Figure 7.4, blue line).[36] The 
L-DLPC only sample remained colourless (Figure 7.4, inset B right vial). These results 
further confirm that the cholesterol present at aqueous-LC interface. Our observation is 
A B 
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consistent with previous studies that reported the formation of one-electron oxidation 
product of TMB (blue colour) through H2O2 catalyzed by HRP and two-electron 


















Figure 7.4. Absorbances (graph) and photographs (insets) of solutions containing 
samples from mixed L-DLPC/cholesterol (red line, blue line and left vial in both inset) or 
L-DLPC only (green line and right vial in both inset A & B), which have been exposed to 
cholesterol oxidase, and subsequently mixed with TMB and HRP. In the case of blue line 
and left vial in inset B, H2SO4 was further added. 
 
7.3.2 Interactions between mixed phospholipid-cholesterol monolayer and protein-
coated gold nanoparticles 
 Adsorption of protein on the surface of nanoparticles is expected to occur when 
nanoparticles contact body fluid. Consequently, cell membrane is likely to interact with 
protein-coated nanoparticles instead of bare ones. In addition, stabilization of 
nanoparticles using proteins is a common method used in immunochemistry, cell 
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nanoparticles to a biological body even higher.[3, 20, 22] The adsorbed protein on 
nanoparticles may facilitate nanoparticles binding to transmembrane receptors and induce 
specific receptor-mediated endocytosis. The protein-coated nanoparticles may also bind 
onto cell membrane non-specifically, and subsequently be internalized through normal 
metabolic endocytosis (i.e. not receptor-mediated endocytosis). In addition, it is not 
known whether direct penetration of nanoparticles through cell membrane can occur if 
the binding of nanoparticles elicits sufficient disruption on the phospholipid membrane. 
 To understand further the interaction between protein-coated nanoparticles and 
cell membrane, we coated AuNPs with two different proteins (BSA and fibrinogen) and 
exposed them to 5CB films laden with the mixed phospholipid/cholesterol monolayer. 
Because desorption of proteins from AuNP surface was not observed (See Section 2.9 for 
details), we assumed that there was no free protein available in the solution for binding 
with the mixed L-DLPC/cholesterol monolayer. After exposing 50 nM protein-coated 
AuNPs to 5CB films laden with mixed L-DLPC/cholesterol monolayers at various 
cholesterol compositions (0, 5, 10, 20, 30, and 50 mol%), optical appearances of 5CB 
from dark to bright red were observed in all samples (Figure 7.5A and B inset). The red 
colour was caused by the presence of AuNPs in the solution. For BSA-coated AuNPs and 
for the monolayer with 0, 5, and 10 mol% cholesterol, the optical appearance changed to 
fully bright red after 40 h (Figure 7.5A). For 20 mol% cholesterol, the fully red 
appearance occurred after 34 h. For 30 and 50 mol% cholesterol, the fully red appearance 
occurred after 30 h. A similar trend was observed when the 5CB films were exposed to 
fibrinogen-coated AuNPs, but the LC transition occurred much faster (Figure 7.5B). For 
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0, 5, and 10 mol% cholesterol, the fully bright red appearance occurred after 2 h. whereas 









0 10 20 30 40 50




























0 10 20 30 40 50







Figure 7.5. Time responses of 5CB films with mixed L-DLPC/cholesterol monolayer at 
the aqueous-LC interface after exposing to 50 nM of either (A) BSA-coated AuNPs or (B) 
fibrinogen-coated AuNPs in TBS solution at pH of 8.9. Cholesterol molar compositions 
in the solution were 0, 5, 10, 20, 30 and 50 mol%. Insets show the corresponding cross-
polarized optical images of 5CB (left) before and (right) after exposure to AuNPs. Scale 
bar = 283 μm.  
A 
B 
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These results suggest that the mixed phospholipid/cholesterol monolayers with higher 
cholesterol content are more susceptible to bind with protein-coated AuNPs. Based on 
previous studies, a possible explanation for these findings is that the cholesterol can 
create free spaces between phospholipid headgroups in the mixed 
phospholipid/cholesterol layers, and these free spaces can accommodate amphiphilic 
molecules to bind on the layers.[28] Other recent cellular studies also reported that the 
cellular uptake of alkyl-capped silicon nanocrystals is cholesterol-dependent, and 
liposome-encapsulated AuNPs can be uptaken through caveolae, the domains with high 
cholesterol content in cell membrane.[40, 41] The reason for the faster interaction for 
fibrinogen-coated AuNPs compared to BSA-coated ones is currently unknown. It may be 
due to the more surface-adhesive nature of fibrinogen compared to BSA[19, 42, 43] but 
further investigation is required.  
 
7.3.3 Driving force for the disruption of mixed phospholipid/cholesterol monolayer 
by protein-coated AuNPs 
 We next investigated the driving force in the disruption of mixed 
phospholipid/cholesterol monolayer by protein-coated AuNPs. Based on the zeta 
potential measurements (Table 7.1), the charge of uncoated AuNPs (-39.5 mV) was 
significantly higher than those of all protein-coated AuNPs measured. BSA and 
fibrinogen-coated AuNPs exhibited the zeta potentials of -12.9 and -10.6 mV respectively. 
There was no significant difference when the zeta potential of these two protein-coated 
AuNPs were compared. Likewise, minimal difference was found in the zeta potential of 
mixed L-DLPC/cholesterol at different molar ratios (Table 7.1). Since all components 
 149  
exhibited negative zeta potential, electrostatic interaction is unlikely to play a major role 
in the different degree of mixed L-DLPC/cholesterol disruption by the three protein-
coated AuNPs shown here.  
 
Table 7.1. Zeta potential of citrate-stabilized AuNPs, protein-coated AuNPs and mixed 
L-DLPC/cholesterol. 
 





L-DLPC/cholesterol (100/0) -2.4 
L-DLPC/cholesterol (80/20) -2.78 
L-DLPC/cholesterol (60/40) -2.79 
 
To further investigate whether hydrophobic interaction can also be the main 
driving force in the disruption of the mixed phospholipid/cholesterol monolayer by 
protein-coated AuNPs, we exposed 5CB films, which were first self-assembled with 
mixed L-DLPC/cholesterol, to 50 nM of BSA or fibrinogen-coated AuNPs at pH equal to 
isoelectric point (pI) of the respective proteins. In this condition, the electrostatic 
interaction between protein-coated AuNPs and mixed phospholipid/cholesterol 
monolayer is assumed to be minimal. Sodium acetate buffers at pH of 4.8 (pI of BSA) 
and 5.5 (pI of fibrinogen) were used to prepare the BSA and fibrinogen coated AuNP 
solutions respectively. For both cases, we observed changes in the optical appearances of 
5CB from dark to bright red much faster than the previous cases when TBS buffer at pH 
of 8.9 was used (Figure 7.6A and B insets). In the case of BSA-coated AuNPs, the fully  
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Figure 7.6. Time responses of 5CB films with mixed L-DLPC/cholesterol monolayer at 
the aqueous-LC interface after exposing to 50 nM of either (A) BSA-coated AuNPs at pH 
4.8 or (B) fibrinogen-coated AuNPs at pH 5.5. Cholesterol molar compositions in the 
solution were 0, 5, 10, 20, 30 and 50 mol%. Insets show the corresponding cross-
polarized optical images of 5CB before (left) and after (right) exposure to AuNPs. Scale 
bar = 283 μm.  
A 
B 
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bright red optical appearances of 5CB was observed after 8h for 0, 5 and 10 mol% 
cholesterol and after 6h for 20, 30 and 50 mol% cholesterol (Figure 7.6A). In the case of 
fibrinogen-coated AuNPs, the fully bright red appearances was observed after 1.5 h for 0, 
5 and 10 mol% cholesterol and after 1 h for 20%, 30 and 50 mol% cholesterol (Figure 
7.6B). In the control experiment where 5CB films laden with mixed L-DLPC/cholesterol 
monolayer were exposed to sodium acetate buffers at pH of either 4.8 or 5.5, the optical 
appearances of 5CB remained dark for more than 24h, indicating that the mixed L-
DLPC/cholesterol monolayer was still intact under the different buffer conditions. Since 
the electrostatic interaction between mixed L-DLPC/cholesterol and protein-coated 
AuNPs is minimal at pI of respective proteins, the fast LC responses observed in Figure 
7.6 likely indicate that the hydrophobic interaction mainly contributes to the binding and 
disruption of the mixed L-DLPC/cholesterol monolayer by protein-coated AuNPs. 
Furthermore, we observed that the binding rates were faster with higher cholesterol 
content, similar to what we observed when using TBS buffer at pH of 8.9.  
 
7.3.4 Comparison of specific and non-specific interactions between protein-coated 
gold nanoparticles and LC-supported cell membrane model 
 Non-specific interactions are often overlooked when considering the interactions 
between nanoparticles and cell membrane but they may offer unexplored pathway for 
nanoparticle uptake by biological cells. To compare the specific and non-specific 
interactions between protein-coated nanoparticles and cell membrane model, we prepared 
neutravidin-coated AuNPs and exposed them to two films of 5CB, one was laden with 
mixed L-DLPC/biotin-capped phospholipid and the other with mixed L-
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DLPC/cholesterol. In this model, binding of neutravidin-coated AuNPs to mixed L-
DLPC/biotin-capped phospholipid represent specific interactions while binding of the 
same nanoparticles to mixed L-DLPC/cholesterol represent non-specific ones. In the 
former case, we observed the fully bright red appearance of 5CB after 1.5h (Figure 7.7A). 
In the latter case, however, the fully bright red appearance was observed only after 12h 
(Figure 7.7B). These results indicate that the specific binding rate between neutravidin-
coated AuNPs and the mixed L-DLPC/biotin-capped phospholipid monolayer is faster 
than the non-specific binding rate between the same AuNPs and the mixed L-
DLPC/cholesterol monolayer. However, when the mixed L-DLPC/cholesterol monolayer 
was exposed to fibrinogen-coated AuNPs, the bright red appearance of 5CB was 
observed after 1.5h (Figure 7.7C). The time-scale of this change is similar to the binding 
of neutravidin-coated AuNPs to the mixed L-DLPC/biotin-capped phospholipid 
monolayer (Figure 8A), and is faster compared to the binding of neutravidin-coated 
AuNPs to the mixed L-DLPC/cholesterol monolayer (Figure 7.7B). These results 
highlight that the types of proteins adsorbed on nanomaterial surfaces may determine the 
rate of nanomaterial non-specific interactions with cell membrane. Studies have shown 
that replacement of the low surface affinity proteins on nanomaterial surfaces with the 
higher affinity ones can occur through the Vroman effect.[44, 45] This replacement can 
alter the surface properties of the nanomaterials and can determine the in vivo fate of 
these nanomaterials. Our results suggest that a similar nanomaterial, when decorated with 
different proteins, can have different rate of non-specific binding to cell membrane, in 
which, the rate, in some situation, can be comparable to specific binding events. 
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 The results on protein-coated AuNPs presented in this work can be relevant to the 
real events when nanoparticles enter human body as protein adsorption inevitably occurs 
onto the surface of foreign particles. Phospholipid and cholesterol are two main  
 
    
 
 
Figure 7.7. Cross-polarized optical images of 5CB which have been exposed to (A) 
mixed L-DLPC/biotin-capped phospholipid, (B,C) mixed L-DLPC/cholesterol at 
equimolar composition, and subsequently exposed to 50 nM of (A,B) neutravidin-coated 
AuNPs, (C) fibrinogen-coated AuNPs in PBS solution. Scale bar = 283 μm. 
 
constituents of cell membrane and their non-specific binding with protein-coated 
nanomaterials can play important roles in the nanomaterial uptake by the cells. 
Furthermore, domains of high and low cholesterol contents coexist in cell membrane. 
Caveolae and lipid rafts are the examples of rich-cholesterol domains in cell membrane. 
Both of these domains are known to involve in endocytic pathway.[46, 47] Recent studies 
have shown that the cellular uptakes of some nanomaterials is cholesterol-dependent and 
can be through caveolae domains.[40, 41] The internalization of nanomaterials can also 
occur through other routes, such as clathrin-mediated endocytosis, pinocytosis, hole 
formation and direct passage of plasma membrane.[7, 14, 17, 41] It is likely that 
nanomaterials enter the cells through more than one route, but any factors that favour a 
A C B 
1.5 h 12 h 1.5 h 
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particular route is not well understood. Therefore, studying interactions between 
nanomaterials and a model cell membrane can be useful in understanding how 
nanomaterials interact with, bind with and enter into the cell membrane. At this stage, 
however, it is premature to speculate whether the observed interaction can lead to other 
adverse consequences such as membrane integrity compromise, transmembrane protein 
disruption, or nanoparticle penetration into the cytoplasm observed in other studies. More 
work is required to confirm the effects of nanoparticle binding on cell membranes. 
 
7.4 Conclusion 
We have studied the effect of cholesterol on the biophysical interactions between 
protein-coated gold nanoparticles (AuNPs) and supported phospholipid/cholesterol 
monolayer self-assembled at aqueous-LC interface. Protein-coated AuNPs were found to 
disrupt the mixed phospholipid/cholesterol monolayer. As a result, orientational 
transitions of LCs were triggered and  optical responses of LCs from dark to bright red 
were observed. We found that the mixed monolayers with higher cholesterol contents are 
more susceptible to the disruption by protein-coated AuNPs. The disruption of the mixed 
monolayer was found to be dependent on the types of proteins (albumin and fibrinogen) 
adsorbing onto AuNP surfaces. Furthermore, our results suggest that hydrophobic 
interaction plays a major role in the monolayer disruption. Finally, we found that the time 
for non-specific binding of fibrinogen-coated AuNPs to the mixed 
phospholipid/cholesterol monolayer was similar to that of specific binding of neutravidin-
coated AuNPs to the mixed phospholipid/biotin-capped phospholipid monolayer. Results 
obtained from this study may offer new understanding in the potential nanotoxicity 
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pathway, where the biophysical interaction between nanomaterials and cell membrane is 
an important step.  
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CHAPTER 8. Conclusions and Recommendations 
 
8.1 Conclusions 
 Throughout this thesis, the use of thermotropic liquid crystals (LCs) for 
characterizing biomolecules and nanomaterials was explored. A novel air-supported LC 
system for analyzing interfacial phenomena occurred based on the molecular interaction 
between LCs and adsorbed molecules of interest at the aqueous-LC interface was 
developed. Compared with existing LC-based system, the miniature air-supported LC 
system requires less sample quantity and involves simpler preparation. Using this system, 
we characterized the enzymatic hydrolysis of various phospholipases such as 
phospholipase A2 (PLA2), phospholipase C (PLC) and phospholipase D (PLD). The 
hydrolysis of phospholipid monolayer self-assembled at aqueous-LC interface induced an 
orientational response of LCs. As a result, optical signal that reflected the spatial and 
temporal distribution of phospholipids during the enzymatic reaction could therefore be 
generated in a real-time manner. When well-known phospholipase inhibitors were 
introduced together with respective phospholipases, no orientational response of LCs was 
observed. In the case of inhibitors MJ33 and compound 48/80, cross-inhibitions among 
phospholipases were also observed.  
 The air-supported LC system was also used as a sensor for real-time and label-
free identification of phospholipase-like toxins. Beta-bungarotoxin exhibits Ca2+-
dependent phospholipase A2 activity whereas alpha-bungarotoxin and myotoxin II do not 
exhibit any phospholipase activity. The sensor could selectively identify beta-
bungarotoxin, when it hydrolyzed a phospholipid monolayer self-assembled at aqueous-
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LC interface through orientational responses of LCs. The sensor was very sensitive and 
required less than 5 pg of beta-bungarotoxin for the detection. When phospholipase A2 
inhibitors were introduced together with beta-bungarotoxin, no orientational response of 
LCs could be observed. In addition, the regeneration of the sensor could be done without 
affecting the sensing performance. This work demonstrates that the air-supported LC 
system provides a facile real-time and label-free sensor for characterizing the activities of 
phospholipases and phospholipase-like toxins, as well as for screening their inhibitors.  
 Furthermore, the use of air-supported LC system has been expanded for other 
biomolecule characterization, specifically for characterizing protein-protein binding 
events. To achieve this, a novel method of immobilizing proteins with well-defined 
orientation directly on liquid crystal surfaces was employed. This subsequently allowed 
direct real-time detection of specific protein-protein binding without multiple 
experimental steps. Self-assembly of nitrilotriacetic acid (NTA)-terminated amphiphiles 
loaded with Ni2+ ions at aqueous-LC interface generated liquid crystal surfaces capable 
for immobilizing histidine-tagged ubiquitin through complex formation between Ni2+ and 
histidine. When these surfaces containing immobilized histidine-tagged ubiquitin were 
exposed to anti-ubiquitin antibody, the spatial and temporal of specific protein-protein 
binding events triggered orientational transitions of liquid crystals. These transitions can 
easily be visualized under crossed polarizers as sharp LC switching from dark to bright. 
The protein-protein binding can be observed within seconds and only requires nanogram 
quantities of proteins. This work demonstrates a simple strategy to immobilize proteins 
with well-defined orientation on LC surfaces for real-time and label-free detection of 
specific protein-protein binding events, which may find use in biomedical diagnostics. 
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Besides biomolecule characterization, the use of LCs for nanomaterial 
characterization has also been explored. Based on the optical appearance of LCs, protein-
coated gold nanoparticles were found to disrupt cell membrane model system consisting 
of either phospholipid or mixed phospholipid/cholesterol monolayers self-assembled at 
aqueous-LC interface. The monolayer disruption depended strongly on the type of protein 
(albumin, neutravidin and fibrinogen) adsorbing onto nanoparticle surfaces. In addition, 
hydrophobic interaction was found to play a major role in the disruption. Furthermore, 
mixed phospholipid/cholesterol monolayers with higher cholesterol contents were more 
susceptible to the disruption by protein-coated gold nanoparticles. This work offers an 
easily-visualized platform to investigate biophysical interaction between nanomaterials 
and cell membrane model system, where LC is used as a signal-readout medium to reflect 
the molecular interaction between cell membrane constituents and nanomaterials. Results 
obtained from this study may offer new understanding in the potential nanotoxicity 
pathway, where the biophysical interaction between nanomaterials and cell membrane is 
an important step.  
 
8.2 Recommendations 
As the interactions between nanomaterials and biological cells depend strongly on 
the surface functionalization of nanomaterials, recent studies have shown that gold 
nanoparticles functionalized with subnanometre striations of alternating anionic and 
hydrophobic groups can penetrate the plasma membrane of the dendritic and fibroblast 
cells without bilayer disruption.[1, 2] For future studies, it is interesting to investigate how 
these nanoparticles interact with liquid crystal-supported cell membrane model system. 
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The information on the details of these interactions may elucidate the mechanism by 
which these nanoparticles can slip through the cell membrane barrier. 
Furthermore, diverse engineered nanomaterials with their novel and tunable 
physicochemical properties have been produced for use in diverse fields including in 
chemical manufacturing, medicine, personal care, electronics, sensor and catalysis. 
Besides gold nanoparticles, semiconductor quantum dots (QDs) and magnetic iron oxide 
nanoparticles are amongst the most popular nanoparticles to be used, especially in 
biomedical application in vivo, such as bioimaging, diagnostics and therapeutics.[3-5] 
Therefore, using LCs as a sensing platform to probe the biophysical interactions of QDs/ 
iron oxide nanoparticles with cell membrane constituents can be of great interest. The 
detailed information on these interactions can be crucial in establishing possible 
nanotoxicity pathway of these two types of nanoparticles as well as in designing better 
nanoparticles with improved performance and minimum toxicity. 
 In the case of using LCs for biomolecule characterization, we have demonstrated 
a number of advantages of our air-supported LC system, including high sensitivity and 
small sample quantity. A potential research direction worth to pursue is on real-time and 
label-free detection of DNA hybridization. Since this system can be extended for high 
throughput screening, it can impact the field of disease diagnostic, gene therapy and 
pathogen detection.  
Infectious diseases rank second globally in causing human deaths, making 
diagnosis of the diseases a great importance. Since these diseases are always caused by 
pathogenic agents such as viruses, bacteria, and parasites, detection of these pathogenic 
agents using the air-supported LC system is another potential research direction worth to 
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pursue. One way to realize this detection, for example, is to immobilize recombinant 
antibodies, which specifically recognize certain pathogenic agents, on LC surfaces. 
Genetic engineered antibodies containing histidine tags can further be developed to 
immobilize and orient the antibody molecules on LC surfaces with well-defined 
orientation (as described in Chapter 5). Subsequently, this antibody-decorated LC surface 
can serve as a potential platform for direct real-time and label-free detection of 
pathogenic agents through antibody-pathogen binding events. This LC-based sensor may 
find useful applications in infectious disease diagnostics. 
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